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Background: It has been suggested that dietary habits are associated with multiple sclerosis. 
Some eating patterns have been considered protective while others harmful.  
 
Objectives: A case–control study was used to examine the association between multiple 
sclerosis and the Mediterranean diet, food groups and individual foods. 
 
Methods: A total of 127 multiple sclerosis cases and 718 controls from across The Republic 
of Cyprus completed a self-reported questionnaire which included lifestyle and food 
questions. A 9-unit Mediterranean diet score (MDS) was calculated. Logistic regression was 
used to assess associations. An age-matched analysis of 119 cases and 119 controls was 
evaluated using conditional regression.  
 
Results: In the logistic regression analysis adjusted for age, a higher MDS (OR=0.96, 95% 
CI: 0.93-1.00, p: 0.04) was inversely associated with being a multiple sclerosis case.  
Significant inverse associations were found in the following groups: vegetables (OR=0.83, 
95% CI: 0.70-0.98, p: 0.03) alcohol (OR=0.87, 95% CI: 0.80-0.95, p: 0.001) legumes 
(OR=0.78, 95% CI: 0.64-0.95, p: 0.01) non-refined cereals (OR=0.81, 95% CI: 0.66-0.98, p: 
0.03) while significant associations were found with dairy products (OR=1.24, 95% CI: 1.05-
1.46, p: 0.01).  Similar results were seen in the age-matched conditional regression analysis.  
 
Conclusions: There was found to be a statistically significant association between a 
Mediterranean type diet and multiple sclerosis. There was an inverse association of being a 
multiple sclerosis case, with an increase in the MDS. Certain food groups and individual 
foods may also be associated with an increased or decreased association of being a multiple 
sclerosis case. This study may have significant effects on health planning in The Republic of 
Cyprus. When interpreting the results, there is always the possibility of reverse causality. That 
is, the disease itself, or the diagnosis of the disease, may lead to a change in eating habits. It is 
recommended that a Mediterranean type diet type be considered as a prevention measure to 
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1 Chapter 1. Introduction 
 The Study  
This case-control study in The Republic of Cyprus, compares Mediterranean diet 
adherence between people with multiple sclerosis (the cases) and people without multiple 
sclerosis (the control participants). The rationale for the work is that very few studies 
exist on the subject and none have been performed in Cyprus or Europe before.  
 
1.1.1 An introduction to The Mediterranean Diet 
The Mediterranean diet is not one specific diet. It has existed primarily in the 
Mediterranean basin area for centuries. It is regarded as a rather frugal eating pattern with 
high consumption of fruits, vegetables, whole grains, nuts and legumes. Meat 
consumption, especially red meat and processed meat products is low (Devries Van Horn 
and Willett 2018). Since the early 1960s, the health benefits of the Mediterranean diet 
have been widely documented (Keys 1995) and “robust evidence” is said to exist for 
health benefits of Mediterranean diet adherence in cardiovascular diseases, 
neurodegenerative diseases and diabetes (Dinu et al. 2017). The literature review in 
Chapter 2 will discuss in detail The Mediterranean diet and potential health benefits. 
The role of diet in susceptibility to disease including multiple sclerosis is also dealt with 
in detail in Chapter 2. 
 
1.1.2 Why study multiple sclerosis? 
Multiple sclerosis is a chronic progressive, debilitating disorder of the central nervous 
system, which is probably caused by genetic susceptibility combined with an 
environmental trigger or triggers (Wu and Alvarez 2011). It is an interesting disease for 
study as there remain many unanswered questions. Few case-controls studies involving the 
Mediterranean diet and multiple sclerosis have been published. The Mediterranean diet is 
a lifestyle choice that has been advocated for other chronic disease prevention, but 
insufficient scientific evidence is currently available to recommend it in multiple sclerosis 
prevention.  




1.1.3 Why Cyprus? 
Cyprus is an island situated at a latitude of 35.1264° N, and a longitude of 33.4299° E. 
Latitude or more accurately, distance from the equator, has been regarded as a risk factor 
to acquiring multiple sclerosis (Sundström and Salzer 2013). Other countries 
approximately on the same latitude and within 2000 Km include Crete, Malta, Tunisia, 
Syria, Iraq and Iran. It might be expected that Cyprus would have a similar prevalence of 
multiple sclerosis to the countries on the same latitude and a lower prevalence than some 
more northern countries in Europe. Unfortunately, Cyprus does not have a data base 
recording all multiple sclerosis cases yet, and the prevalence is therefore unknown. 
Anecdotal evidence from current hospital appointments in Cyprus suggests that the 
incidence of multiple sclerosis cases per 100,000 population is higher than countries on 
the same latitude (Charalambidou Pantzaris and Patrikios 2016). This begs the question 
why? Although a definitive answer cannot be given, it is possible that demographics and 
lifestyle are different between Cyprus and other countries on the same latitude. The 
prevalence section of this introduction will deal with this in more detail. 
A brief overview of Cyprus 
Cyprus is the third largest island in the Mediterranean Sea at around 9,251 square 
kilometers. It is 225 kilometers (km) long at its longest point and 96.5 km at its widest 
point (The World Factbook 2016-17). The island is situated in the Eastern 
Mediterranean Sea with its nearest neighbours being Turkey, which lies approximately 
113 km to the north and Syria which lies 120 km to the east. Lebanon and Israel also lie 
to the east being 264 km and 472 km east respectively. To the west, on approximately the 
same latitude, Crete is 785 km away and Rhodes, to the north west, is the nearest of the 
Greek islands (492 km) while Egypt is the nearest country to the south of Cyprus at 
approximately 954 km (The World Factbook 2016-17). The island was effectively 
divided in 1974 after an invasion by Turkey and a UN buffer zone remains unoccupied 
and divides the island into Greek and Turkish territories including the city of Nicosia.  
Gathering research material in the occupied area had significant challenges, so this 
research was confined to The Republic of Cyprus and from this point on, this region will 
be called Cyprus.  
Cyprus has four major cities and 5 districts as shown in Figure 1. Nicosia is the capital 
and the largest city. It has two public hospitals, Nicosia General Hospital and Archbishop 
Makarios lll Hospital, which is the main hospital for children and maternity treatment. 
Most neurology, including consultations for patients with multiple sclerosis occurs at The 
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Cyprus Institute of Neurology and Genetics (CING) which is a public institution in 
Nicosia. Limassol, Larnaca and Paphos have public general hospitals, but multiple 
sclerosis patients are generally referred to CING in Nicosia. Cyprus has numerous private 
hospitals and many small private clinics but multiple sclerosis patients attending these 
private centres can get free prescriptions via the dispensary at CING, so they also attend 
there. 
 





The most recent estimate by The Republic of Cyprus Statistical Service (2017) is that at 
the end of 2016 there were 706,800 Greek Cypriots (74,6%) 92,200 Turkish Cypriots and 
148,000 Foreign residents on the island (excluding illegal settlers from Turkey and 
elsewhere). The total population of the Government controlled area was estimated at 
854,800. Tertiary education attainment in Cyprus, is the 2nd highest in the EU and is 
higher amongst women than men.  About 38% of women aged 25 and over have 
completed tertiary education and by 34 years of age 63.5% of women and 47.2% of men 
have successfully completed tertiary education. Around 58% of women aged 15 years and 
over are in the labour force, and 66% of men. Monthly earnings are around €1,600 for 
women and €2,100 for men.  Cypriots are among the most prosperous people in the 
Mediterranean region with nominal GDP per capita exceeding $28,000 in 2018 (IMF 
2019). Despite this, around 30% of women are said to be at risk of poverty or social 
exclusion. The life expectancy of woman in Cyprus at birth is 83.5 years compared with 
79.8 years for men (The Republic of Cyprus Statistical Service 2017). Socioeconomic 
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status has been suggested as a risk factor for multiple sclerosis and this is discussed in 
detail later. 
 Multiple Sclerosis 
Multiple Sclerosis (MS) is a chronic, mostly progressive, inflammatory disease of the  
nervous system, which mainly affects young and middle-aged adults (Rice et al. 2001;  
Dendrou et al. 2015). It is the most common autoimmune disorder affecting the central 
nervous system and is about three times as common in women as men, although the sex 
ratio has shifted over the years and this will be described in more detail in chapter 2 
(Golden and Voskuhl 2017; Waubant 2018). Serious disability such as, bowel and urinary 
incontinence, cognitive impairment and difficulty walking (Kister et al. 2013) can result 
from repeated damage to the myelin sheaths of nerves (Jagannath et al. 2010).  In 
simplistic terms, it is thought that in genetically susceptible people, an environmental 
trigger leads to a complex cascade of events, ultimately resulting in lymphocytes 
targeting oligodendrocytes and myelin. This can cause a number of signs and symptoms. 
The main symptoms are shown in Figure 2. 





1.2.1 Environmental determinants of autoimmunity 
Genetic predisposition is thought to account for about 30% of all autoimmune diseases 
while 70% is due to environmental factors (Vojdani Pollard and Campbell 2014). The 
main environmental elements are summarised in Figure 3. 
Figure 3 The interplay of genetics and environmental factors in autoimmunity (Vojdani 
Pollard and Campbell 2014). 
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According to the American Autoimmune Association (2018) over 100 autoimmune 
diseases have been identified. These diseases may be organ specific or systemic. Well 
known examples include multiple sclerosis, type 1 diabetes and rheumatoid arthritis. The 
prevalence of these diseases is higher in developed countries and the incidence is 
increasing (Chowaniec Kawalec and Pawlas 2017). It is thought this is most likely due to 
exposure to environmental factors.  The environmental factors thought to influence 
acquiring multiple sclerosis are dealt with in detail in the literature review and the 
immunopathology of multiple sclerosis will be discussed later in this chapter. 
 
1.2.2 A brief history of multiple sclerosis  
In 1395, a 16year-old girl from Schiedam in Holland developed an illness and fell while 
skating on a frozen canal. She later developed blindness in one eye, weakness and pain. 
She died in 1433. She was canonised by the church and became the patron saint of figure 
skating and sickness. She was named Lidwina The Virgin. It has been suggested by Orrell 
(2005) that this was the first recorded case of multiple sclerosis. Augustus d'Este (1794–
1848), who was the grandson of George III of England, is also said to have had of 
multiple sclerosis (Murray 2004). He exhibited transient blindness at the age of 28 years 
as the first symptom. He documented his illness in a diary for the next 44 years. He 
eventually could not walk and used a wheelchair before being confined to bed. He died 
aged 54 in1848 (Murray 2004).  
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In 1868 the French neurologist Jean-Martin Charcot described the disease and the phrase 
“Charcot's triad” was coined. It refers to intention tremor, nystagmus, and scanning 
speech which are common in multiple sclerosis. He suggested these clinical signs were 
associated with the destruction of myelin (Talley 2005). 
 
1.2.3 The diagnosis of multiple sclerosis 
The diagnosis of multiple sclerosis is a combination of clinical and magnetic resonance 
data, with cerebrospinal fluid (CSF) analysis and other paraclinical tests sometimes being 
used. There are no pathognomonic tests (Pugliatti et al. 2006). The diagnostic critera have 
evolved with advances in technology, particularly magnetic resonance imaging (MRI) 
(Poser and Brinar 2004). The Schumacher et al. criteria (Kurtzke 1993) were the first to 
be internationally recognised criteria for diagnosis in 1965 (Poser and Brinar 2004). The 
McAlpine, Lumsden, and Acheson criteria were also suggested in 1965 and the Poser et 
al. criteria published in 1983 (Poser and Brinar 2004). The McDonald Diagnostic Criteria 
were adopted in 2001 (Poser and Brinar 2004), revised in 2005 and again 2010 (Polman 
et al. 2011). In 2017, a revision was made to the 2010 McDonald Diagnostic Criteria by 
the International Panel on Diagnosis of Multiple Sclerosis (Thompson et al. 2018). The 
diagnostic criteria have been simplified and are shown in Figure 4. 
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Figure 4 The 2017 update to 2010 McDonald Diagnostic Criteria (Thompson et al. 2018). 
 
Dissemination in Space (DIS) can be demonstrated when lesions on T2 MRI can be seen 
in at least two out of four areas of the CNS: periventricular, juxtacortical, infratentorial, 
or spinal cord. Dissemination in Time (DIT) requires a new T2 and/or gadolinium-
enhancing lesion(s) on follow-up MRI, with reference to a baseline scan, irrespective of 
the timing of the baseline MRI or the simultaneous presence of asymptomatic 
gadolinium-enhancing and non-enhancing lesions at any time. 
The clinical course of multiple sclerosis is characterized by relapses and/or disease 
progression which will be explained in the section on clinical phenotypes.  
 
1.2.4 Clinical Phenotypes  
The disease course varies from patient to patient, but a number of clinical phenotypes 
have been described over the years for the purposes of communication and management. 
In 1996 the US National Multiple Sclerosis Society defined the clinical subtypes in order 
to standardize the terminology (Lublin and Reingold 1996). 
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Four categories of phenotype are classically described in the literature based on the 
course of disease (Roosendaal and Barkhof 2015). 
1. Relapsing–remitting multiple sclerosis is the most common form. About 85% of 
multiple sclerosis patients are affected. The disease typically shows relapses or 
flare ups of symptoms followed by periods when symptoms improve or disappear 
(remission). 
2. Secondary progressive multiple sclerosis. This may develop in some patients with 
relapsing–remitting disease when the disease continues to worsen with or without 
periods of remission or leveling off of symptom severity (plateaus). 
3. Primary progressive multiple sclerosis affects approximately 10% of multiple 
sclerosis patients. Symptoms gradually worsen from the beginning without 
relapses or remissions.  
4. Progressive-relapsing multiple sclerosis is rare and affects less than 5% of 
patients. It is progressive from the start, with no periods of remission, but there 
may be intermittent flare-ups of worsening symptoms at times.  
The first demyelinating event which is labelled “clinically isolated syndrome” (CIS) may 
prompt suspicion of multiple sclerosis, but until the patient fulfils the McDonald 
Diagnostic Criteria (revised in 2017) the condition cannot be called multiple sclerosis 
(Direnzo et al. 2015). In one study between 30% and 40% of patients showing CIS 
symptoms progressed to a diagnosis of multiple sclerosis within one year and 60% within 
three years (Wottschel et al. 2014). However, 20 % of CIS patients do not convert to 
multiple sclerosis within two decades. Briggs et al. (2019) found that obesity and 
smoking were two risk factors that modulated different phenotypes but in the current 
study all phenotypes were recruited as cases so long as they met the selection criteria. In 
part, this was due to the small numbers of phenotypes 2,3 and 4 and also the general 
slowness in case recruitment. 
1.2.5 Simplified Pathophysiology and immunopathology of multiple sclerosis. 
 
Introduction 
Multiple sclerosis is a complex neurodegenerative disease of the central nervous system 
which is considered to be autoimmune (Huang Chen and Zhang 2017). It is a 
dissemination of plaques and neurological changes found throughout the central nervous 
system including white matter, gray matter, brain stem, spinal cord, and optic nerves 




Figure 5 The topography of multiple sclerosis lesions (Longo et al. 2018). 
 
 
A denotes the periventricular region, B the cortex, C the leptomeninges, D the thalamus 
and pons, E the spinal cord, F the optic nerve, G the retina. MRI findings from different 
patients are shown along with histology results at post-mortem. 
The myelin sheath in the central nervous system is an insulating layer of protein and fat 
made by oligodendrocytes and acts to allow fast and efficient transmission of impulses 
along the nerve axon. Inflammation leads to demyelination and damaged nerves which 
cannot transmit the nerve impulse either at all or as effectively as before (Frohman Racke 
and Raine 2006). 
Inflammation of the central nervous system (CNS), demyelination, axonal injury and 
eventually axonal loss are characteristic of multiple sclerosis, but the antigen or antigens 
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in this immune-mediated response have yet to be found (Kamm Uitdehaag and Polman 
2014). In the early stages of relapsing-remitting multiple sclerosis, there is focal 
inflammation resulting in white matter plaques. These are areas of demyelination and 
they may be accompanied by varying degrees of axon loss and subsequent reactive gliosis 
with the production of hypertrophic astrocytes. Typical areas of pathology seen on MRI 
are found in the periventricular, juxtacortical and infratentorial areas of the brain, or in the 
spinal cord (Thompson et al. 2018). 
 
Histopathology  
While focal white matter lesions are characteristic of histopathology seen at post-mortem 
and are characterized by demyelination and inflammation, gray matter demyelination 
varies considerably between individuals. Infiltration of immune cells, including T cells, B 
cells and myeloid cells, into the central nervous system are thought to cause injury and 
form the focal lesions (Filippi et al. 2018). 
 
The histology of a chronic lesion is shown in Figure 6. 
 
Panel A shows demyelination of a myelinated fibre. 
Panel B shows astrocytes (AS) and astroglial scar tissue 
Panel C shows demyelinated axons(A) within the glial scar 
Panel D shows an area of remyelination with overabundant oligodendrocytes (OL) 
Panel E shows remyelination but with thin myelin sheaths 
Panel F shows there is an abrupt boundary between myelinated fibres (blue) and 








As mentioned earlier, in genetically predisposed people, an environmental trigger or 
triggers is thought to activate a complex immune response. The immune system mistakes 
a patient’s tissue as foreign and attacks it via a cascade reaction. In simplistic terms, this 
is the basis of autoimmunity. A possible group of cellular components interact in multiple 
sclerosis as shown in Figure 7. 
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Figure 7 A schematic representation of key cellular players in the autoimmunity of 
multiple sclerosis (Grigoriadis and Van Pesch 2015). 
 
At some point in the pathogenesis the blood brain barrier is breached, and it seems likely 
that immune dysregulation leads to perivenular inflammatory lesions with demyelinating 
plaques. This “perivascular cuffing” a term used to describe the immune cell influx that 
forms around vessels is mainly composed of T lymphocytes, monocytes and macrophages 
(Wu and Alvarez 2011) but B-cells and plasma cells are also present. Foamy 
macrophages are involved in the stripping of myelin and there is a varying degree of 
oligodendrocyte apoptosis. Axons are initially preserved, but with disease progression 





1.2.6 Epidemiology and suggested Aetiology of multiple sclerosis 
 
Introduction 
It is often said that the aetiology of multiple sclerosis is unknown, but substantial 
evidence exists to support associations of various factors in developing the disease. 
Over 40 factors have been proposed as risks for acquiring multiple sclerosis with some 
risks having more evidence than others to support their role. In a genetically susceptible 
person, infection with the Epstein–Barr virus, low vitamin D concentrations and a lack 
of sun exposure, smoking and adolescent obesity have been well established as 
individual associations with increased risk for acquiring multiple sclerosis (Olsson 
Barcellos and Alfredsson 2017). The literature review deals with possible aetiology in 
detail in the next chapter. Kockum Alfredsson and Olsson (2014) state that along with at 
least 50 genetic polymorphisms, groups of risk factors have been identified that are 
jointly involved in the pathogenesis. Migration studies have supported the view that 
multiple sclerosis is due more to environmental exposure than genetics (Kurtzke 2013). 
However, genetics account for between 15-30% (Wang et al. 2016), as when compared to 
the general population. In the general population there is a risk of 0.1%, people with an 
affected first-degree relative have a 2 to 4% risk of multiple sclerosis (Salroo et al 2016). 
While concordance in monozygotic twins is between 30 and 50% (Longo et al. 2018). 
While the consensus view is that environmental exposure amounts to a large part of the 
aetiology, Ebers (2013) argues that there is no particular value in trying to estimate the 
relative importance of either, since the risk requires interaction between both elements. 
The disease affects about 3 times more women than men and the sex ratio has changed 
over the years (Waubant 2018), and women are diagnosed usually 2-5 years earlier than 
men. The literature review deals with this in more detail. Incidence declines with age in 
both sexes and initial diagnosis is less common in those over 60 years (Polliack Barak 
and Achiron 2001). Life expectancy in multiple sclerosis patients is reduced by 7-10 
years compared with people without the disease (Kamm et al. 2014). It is a debilitating 
disease with significant impact on the patient, their family and society 
Prevalence and incidence 
The prevalence of multiple sclerosis is the number of patients with multiple sclerosis 
alive on a specific date per 100 000 of a population, whereas the incidence is the number 
of new cases of patients with multiple sclerosis per 100,000 over a given period of time (a 
year is often used for multiple sclerosis). The disease is rare in children and the adult 
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prevalence peaks at 50 years of age, whereas the incidence for multiple sclerosis peaks at 
approximately 30 years of age (O’Gorman 2012). Incidence peaks close to the average 
age of diagnosis, while prevalence peaks much later and includes later diagnosed cases 
and is also influenced by survival. Wallin et al. (2019) suggest improved survival has 
resulted in a rising prevalence in the last fifty years, particularly in high income countries. 
Several countries in the world have registers of multiple sclerosis cases (Flachenecker et 
al. 2014). For example, Denmark has aimed to register all of its multiple sclerosis patients 
in a data bank. This allows prevalence and incidence, disease progression and treatment 
to be accurately recorded and monitored. In other countries registries have been set up 
where individuals volunteer to join but these data cannot be used to assess prevalence and 
incidence, since the data are incomplete. These registries rely totally on volunteer 
information. 
While it is estimated there are over 2 million people with multiple sclerosis worldwide 
(Huang Chen and Zhang 2017), the prevalence is low in the tropics and increases as one 
moves north or south of the tropics as can be seen in Figure 8. 
Figure 8 Map of the World showing areas of high multiple sclerosis prevalence and areas 
of low prevalence (Pierrot-Deseilligny and Souberbielle 2010). 
 
 
Meta-analysis has confirmed the long-held view that a latitude gradient of multiple 
sclerosis incidence in Europe exists (Alcalde-Cabero et al. 2013; Kingwell et al. 2013; 
Sundström and Salzer 2013; Wang Simpson and Taylor 2018), although it is possible this 
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may reflect vitamin D levels which are affected by seasonal changes in sunlight exposure 
(Longo et al. 2018). This will be discussed later in the literature review. Other studies 
have suggested this latitude gradient has declined for example in Norway where Grytten 
Torkildsen and Myhr (2015) suggest there is no longer evidence of a latitude gradient. 
This may be due to people being exposed to similar environmental risk factors 
independent of geography. One possibility is that any vitamin D deficiency induced by 
latitude, has been addressed with vitamin D tablets, although there is no strong evidence 
to support this. In the UK several studies have attempted to provide up-to-date 
information on multiple sclerosis prevalence, and the UK remains one of the most studied 
areas in the world for multiple sclerosis prevalence (Kingwell et al. 2013). By 2012 there 
had been 28 unique prevalence or incidence studies of which 13 were from England, 6 
from Scotland and 3 from Wales and 3 from Northern Ireland and 1 from Guernsey 
(Kingwell et al. 2013).  In a descriptive study using data from the UK General Practice 
Research Database (GPRD) Mackenzie et al. (2014) suggest that the prevalence of 
multiple sclerosis in the UK (as at 2010) was 200 per 100,000 and there was an increase 
in prevalence when moving from the south to the north. The prevalence rate of 187 per 
100 000 in south-east Scotland in 1995 was more than twice that for England and Wales 
at that time (Pugliatti et al. 2006). Robust evidence and meta-analyses tend to support this 
gradient. Wallin et al. (2019) suggest an increase in prevalence of 1·03 times per degree 
of latitude in the US. It is possible the south to the north increase in prevalence (in the 
northern hemisphere) could be an artefact. This might due to better case finding and/or 
better survival. 
Alternatively, a true gradient of prevalence might exist due to prevalence differences. 
Carod Artal (2019) carried out a cross sectional observational study using data from the 
Raigmore Hospital register in the Scottish Highlands to establish the prevalence of 
multiple sclerosis in this population of around 250,000 people between 1 January 2016 to 
31 December 2016. He found 745 patients met the inclusion criteria. Of these, 75.4% 
(562 cases) were female. He estimated the crude prevalence rate for multiple sclerosis in 
this population (the Highlands) was 300 cases per 100,000 inhabitants (95% CI: 280 to 
320) and the mean age at diagnosis was 45.45 ± 13.27 years [range: 14-84 years]. This 
study provides the most up-to-date prevalence of multiple sclerosis available for this part 
of Scotland. Other UK prevalence data, for example that quoted by The Multiple 
Sclerosis Society (2019) uses 5-year-old data and applies a 2.4% increase per year to 
achieve an estimated figure. 
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The shifting incidence of multiple sclerosis 
The incidence of multiple sclerosis appears to be increasing throughout the world in both 
developed and developing countries with increased smoking suggested as being a partial 
reason for the increase in incidence among women (Dobson and Giovannoni 2018). 
While smoking is decreasing in many high-income countries, multiple sclerosis appears 
still to be rising, suggesting factors other than smoking are involved. 
Grytten Torkildsen and Myhr (2015) reported that the incidence of multiple sclerosis rose 
from 1.9 to 8 per 100,000 between 1961 and 2007 in Norway. The results are represented 
graphically in Figure 9. 
  
20 
Figure 9 Graph of multiple sclerosis incidence against time in Norway (Grytten 
Torkildsen and Myhr 2015). 
 
 
In the Scottish Highlands, the data from Carod Artal (2019) show that there is a general 
trend of increasing incidence over even a short period of seven years as seen in Table 1. 
Table 1 The incidence of multiple sclerosis in the Scottish Highlands between 2010 and 




Diagnosis 2010 2011 2012 2013 2014 2015 2016 
Incident 
cases 36 23 30 39 45 41 47 
 
The reason for this shifting incidence is uncertain, but it can be speculated that it is due to 
one or more of the following factors: 
1. A true increase in multiple sclerosis incidence 
2. An increase in early diagnosis of multiple sclerosis 
3. A better multiple sclerosis service with easier access to MRI facilities 
4. An increase in the number of multiple sclerosis specialist doctors and nurses, since 
more specialists might increase access to services and so increase diagnosis. 
Alternatively, an increase in multiple sclerosis incidence might increase the need for 
more multiple sclerosis specialist doctors and nurses. 
1.2.7 Methods of measuring new lesions in multiple sclerosis  
In addition to aiding diagnosis, MRI is being used to assess response to treatment and 
disease progression. New lesions (plaques and scars) found on MRI are usually but not 
always associated with disease symptoms (Kaunzner and Gauthier 2017). While specific 
imaging protocols are not suggested in the McDonald Criteria, evidence-based guidelines 
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were produced by The Magnetic Resonance Imaging in MS (MAGNIMS) network 
(2015).  
A meta-analysis by Sormani and Bruzzi (2013) found an association between lesion 
development and relapses and Ontaneda and Fox (2017) suggest that with every clinical 
relapse, between 10 and 15 new lesions are formed. When new lesions are detected on 
MRI, it is possible to use MRI scans as a screening tool for disease activity or as a 
measure of therapeutic medication efficacy. 
 
1.2.8 Relapse and Remission in multiple sclerosis 
Relapses are defined as neurological symptoms that last for more than 24 hours in the 
absence of fever or infections while remissions are times in which symptoms may 
partially or completely subside. Remissions may be short periods of days or weeks, or 
longer periods of months or years and may be characterized by a return to a level of 
health similar or equal to that experienced prior to the last relapse (Pappalardo and Hafler 
2019). Steinman (20209) suggests there are three main molecules involved in the process 
of relapses and remissions. These are α4β1 integrin and osteopontin which lead to the 
production of pro-inflammatory cytokines and αB crystallin which inhibits 
inflammation. 
 
1.2.9 Multiple sclerosis and the microbiome 
Gut microbiota are the naturally occurring organisms in the human gut once referred to as 
“gut flora”. The human gut microbiota consists of trillions of cells including bacteria, 
fungi and viruses which exist as a dynamic population and have an influence on 
homeostasis and disease (Thursby and Juge 2017). The gut microbiome is a term 
referring to the sum of these microorganisms with their genetic material, and products of 
their metabolism at any one time.  
Carabotti et al (2015) suggest that the gut microbiome can interact with the central 
nervous system through bidirectional signaling.  
It is thought that the diet in infancy establishes the initial microbiota and this is altered 
throughout life by dietary habits. Divergence from the “normal” gut microbiota 
composition is referred to as dysbiosis and may occur after antibiotics (Ferreyra et al. 
2014) or in the presence of pathology (Lopez-Siles et al. 2017). As well as being the 
result of pathology, dysbiosis may be the cause of pathology for example the expansion 
of a pathogenic colony in the gut after antibiotics (Ferreyra et al. 2014) or it is possible 
that dysbiosis may trigger pathology elsewhere in the body such as cardiovascular 
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disease, asthma, metabolic syndrome, and obesity (Carding et al. 2015). The interaction 








Indeed, it is possible that interactions between microbiota and the host are reciprocal. In 
patients with multiple sclerosis the gut microbiome is significantly different to people 
without multiple sclerosis (Kirby and Ochoa-Repáraz 2018). For example, in multiple 
sclerosis patients Akkermansia muciniphila and Acinetobacter calcoaceticus are increased 
while Parabacteroides distasonis is reduced (Cekanaviciute et al. 2017). Also reduced are 
other bacteria such as Clostridia, Actinobacteria and Bacteroides which are capable of 
limiting inflammation (Tremlett and Waubant 2017). 
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Some microbiota appear to favour an environment which is pro-inflammatory, while 
other microbiota favour an anti- inflammatory environment. Diet appears to affect the 
balance between these two states. Low fibre Western-style diets for example, seem to 
lead to a proliferation of certain microorganisms. On the other hand, a quite different 
colony of microorganisms proliferate when the diet is more vegetable-based, as is the 
case in the Mediterranean diet. One suggestion is that the high fibre diet provides a better 
environment for these particular types of microorganisms. Riccio and Rossano (2018) 
suggest that the microorganisms that flourish in the vegetable-based diet exhibit 
protective and anti-inflammatory properties. They might do this by reducing oxidative 
stress and inhibiting nuclear factor kappa B which is a proinflammatory transcription 
factor. Multiple sclerosis is a disease whose pathophysiology involves inflammatory 
processes. It is feasible that the gut microbiota of multiple sclerosis patients is a factor in 
the cause of the disease or a result of the disease. Either way, it is associated with the 
promotion of inflammatory cytokines and overall stimulation of inflammation. A diet 
such as the Mediterranean diet might alter the microbiota to produce a microbiota that 
provides a protective and anti-inflammatory outcome. If there were more evidence to 
support any potential health benefits, then it might be reasonable to suggest dietary 
interventions as a prevention measure.  
 
1.2.10   Multiple sclerosis in Cyprus 
Middleton and Dean (1991) studied prevalence of multiple sclerosis in three areas of 
Cyprus.  The Greek speaking district of Paphos, the eastern Famagusta area and an area in 
the Troodos mountains. They suggested the prevalence of multiple sclerosis in Cyprus 
was 44.5 per 100,000. In a study sponsored by the United Nations, Dean et al. (1997) 
studied the prevalence of multiple sclerosis in the Turkish-speaking occupied area and the 
Greek-speaking Republic of Cyprus. It was found that the prevalence of multiple sclerosis 
was highest in Turkish-speaking Cypriot men. The prevalence in the Greek-speaking part 
of Cyprus, was 42 per 100,000, with males 39 per 100,00 and females 46 per 100,000. 
Charalambidou Pantzaris and Patrikios (2016) studied patients from CING using data 
from 2000-2014. They used records of patients attending during this period and estimated 
the total individual multiple sclerosis patients based on appointments. Their estimate of 
prevalence of multiple sclerosis in The Republic of Cyprus was 198 per 100,000. It is 
possible that the 1991estimate of prevalence had under-recorded the true prevalence 
and/or the 2016 estimate of prevalence is an over estimate, although there is no 
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evidence to support either suggestion being the case. It is also possible that diagnosis 
has improved with time due to advances in technology.  
Thesis structure 
Chapter one is the introduction and includes a description of multiple sclerosis as well as 
an introduction to the study and Cyprus. The literature is reviewed in Chapter 2 with 
emphasis on food stuffs, diet and in particular The Mediterranean diet. Chapter 3 
describes the aims and objectives of the study while Chapter 4 describes the methodology 
used. The results are presented in Chapter 5 and discussed in Chapter 6 together with 
conclusions and ideas for future research. All the references cited are listed in “The 
Reference Section”. Finally, there are Appendices which include the questionnaire in 
English and Greek as well as all the official forms such as the consent form, participation 
form, ethics approval, and debrief forms in English and Greek. Tables of results not 
included in the thesis can also be found in the appendices. 
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2 Chapter 2. Literature Review 
 
Insufficient published papers on the risk of multiple sclerosis and the Mediterranean diet 
prevented a “standard” systematic review using the PRISMA protocol (Moher et al. 
2015). Instead, the literature was reviewed in relation to the Mediterranean diet and health 
and the risk of multiple sclerosis where available. 
The review of literature began with a brief history of the Mediterranean diet and included 
the composition of the diet and the concept of the Mediterranean diet food pyramid. The 
various foods that are included in or excluded from the diet were reviewed in the 
historical context. Then the concept of “The effects of Adherence to the Mediterranean 
diet” were reviewed along with a brief mention of other foods and “Western diets”. The 
suggested health benefits of the Mediterranean diet were examined and the evidence for 
anti-inflammatory properties of the Mediterranean diet were reviewed. The association of 
the Mediterranean diet and the risk of multiple sclerosis were then reviewed. 
Literature on potential confounders were next reviewed. More than forty environmental 
factors have been suggested as risks to acquiring multiple sclerosis (Belbasis et al. 2015), 
and some of these risk factors may be confounders in this case-control study. According 
to the Boston University School of Public Health (2013) Three conditions must be present 
for confounding to occur: 
1. The confounding factor must be associated with both the risk factor of interest and 
the outcome. 
2. The confounding factor must be distributed unequally among the groups being 
compared. 
3. A confounder cannot be an intermediary step in the pathway from the exposure of 
interest to the outcome of interest. 
The possible confounders are reviewed in detail while unlikely confounders are briefly 
mentioned. The more likely confounders include sex (gender), obesity, smoking, and 
socioeconomic status. Finally, other suggested associations unlikely to be confounders in 
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As a result of the inclusion and exclusion criteria, papers that examined disease 
progression and the Mediterranean diet were excluded. The literature search found only 
one unique study that examined the Mediterranean diet and the aetiology of multiple 
sclerosis and six studies relating to diet generally and the aetiology of multiple sclerosis. 
Many other papers were reviews, systematic reviews and meta-analyses. 
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2.1.1 The Mediterranean diet history 
Ancel Keys might be credited with the recent interest in the Mediterranean diet in the 20th 
Century, but the diet consumed around the olive growing region of the Mediterranean 
basin has a history predating Biblical times. Agriculture or the domestication of crops 
occurred between 10000 to 4000 BCE and was dictated by climate and religious practice 
(Berry et al. 2011). The term Biblical diet has been coined to refer to the food consumed 
during the biblical period from the time of the Patriarchs until King David in Jerusalem 
from 1750 to 1100 BCE (Berry et al. 2011). Both archaeo-botany and written records 
have provided evidence of foods eaten during this period and their influence on the 
current Mediterranean diet. The Bible provides written evidence of the so-called “seven 
species” – wheat, barley, grapes, figs, pomegranates, olives and date honey 
(Deuteronomy 8:8). These staples can be found in variations of the Mediterranean diet 
still today. There is also hieroglyphic evidence of wine and olive exports from Canaan to 
Egypt (both components of the current Mediterranean diet) (Berry et al. 2011).  
The first five books of The Jewish Torah and Christian Bible were probably written over 
a couple of centuries around the 6-7th BCE. These books make many references to food, 
agriculture and animal husbandry. The so-called Pentateuch diet refers to the diet 
mentioned in these books and has some similarities to the Mediterranean diet since both 
are characterised by a diet based mainly on whole-grain cereals, fruits, nuts, vegetables, 
legumes and a moderate consumption of fish, poultry, dairy products, and a daily glass of 
red wine taken with food. The Mediterranean and Pentateuch diets both limit the 
consumption of red meats and sweets, to festivals and feasts (Kastorini et al. 2011). There 
are large quantities of plant-derived foods consumed. These are mainly, vegetables, 
legumes, nuts, fruits and seeds, and whole grain cereals. Seafood and some dairy products 
especially yogurt and cheese are also eaten. However, there is low consumption of sweet 
desserts and whole milk, butter or cream (Issa et al. 2011).  Sweet tastes in foods are 
derived from figs and carobs and there are virtually no refined sugars. The consumption 
of poultry and eggs is also limited (Martínez-González et al. 2015). The diet may include 
one glass of wine daily (especially red wine), which is usually taken with meals 
(Lamuela-Raventós and Andres-Lacueva 2004; Rodríguez-Morató Boronat Dierssen and 
de la Torre 2018).  
Cultivation of wild olive trees appears to have a history of at least 6,000 years, according 
to religious texts and archaeological discoveries. For example, archaeological studies by 
Zohary & Spiegel‐Roy (1975) suggest evidence exists of domestication of the wild olive 
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to Olea europaea L. around 4000 BC in Palestine and cultivation gradually continued 
from East to West. This was most likely carried out by the Phoenicians, Etruscans, 
Greeks and Romans (van Zeist 1980). The name Olea europaea L. sativa has been used 
to distinguish it from the wild olive subspecies oleaster (Lavee, 1996).  
Figure 11 shows the probable spread of cultivated olive trees from East to West in the 
Mediterranean basin (http://www.mikpens.com/mediterraneanolivehistory.html).  
 
Figure 11 The probable spread of cultivated olive trees from East to West in the 
Mediterranean basin. Source (http://www.mikpens.com/mediterraneanolivehistory.html 
 
 
The domestication of crops in Western civilization most likely took place from ca. 10,000 
to 4000 BCE. (Berry et al. 2011). To place this in context, the invention of the wheel, the 
development of writing and the use of metals came later around 4000 to 1000 BCE. The 
evolution of civilization and domestication of crops is thought to have originated in the 
“Fertile Crescent” which refers to fertile soil bordering the rivers Nile, Tigris and 
Euphrates and includes parts of modern-day Egypt, Lebanon, Israel, Jordon, Syria, Iran 
and Iraq which can be seen in Figure 12 (Harlan and Zohary 1966). The progenitor of 




















Figure 12 The distribution of wild emmer (Triticum dicoccoides) in the Near East. Solid 




2.1.2 The Food Pyramid  
The Mediterranean diet pyramid is based on food typical of the Greek island of Crete. The 
three Pyramids used mainly in research are those devised by “The 1999 Greek Dietary 
Guidelines” (1999), “Oldway’s Preservation and Trust” (2009), and “The Mediterranean 
diet foundation” (2011).  As an example, Figure 13 shows a food pyramid from Oldways 
Preservation & Exchange Trust (2009). 
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Figure 13 An example of The Mediterranean diet food pyramid (image credit 
oldwayspt.org © 2009 Oldways Preservation & Exchange Trust) 




The Mediterranean diet might be considered as a lifestyle choice not just a diet pattern 
(Bach-Faig et al. 2011). The foods that ought to be eaten in the largest amounts and the 
lifestyle activities most important in the Mediterranean diet appear at the bottom of the 
pyramid whilst foods which should be eaten rarely or in moderation are placed at the top 
(Willett et al. 1995). It is difficult to define the absolute components of the Mediterranean 
diet as the constituents can be variable for example, geographically, and the diet can still 
fall into the category of the Mediterranean diet. One current definition is that the 
Mediterranean diet is based on consumption of extra-virgin olive oil, unrefined cereals, 
legumes and diverse vegetables (in particular tomatoes) (Riccio and Rossano 2015). 
Olive oil is used for cooking and in salads and is the main source of fat. The 
Mediterranean diet "lifestyle choice"(Bach-Faig et al. 2011) has at its foundation daily 
physical activity. The major food components are plant based, with daily consumption of 
fruits, vegetables, legumes, nuts and whole grains. Extra virgin olive oil is the 
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predominant fat used in cooking and food dressings. Dairy products, poultry and eggs are 
eaten in moderation while sweets and red meat are eaten monthly or perhaps limited to 
festivals. 
Olives 
Olive growing requires a Mediterranean climate, which typically features warm, wet 
winters and hot, dry summers.  These conditions can be found in the Mediterranean basin 
and parts of South West Australia and also California, Chile and South Africa. As a 
result, areas with this type of climate account for the geographical distribution of current 
olive cultivation as shown in Figure 14. 
 





Olives can be eaten as fruit immediately after curing, once the bitter compound 
Oleuropein has reduced (Johnson et al. 2018), or they may be canned or bottled and eaten 
later. Alternatively, they may be used to produce olive oil. Ripe olives are picked and 
taken to an olive mill where they are washed and crushed. The resulting paste releases oil 
droplets in a process known as maceration (Olive Times 2018). Extra virgin olive oil is 
the top grade of olive oil and is produced by centrifuge spinning that pulls out the oil and 
water. Whereas with lower grade refined oil, the extraction process uses heat or 
chemicals. Removing the water then leaves the oil (California Olive Ranch 2018). Olives 
and their products are important components of the Mediterranean diet with supposed 
health benefits which are discussed later. Extra virgin olive oil is considered the most 
important of the various olive oils and is dealt with in detail later. 
Grains  
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The Gramineae family of grasses (which includes barley, oats, maize, rice and wheat) 
have been grown in the Mediterranean area for thousands of years. The seeds of these 
plants are harvested to make cereal (Seal et al. 2006). Wheat and barley nn the Pentateuch 
diet, and are major components of The Mediterranean diet which also includes rye and 
oats.  Barley was traditionally harvested in the spring and wheat in the summer. 
 A whole grain consists of three parts: 1. The outer bran or aleurone layer. 2 The 
endosperm and 3. The germ (Ross et al. 2015). Grains cannot usually be digested raw, so 
they must be flaked, cracked, puffed, popped or ground before being consumed. They 
also include inedible parts such as the hull and husk which must be removed during 
processing to make the grains edible (Seal et al. 2016). Grains are either intact or 
processed. Even if processed, to be called whole grain, it must contain all three 
components. So, intact whole grains are grains in their natural state, with all three parts of 
the grain still intact and in their original proportions. Grains are rarely consumed in this 
form since they are difficult to chew and digest.  While a processed version must contain 
all three parts of the grain, it will have been milled into flour instead of being left intact. 
Some examples of whole grain foods include 100% whole wheat bread, wholemeal pasta 
or crackers. The amount (%) and ratio of bran endosperm and germ varies in the 
processed version compared with the intact whole grain. This has led to food labelling 
issues with manufacturers and processors (Van Der Kamp et al. 2014). The consortium of 
the HEALTHGRAIN EU project identified the need for developing a definition of whole 
grain to avoid this variability. Indeed, they proposed a definition of whole grain as an 
ingredient as follows: “Whole grains shall consist of the intact, ground, cracked or 
flaked kernel after the removal of inedible parts such as the hull and husk” (Van Der 
Kamp et al. 2014). Refined grains are the most highly processed form of grains and 
examples of foods made from them include white bread, white pasta, white rice, and 
pearled barley. Although these refined grains start out as whole grain, the milling 
processes removes the bran and germ to ensure a finer textured whiter flour (in the case 
of wheat) with longer shelf life but this results in lower dietary fibre, iron, and many B 
vitamins (Ferruzzi et al. 2014). Some producers of refined grain add back certain vitamins 
and minerals under fortification regulations, but this is variable between countries. 
Enriched grain means nutrients that were lost during grain processing have been added 
back such as flours enriched with germ. Fortified means vitamins or minerals have been 
added to a food that were not originally in the food.  
Fruits and nuts 
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Fruits are an integral part of the Mediterranean diet and may include citrus fruits, such as 
oranges, lemons, grapefruit in addition to apples and pears. Figs grow on the ficus tree 
(Ficus carica) and were one of the first fruits to be cultivated in the Mediterranean region 
and remain an important fruit in the Mediterranean diet. The persimmon (Diospyros kaki, 
Ebenaceae) originated in China and has been cultivated in the Mediterranean basin for 
over a hundred years (Tous and Ferguson 1996). Other fruits common to the traditional 
Mediterranean diet include apples, apricots, avocados, cherries, clementines, grapefruits, 
grapes, melons, nectarines, peaches, pears, strawberries, tangerines and tomatoes (Davis 
et al. 2015). Tree nuts are dry fruits with one seed. At maturity, it is the ovary wall that 
becomes hard. Nuts are integral components of the Mediterranean diet, especially 
almonds, hazelnuts, pine nuts, pistachios, and walnuts (Ross et al. 2015).  
Vegetables  
Traditionally, the vegetables eaten in the Mediterranean diet depend on those that flourish 
in the soils and climate of that region and are often grown for raw consumption in salads. 
For example, Greek salad may include tomatoes, cucumber, peppers, olives (which are all 
technically fruits), onions along with pickled capers which are the flower buds of 
Capparis spinose. The fresh salad is usually dressed with olive oil. Other vegetables 
common to the traditional Mediterranean diet include brussels sprouts, cabbage, peas, 
leeks and turnip. These vegetables are more likely to be cooked than eaten raw.  
Fish 
Fish and shellfish have been caught around the Mediterranean coast for thousands of 
years and fish consumption is regarded a major component of the Mediterranean diet 
(Willett et al. 1995). The fish species found in the Mediterranean region include: 
anchovy, common sole, gilthead sea bream, hake, mackerel, sardine and sea bass. Of 
these, anchovies, sardines and mackerel are oily fish. These fish are a good source of 
vitamin D.  
Legumes  
There are over 18,000 species of legumes (Sprent and Platzmann 2001). They are key 
components of traditional diets (Messina 1999) such as the Mediterranean diet and 
include lentils, chickpeas, beans, peas, flat beans, split peas and peanuts. Essid (2012) 
states that the Romans (between the 7-3rd centuries BCE) spread the cultivation of 
legumes and agriculture generally at this time was helped by the Roman introduction of 
irrigation systems. Legumes which are a good source of protein were eaten in areas where 
cattle could not be reared, or meat was too expensive. 
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The health benefits of legumes are discussed in a later section, but it is worth noting that 
Darmadi-Blackberry et al. (2004) suggest a higher intake of legumes are a dietary 
predictor of survival among elderly people when compared with other food groups. 
 
Alcohol, especially red wine  
Red wine has been produced in the region for centuries and small quantities (1-2 glasses) 
are often drunk with meals. Alcohol and red wine are discussed in detail later. 
Low consumption of red meat and processed meat 
The consumption of red meat and processed meat in the Mediterranean diet is typically 
small and is usually restricted to a couple of times per month or at festivals. 
Low consumption of poultry, and dairy products 
Small amounts of poultry and dairy produce in the Mediterranean diet reflect the 
historical scarcity of these foods in the area. 
2.1.3 Epidemiology 
Since the early 1960s, there has been extensive epidemiological research on the 
individual elements of the Mediterranean diet studying disease risk or disease progression 
and reduced mortality. The hope was that any food or item of food that was found to be 
beneficial could be added to the Western diet to improve health outcomes. However, 
studies have failed to find statistically significant associations with separate components 
of the Mediterranean diet (Hernández Ruiz et al. 2015). More recent research has focused 
on the effect of adherence to the Mediterranean diet as a whole (Martínez-González et al. 
2015). The term “adherence” has been coined to denote how closely a person follows the 
Mediterranean diet, usually described using a diet scoring system. A high Mediterranean 
diet score suggests the person is following the Mediterranean diet more closely than a 
person with a low Mediterranean diet score. It has been suggested that the elements of the 
Mediterranean diet act synergistically, and it is the whole rather than the parts that are 
important (Trichopoulos and Trichopoulo 2008). 
Various indices have been published to assess the effect of adherence to the 
Mediterranean diet. The first index was first proposed in 1995 by Trichopoulou et al., 
who were assessing the adherence to the Mediterranean diet and mortality risk in an 
elderly Greek population. There were eight components to this index; a ratio of quality of 
fat and seven food groups present in the diet. The seven food groups included: vegetables, 
legumes, grains, fruits and nuts, meat and meat products, milk and dairy products and red 
wine intake. Later, this index was modified to include fish intake (Trichopoulou et al. 
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2003). The effect of adherence to the Mediterranean diet can be assessed using the 9-Unit 
dietary score proposed by Trichopoulou (Trichopoulou et al. 2003) while other indices 
use slight modifications.  
An example of a 9 component Mediterranean diet adherence score such as that used by 
Trichopoulou uses the following foods: 
Fruit and nuts 
Vegetables 
Legumes 




Low consumption of red meat and processed meat 
Low consumption of poultry, and dairy products 
 
On the other hand, some indices do not share important aspects of its definition due in 
part to different populations, and the age of people studied. This gives rise to a large 
number of different scoring systems in existence (Hernández Ruiz et al. 2015) and makes 
comparison of different studies sometimes difficult.  
For example, some scores include lifestyle factors, while others do not.  
Hernández Ruiz et al. (2015) reviewed the literature for adherence to the Mediterranean 
diet and examined evidence for lower mortality risk when the Mediterranean diet was 
adhered to. They found that while a whole Mediterranean diet showed significant 
associations with reduced mortality in several studies, there were no statistically 
significant associations with separate components of the same diet to reduced mortality. 
Several studies have used Trichopoulou’s Mediterranean diet index (or modifications of 
it) (Bamia et al. 2017). 
In order to calculate an individual’s Mediterranean diet score the individual provides a 
record of their diet, usually over several days or through the use of a diet recording tool 
such as a Food Frequency Questionnaire (FFQ).  Each of nine components of the 
Mediterranean diet are assigned a value of 0 or 1 with the use of the sex-specific median 
intake of the food as the cut off. A value of 1 is assigned to the diet where consumption of 
the 5 expected beneficial food components (vegetable, legumes, fruits/nuts, cereals and 
fish) is equal or above the sex specific median intake level and a value of 0 is assigned 
when the consumption is below the median intake level. For meat, poultry, and dairy 
products (which are presumed detrimental) a value of 1 is assigned to the diet of 
participants where consumption is below the sex specific median intake level and 0 when 
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it is above the median intake level. A value of 1 was assigned to the diet of male 
participants who consumed between 10 and 50g of alcohol per day and to the diet of 
women who consumed between 5 and 25g of alcohol per day. Therefore, using this 
10point index, a total Mediterranean diet score would range from 0 (minimal adherence 
to the traditional Mediterranean diet) to 9 (maximal adherence).  It is then possible to 
produce categories of 0-3, 4-6 and 7-9 to represent poor adherence, average adherence 
and high adherence to the Mediterranean diet (Mirmiran et al. 2015). The sex-specific 
median intake level is calculated for each of the 9 components, using data from the whole 
group ie cases and controls. For example, the weekly amount of (125ml) glasses of red 
wine is recorded for males and females in the study population and the median value for 
each gender calculated. The diet of people where alcohol intake is above the median 
value are allocated a score of 1 and those below, a score of 0.  This is repeated for each of 
the other 8 categories of the Mediterranean diet adherence index, giving a total score out 
of 9.  
The Mediterranean diet score devised by Panagiotakos et al. (2007) uses 9 food groups 
plus Olive-oil in cooking and alcohol. These are represented in Table 2. 
Table 2 The Mediterranean diet score devised by Panagiotakos et al. (2007) 
Frequency (servings per week) and allocated score 
1.Non-refined 
cereals 
Never =0 1-6 =1      7-12 =2     13-18 =3    19-31 =4      >32 =5 
2.Potatoes Never =0 1-4=1 5-8=2 9-12=3 13-18=4 >18=5 
3.Fruits Never =0 1-4=1 5-8=2 9-15=3 16-21=4 >22=5 
4.Vegetables Never =0 1-6=1 7-12=2 13-20=3 21-32=4 >33=5 
5.Legumes Never =0 <1=1 1-2=2 3-4=3 5-6=4 >6=5 
6.Fish Never=0 <1=1 1-2=2 3-4=3 5-6=4 <6=5 
7.Red Meat and 
products 
<1=5 2-3=4 4-5=3 6-7=2 8-10=1 >10=0 
8.Poultry <3=5 4-5=4 5-6=3 7-8=2 9-10=1 >10=0 
9.Full fat dairy 
products 




Never=0 Rare=1 <1=2 1-3=3 3-5=4 Daily=5 
11.Alcohol 10 
units=1000ml. 
<300=5 300=4 400=3 500=2 600=1 >700=0 
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Intake of each food is estimated, and a score allocated from 0-5 (or the reverse) allocated 
to each group according to the position of the food group in the Mediterranean diet 
pyramid. The total Mediterranean diet score is the addition of each group and ranges from 
0-55.  People with the highest scores are considered to adhere more closely to the 
Mediterranean diet. For example, a food such as fruit, that is considered to be typical of 
the Mediterranean diet, is given a score of zero if fruit is never eaten in a week and 5 if it 
is eaten more than 32 times in a week.  
The converse for a food such as red meat, that is not considered to be typical of the 
Mediterranean diet, a score of 5 is given if the red meat is never eaten in a week and 0 if 
it is eaten more than 10 times in a week. 
 
 The Mediterranean diet and health benefits 
Health benefits of the Mediterranean diet were first proposed by the American doctor 
Ancel Keys in 1960 (Keys 1995). He noticed that coronary heart disease incidence was 
lower in certain parts of Southern Europe where people were eating a mainly vegetable-
based diet.  Since this work, there have been a number of studies that primarily focused 
on the single nutrients or single parts of the Mediterranean diet in relation to the 
occurrence of disease. The hope was to find the beneficial elements of the Mediterranean 
diet and to add these to a non- Mediterranean diet to improve health (Keys 1995). Ancel 
Keys is well known for his “Seven Countries Study” which was 
an epidemiological longitudinal study that examined the relationships between lifestyle, 
diet, coronary heart disease and stroke in seven countries (USA, Finland, Greece, Japan, 
The Netherlands, Italy and the former Yugoslavia) (Menotti et al. 1989).  The study 
found an increased risk of heart disease in subjects following a “Western diet pattern” 
compared with subjects following a Mediterranean diet. Sofi et al. (2008) systematically 
reviewed all the prospective cohort studies investigating the association between 
adherence to a Mediterranean diet and health outcomes up to June 2008. 
 The meta-analysis concluded that adhering to the Mediterranean diet reduced age-
adjusted mortality from cardiovascular diseases by 9% and cancer by 6% while the 
incidence of Parkinson’s disease and Alzheimer’s disease was reduced by 13%.  A review 
by Dinu et al. (2017) concluded there was “robust evidence for overall mortality, 
cardiovascular diseases, overall cancer incidence, neurodegenerative diseases and 
diabetes”.  The Mediterranean diet also appears to reduce the risk of other diseases caused 
by chronic inflammation (Gotsis et al. 2015). 
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2.2.1 Evidence for the anti-inflammatory action of the Mediterranean diet  
The Mediterranean diet is considered to be anti-inflammatory (Martínez-González et al. 
2015) and a considerable amount of evidence supports this. For example, Chrysohoou et 
al. (2004) randomly recruited 1,514 men and 1,528 women between 2001 to 2002. They 
found that adherence to the traditional Mediterranean diet was associated with a reduction 
in the concentrations of blood inflammation and coagulation markers. A meta-analysis 
also suggested that a Mediterranean diet decreases inflammation (Schwingshackl and 
Hoffmann 2014).  
Multiple sclerosis is a disease characterised by chronic inflammation (Pantazou Schluep 
and Du Pasquier 2015) and the Mediterranean diet is considered to be anti-inflammatory.  
It is possible that those eating an anti-inflammatory diet could be protected from a 
chronic inflammatory disease like multiple sclerosis while those not eating a 
Mediterranean diet could be at a greater risk of acquiring multiple sclerosis.  However, 
there is a paucity of case-control studies examining the effect of Mediterranean diet 
adherence with risk of acquiring multiple sclerosis. The literature search found only one 
such study, which was an Iranian hospital-based study. The study included 70 patients 
with multiple sclerosis and 142 hospital-based controls. The multiple sclerosis cases were 
compared with controls in relation to adherence of the Mediterranean diet, using a 9-unit 
dietary score similar to that of the Trichopoulou Mediterranean diet index. The results 
showed that higher consumption of fruits reduced the risk of multiple sclerosis (OR=0.28, 
95% CI: 0.12-0.63, p-value: 0.002). While higher vegetables intake also reduced the risk 
of multiple sclerosis (OR=0.23, 95% CI: 0.10-0.53, p-value: 0.001) They concluded that 
the Mediterranean dietary pattern is associated with a reduced risk of multiple sclerosis 
(Sedaghat et al. 2016). The study included many more female than male multiple 
sclerosis cases (57 female to 12 male), giving a female to male ratio of 4.7:1 which is 
much higher than the world ratio in 2000 of 2.3:1 (Alonso and Hernán 2008). The 
controls (114 female to 26 male). Controls were frequency-matched with cases by sex 
and age (5-yr age groups).  There is no indication if the sex ratio of cases is representative 
of the gender ratio of multiple sclerosis in Iran or whether the reduced risk of multiple 
sclerosis in those people adhering to a Mediterranean diet would be equally as great in a 
male population since such a small number of cases (12) were male. Since people in Iran 
are not expected to consume alcohol, this element of the Mediterranean diet score was 
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omitted. This makes any comparison with this study more difficult as the elements of the 
score are different. 
Black et al. (2018) conducted a case-control study and identified two major dietary 
patterns – healthy and Western. Whilst not The Mediterranean diet, the healthy diet was 
high in vegetables, legumes, poultry, fish, eggs, while the Western diet was high in meat, 
full-fat dairy and low in whole grains, nuts, fresh fruit, and low-fat dairy. An FFQ was 
completed by 252 multiple sclerosis cases and 446 controls. After various adjustments 
(history of infectious mononucleosis, body mass index, serum 25-hydroxyvitamin D 
concentrations, smoking, education and race), they found that a one-standard deviation 
increase in the healthy pattern score was associated with a 25% reduced risk of a first 
clinical diagnosis of central nervous system demyelination (adjusted odds ratio 0.75; 95% 
confidence interval 0.60, 0.94; p=0.011).  
Fibre and short chain fatty acids 
 
Prasad and Bondy (2019) in their review suggest that there is much observational 
evidence that high-fibre diet reduces the risk of developing cardiovascular disease, 
(Lattimer and Haub 2010) and colon cancer (Wong et al. 2006). While Zhao et al. (2018) 
suggest gut bacteria can be selectively promoted by dietary fibre and this can alleviate 
type 2 diabetes. 
Dietary fibre can be categorised as either insoluble, indigestible fiber or soluble as 
depicted in the flow diagram below. 
 







Cereals contain more insoluble than soluble fibers, whereas fresh fruits and vegetables 
contain more soluble fibre (Ötles and Ozgoz 2014). Both soluble and insoluble fiber have 
their own benefits. Insoluble fibre includes cellulose, some hemicellulose, and lignin 
which may bind and eliminate toxin, carcinogens and mutagens (Soliman 2019). Soluble 
fibre is found in oat bran, barley, nuts, seeds, beans, lentils, peas, and some fruits and 
vegetables. It attaches to cholesterol particles reducing the overall cholesterol level and 
lowers the risk of heart disease. After fermentation in the gut, small chain fatty acids are 
produced which have the ability to modulate gene expression. 
In addition to their individual beneficial properties there appears to be interaction 
between insoluble and soluble fibres in the prevention of Cardiovascular Disease (Mudgil 
2017). 
Later in the chapter, the biome is discussed and the effect fibre plays in disease and 
health. 
 
2.2.2 Possible mechanisms 
Vegetables, fruit and nuts  
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While a synergistic action has been suggested to explain the benefits of the Mediterranean 
diet, individual foods within the diet have been recognised as having health benefits. 
Pekmezovic et al. (2009) suggested a protective role of fruits in the aetiology of multiple 
sclerosis, while Bagheri et al. (2014) suggested a protective role of fruits and low-fat 
dairy products in the aetiology of multiple sclerosis. For this reason, individual foods and 
food groups were examined. 
The reason why these foods have been commented on, is that they are foods commonly 
consumed in Cyprus, and that they could be considered part of a Mediterranean diet, and 
that they potentially have effects on the inflammatory response which may be relevant in 
MS. 
The high carotenoid and flavonoids content of fruits have been shown to be inversely 
associated with intima-media thickness which is a prognostic marker for subclinical 
atherosclerosis (Mursu et al. 2007). Ciccone et al. (2013) reviewed the literature and 
found many data supporting the anti-inflammatory action of carotenoids and their 
protective effect on cardiovascular events. There is a paucity of research examining 
dietary carotenoids and multiple sclerosis. Miller et al. (2019) reviewed the literature and 
concluded flavonoids can play an important role in the management of multiple sclerosis, 
possibly by reducing the expression of pro-inflammatory cytokines such as IL-1beta and 
IL-6 and TNF alpha. 
Phenolic compounds have antioxidative roles, anticarcinogenic, anti-inflammatory and 
antimicrobial activities and may have antimutagenic properties. Polyphenol 
concentrations are some of the highest found in commonly consumed fruits and figs are 
also an excellent source of dietary fibre as well as minerals, vitamins and they are also fat 
and cholesterol-free (Solomon et al. 2006). It is suggested that the skin of a fig is a major 
source of anthocyanins and polyphenols and there are benefits of not discarding fig skins 
before consuming the fig (Solomon et al. 2006). There are numerous papers which have 
shown that figs, which are commonly eaten in Cyprus, may have a beneficial impact on 
inflammatory responses. Some of this evidence has recently been reviewed by Arvaniti et 
al. (2019) who presented the phytochemical compounds found in both fresh and dried fig 
varieties and discussed the potential antioxidant effects which may have a beneficial 
effect on health. The authors also reported contradictory results in the literature regarding 
the effect of air- and sun- drying on the total content of phytochemical compounds, as 
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well as on the concentrations of individual phenolic compounds and carotenoids. The 
review concluded the antioxidant capacity of figs was highly correlated with the amounts 
of phenolic compounds. 
Dates are the fruits of the date palm Phoenix dactylifera and may be eaten fresh or dried 
and stored for later consumption or in various processed forms (Chao and Krueger 2007). 
Citrus fruits include oranges, mandarins, lemons grapefruit and limes. The mandarin 
(Citrus reticulata, Rutaceae) is the largest of the edible citrus fruits and was introduced to 
Europe and North Africa in the 16th Century (Tous and Ferguson 1996). Pro-
inflammatory enzymes, such as induced Nitric Oxide synthase (iNOS) and 
cyclooxygenase (Cox-2), have been shown to be responsible for the elevated levels of NO 
and prostaglandins (PGs), in the pathogenesis of many chronic diseases including 
multiple sclerosis, Parkinson’s and Alzheimer ́s disease and colon cancer due to the 
inflammatory cytokines tumour necrosis factor-alpha (TNF-α), interleukin-1β and 
interleukin-6 as well as those mentioned above (Heiss et al. 2001). Similarly, pro-
inflammatory cytokines such as IL-1beta and IL-6 and TNF alpha are found in multiple 
sclerosis so flavonoids, coumarin and volatile oil from citrus fruit exhibit anti-
inflammatory activity, may protect against or ameliorate this chronic inflammatory 
process (Lv et al. 2015).   
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Beneficial effects of olives and olive oil consumption on health were reviewed by Guo et 
al. (2018). They concluded that phenolic components and other antioxidants in olive 
products including oil, were responsible for some of the benefits. Fernandes et al. (2020) 
undertook a systematic literature review to evaluate the effect of regular olive oil 
consumption in inflammation which may be relevant in the context of multiple sclerosis. 
They summarized evidence from randomized controlled trials on the effect of regular 
dietary intake of olive oil on three inflammatory markers: C-reactive protein, interleukin-
6, and tumor necrosis factor-α. They concluded that olive oil consumption reduced the 
levels of a range of inflammation markers.  
A systematic review and meta-analysis by Morvaridzadeh et al. (2020) assessed the effect 
of pomegranate consumption on oxidative stress parameters. They concluded, based on 
the systematic review, that pomegranate has positive effects on oxidative stress 
parameters, but based on the meta-analysis, because of insufficient clinical trials and 
variable inconsistencies no conclusion could be made on the effect of pomegranate on 
these parameters.  
In their review of citrus fruits, Lv et al. (2015) summerised the anti-oxidative, anti-
inflammatory and neuroprotective effects.  
Nuts are generally rich in protein, fibre, and polyphenolic antioxidants, and they are high 
in monounsaturated fatty acids and polyunsaturated fatty acids (Jahromi et al. 2012). 
They are also excellent sources of copper, iron, zinc, selenium, riboflavin, magnesium, 
niacin, and folic acid and a diet high in nuts shows an inverse relationship with risk for 
cardiovascular diseases (Sabaté 1999).  Omega 3 fatty acid can also inhibit tumour 
necrosis factor alpha (TNF-α), and interferon-gamma (INF-γ) and thus potentially 
suppress demyelination of central nervous system nerve cells which occurs in diseases 
such as multiple sclerosis (Jahromi et al. 2012). Almonds are part of the prunus family, 
which are rich sources of mono- and polyunsaturated fatty acids. Sabate and Ang 
(2009) suggest consuming nuts can reduce the intake of saturated fatty acids (SFA) and 
increase the intake of monounsaturated fatty acids (MUFA) and polyunsaturated fatty 
acids (PUFA) with a resulting benefit on heart health (Sabate and Ang 2009). Indeed, the 
US Food and Drug Administration (FDA) has allowed pistachio producers to state the 
following: “Scientific evidence suggests, but does not prove, that eating 1.5 ounces per 
day of most nuts, such as pistachios, as part of a diet low in SFA and cholesterol may 
reduce the risk of heart disease” (US Food and Drug Administration 2003). In addition, 
pistachios contain high levels of protein, and dietary fibre (Dreher 2012). A review by 
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Dreher (2012) suggested that potential health benefits of pistachio nuts were because 
consumption of these nuts may help reduce oxidative and inflammatory stress. While a 
review by Gorji Moeini and Memariani (2018), suggested the anti-inflammatory 
properties of almond, hazelnut and walnut might affect pathways in the pathology of 
neurodegenerative diseases.  
Carotenoids are phytonutrients that give the distinctive yellow, orange and red colour to 
fruits and vegetables. There are at least 700 carotenoids, and some are important food 
micronutrients (Maiani et al. 2009). Lycopene for example, is found in tomatoes and red 
peppers contain zeaxanthine, while cucumber contains lutein. The antioxidant properties 
of these phytonutrients have been suggested as protective against diseases of chronic 
inflammatory origin (Zakynthinos and Varzakas 2016).  
Vegetables 
There is strong evidence that eating vegetables is beneficial to health. Meta-analysis 
indicate that consumption of fruit and vegetables is associated with a reduced risk of 
cognitive impairment and dementia (Jiang et al. 2017). While a systematic review by 
Aune et al. (2017) concluded that fruit and vegetables reduced the risk of cardiovascular 
disease, total cancer and all-cause mortality (Aune et al. 2017).  
Whole grains 
Whole grains provide carbohydrate, protein, nutrients, vitamins and minerals and can be 
found in breads such as Rye bread, multigrain bread, wholegrain bread and high-fibre 
bread made from whole-grain flours (Black et al. 2018).  They can also be found in 
breakfast cereal such as Shredded Wheat, Bran Flakes, Weetabix and porridge and Muesli 
(Quatela et al. 2018). In population studies, increased intake of whole grain has been 
shown to be associated with lower risk of cardiovascular disease and type 2 diabetes. 
Mann et al. (2017) reiterate the benefits of whole grains and suggest a reduction in C- 
reactive protein (a marker of inflammation) with increased whole grains intake.  The 
American Heart Association guidelines recommend a total dietary fibre intake of 25-30 g 
per day. They state cardiovascular disease morbidity and mortality can be reduced with a 
diet high in fibre, such as whole grains (oats and barley) as these produce lipid-lowering 
effects (Van Horn 1997).  
Fish 
Finfish and shellfish contain omega-3 fatty acids. It is said that omega-3 fatty acids have 
anti-inflammatory properties and result in increased cell membrane fluidity. Evidence 
suggests that these fatty acids have associated cardioprotective, and neuroprotective 
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properties and decreased risk of some chronic disorders including multiple sclerosis 
(Hoare et al. 2016; Langer-Gould et al 2018). Hoare et al. (2016), questioned 267 
multiple sclerosis cases and 517 controls. They found that there was a reduced risk of a 
first clinical diagnosis of CNS demyelination in those who had a higher intake (per g/day) 
of omega-3 polyunsaturated fatty acids (PUFA). This risk reduction was as much as 46% 
when the omega-3 PUFA was from fish (AOR=0.54 (95% CI 0.31-0.93). Baarnhielm 
Olsson and Alfredsson (2014) found decreased multiple sclerosis among people eating 
fatty fish. Fish are also good sources of high-value proteins and have a low fat content. 
They contain various vitamins (D, A, and B) and minerals such as calcium, iodine, zinc, 
iron, and selenium (Torpy Lynm and Glass 2006).  Some fish may have contamination or 
have an accumulation of heavy metals such as mercury (Torpy Lynm and Glass 2006). 
Shark, swordfish, king mackerel, and golden bass are known to be potentially dangerous 
to pregnant women because of the risk of mercury on the developing foetus (Torpy Lynm 
and Glass 2006). Dioxins and polychlorinated biphenyls (PCBs) can also accumulate in 
fish, but the health risks of these chemical levels are considered very low (Torpy Lynm 
and Glass 2006).  
Legumes 
Legumes are rich in plant proteins and are considered to be a good source of fibre and 
carbohydrates. Some may also contain vitamins, calcium, iron, potassium, sodium and 
phosphorous. Chickpeas for example, have been shown to reduce LDL-cholesterol 
(Pittaway Robertson and Ball 2008). Carob is a legume which is native to the 
Mediterranean area and is rich in calcium, potassium and small amounts of iron and 
vitamin B (Berry et al. 2011). Dietary fibre has been shown to reduce the of risks of 
chronic diseases such as cardiovascular disease possibly through a mechanism that 
involves lowering LDL-cholesterol via inhibiting the activity of the enzyme hydroxy-3-
methylglutaryl-CoA reductase (Trinidad et al. 2010). Tumour formation in the colon may 
be prevented by butyrate which is produced by the fermentation of dietary fibre (Fung et 
al. 2012). This may explain why the Mediterranean diet has been associated with 
reducing the risk of colon cancer. In a systematic review and meta-analysis 
Schwingshackl et al. (2017) found that colorectal cancer risk was reduced with 
increased Mediterranean diet adherence (RR: 0.82, 95% CI 0.75 to 0.88, I2 = 73%; n = 
11 studies).  
Alcohol  
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Alcohol consumption has been suggested as both a risk factor (Pekmezovic et al. 2006) 
and as a protective factor for multiple sclerosis (D'hooghe et al.2008; Hedström Hillert 
Olsson and Alfredsson 2014). The suggestion is that red wine is protective in those who 
smoke, because it attenuates the effect of smoking by reducing acute endothelial damage 
(Schwarz et al. 2017). Other studies have found no association (Massa O’Reilly Munger 
and Ascherio 2013). One study found drinking spirits daily was a risk for multiple 
sclerosis development. The case-control study by Pekmezovic et al. (2006) compared 210 
multiple sclerosis cases (Poser’s criteria) with 210 age and sex-matched hospital controls. 
The results showed an OR of 6.7, (p = 0.026) suggesting a significant association between 
consumption of hard liquor per day (daily spirits with no quantities stated) and risk 
of multiple sclerosis. Hedström et al. (2014) found that alcohol consumption was 
protective against multiple sclerosis. They used data from two independent population-
based case-control studies. The first study was the Epidemiological Investigation of 
Multiple Sclerosis (EIMS) study. This consisted of a population aged 16 to 70 years in 
Sweden.  Each case was matched by age (predetermined 5-year age groups), sex, and 
residential area with 2 controls. The study lasted from April 2005 to June 2011. The 
second study was called the Genes and Environment in Multiple Sclerosis (GEMS) study. 
Cases fulfilling the McDonald criteria were identified from the Swedish national multiple 
sclerosis registry. For each case, one control was randomly selected from the national 
population register and matched by age, sex, and residential area. This study took place 
between November 2009 and November 2011. The multiple sclerosis cases and controls 
were different in each study. Participants were categorised as drinkers and non-drinkers. 
Drinkers were further divided into subgroups of low consumption (<50 g/wk for women 
and <100 g/wk for men), moderate consumption (50-112 g/wk for women and 100-168 
g/wk for men), and high consumption (>112 g/wk for women and >168 g/wk for men). 
There were no data for former drinkers stated. The alcohol consumption and risk for 
multiple sclerosis based on EIMS included 745 cases and 1761 controls. While the 
GEMS study included 5874 cases and 5246 controls.  A dose-dependent inverse 
association between alcohol consumption and multiple sclerosis risk was found in both 
studies. This was statistically significant in both men and women. In EIMS, women who 
reported high alcohol consumption had an OR of 0.6 (95% CI, 0.4-1.0) compared with 
nondrinking women, whereas men with high alcohol consumption had an OR of 0.5 (95% 
CI, 0.2-1.0) compared with nondrinking men. The OR for the corresponding comparison 
in GEMS was 0.7 (95% CI, 0.6-0.9) for women and 0.7 (95% CI, 0.5-0.9) for men. The 
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authors concluded that alcohol consumption exhibits a dose-dependent inverse 
association with multiple sclerosis which was more pronounced in smokers (Hedström 
Hillert Olsson and Alfredsson 2014). A meta-analysis of 10 observational studies 
including 9 case-control studies by Zhu et al. (2015) found no evidence that alcohol 
consumption was associated with an increased risk of multiple sclerosis. The odds ratios 
of the association between alcohol consumption and multiple sclerosis was 0.92 (95 % 
confidence interval 0.73-1.17) overall. A comprehensive review by Wang et al. (2015), 
concluded that as yet, there was insufficient evidence to draw a conclusion regarding 
alcohol consumption and multiple sclerosis. With these results, reverse causation needs to 
be considered. In other words, rather than alcohol consumption (the exposure) leading to 
multiple sclerosis (the outcome), it is the multiple sclerosis that leads to the alcohol 
consumption? Voci (2015) highlights the association of alcohol misuse and multiple 
sclerosis and suggests reverse causation may be due to the psychological impact of the 
disease.  
Wine  
Wine and red wine in particular, has been traditionally taken with food in the 
Mediterranean area for centuries (Arnoni and Berry 2015.). The health benefits of wine 
have been documented for over 800 years and red wine has been stated as a beneficial 
component of the Mediterranean diet when consumed daily and in moderation. 
Polyphenols in wine appear to have antioxidant properties, and red wine has more 
polyphenols than white. This is due to the fact that in red wine production the grape juice 
and skin are in contact for up to a month (leading to a partial pickling effect) whereas the 
contact time is shorter in white wine production (Howard et al. 2002). Red wine contains 
high levels of flavonols such as anthocyanins, quercetin, catechin, and resveratrol. 
Resveratrol is found in grape seeds and skins and is said to be protective against 
LDL (Frojdo Durand and Pirola 2008). Similarly, Chiva-Blanch et al. (2011) reported that 
red wine had a greater protective effect on lipid profile than other alcoholic beverages 
(Chiva-Blanch et al. 2011). It is also important to note that there is wide variation in the 
flavonol content of different red wines produced in different regions throughout the 
world. It seems that sunlight on grapes during cultivation is one factor which determines 
the flavonol content. This could explain why in a study, Israeli red wine had higher 
antioxidant capability than UK red wine (Howard et al. 2002). While red wine has been 
said to be beneficial in the Mediterranean diet, more recently small quantities of any 
alcohol have been suggested as beneficial particularly for cardiovascular outcomes. 
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Estruch et al. (2004) explored the anti-inflammatory effects of different alcoholic drinks 
on markers of atherosclerosis. They found that both wine and gin showed anti-
inflammatory effects by reducing plasma fibrinogen (wine by 9% and gin by 5%,) and IL-
1 levels (by 21% and 23%, respectively).  Red wine had an additional effect, of 
decreasing hs-CRP a marker of inflammation (Estruch et al. 2004).  
 
Salt  
Brown et al. (2009) suggest the salt content of a Western diet of processed foods is high 
when compared with the Mediterranean diet. Salt intake varies considerably around the 
world and while the physiological need is about 10–20 mmol/day, in some populations 
such as in the Western World and Japan the amount of salt consumed is in excess of 
200 mmol/day. Processed foods and ‘fast food’ eaten regularly in the Western World can 
be more than 100 times higher in salt than that in homemade meals (Brown Tzoulaki 
Candeias and Elliott 2009) and this has been suggested as a plausible reason for an 
increase in the prevalence of multiple sclerosis over the last 20-30 years (Manzel et al. 
2014). Salt has been shown to modulate the differentiation of human interleukin-17 (IL-
17)-producing helper T cells (Th17 cells). These cells are highly proinflammatory (Wu et 
al. 2013). Since multiple sclerosis is an inflammatory state and the Th17 immune 
response could be important for multiple sclerosis onset (Kostic et al.2014) it is 
understandable that salt has been studied in relation to multiple sclerosis aetiology. When 
salt intake is decreased, this is accompanied by reduced production of proinflammatory 
cytokines such as interleukin (IL)-6 and IL-23, and upregulation of the anti-inflammatory 
cytokine IL-10 (Yi et al.2015). Salt intake is modifiable, therefore if high levels of dietary 
salt were found to be a risk factor for the aetiology multiple sclerosis it would be a useful 
preventative measure to reduce salt intake. The only human study to associate high levels 
of salt with multiple sclerosis was the work of Farez et al. (2014). This was an 
observational study (of disease progression) that measured sodium chloride levels in 
urine. Since 80-90% of salt ingested is excreted in urine, then urine levels give an 
approximation of ingested salt levels. However, Ascherio, and Munger (2016) suggest 
that the evidence so far, is insufficient to draw conclusions. They say only one study has 
implicated high salt intake with an increased risk of multiple sclerosis and as yet, this has 
not been confirmed by other studies. In summary, as yet, there are no human studies to 
suggest salt is associated with the aetiology of multiple sclerosis. 
50 
 Potential Confounders 
Confounders have been defined earlier in the chapter, and confounding as a type of 
systematic error is discussed in detail in the methods chapter. It is generally considered 
that sex, smoking, alcohol, obesity/BMI, and socioeconomic status could be confounding 
variables and distort the association between the exposure and the outcome. 
In order for sex/gender to be a confounder, women would have to eat and drink 
differently to men. This is highly likely. Mattioli et al. (2013) suggest women showed a 
higher adherence to the Mediterranean diet than men and León-Munoz et al. (2012) found 
that men drank significantly more alcohol than women.  Consequently, adjustments were 
made statistically to the results of this study to test if sex was a confounder. 
2.3.1 Sex differences in multiple sclerosis    
At the beginning of the twentieth century it was thought that men were more likely to 
develop multiple sclerosis than women (Brain 1930). This assumption has been disputed, 
and there are theories to suggest why this may have occurred. It may well have been that 
as the breadwinners of the family, men were considered more important for diagnosis, 
and so numerically, more men received more of the trained neurologist’s time. Another 
possibility is that misdiagnosis of women was more common in that era. Hysteria was 
often diagnosed for a range of disorders and this may well have been the case in women 
with multiple sclerosis (Magyari 2014). During the 1940s the sex ratio for the prevalence 
of multiple sclerosis started to reverse, and studies were published that described a ratio 
of 1:1 (Talley 2005). Today, it is widely accepted that the prevalence of multiple sclerosis 
is higher amongst women than men (Orton et al. 2006; Alonso and Hernán 2008; Pugliatti 
et al. 2009; Libert, Dejager, and Pinheiro 2010; Greer and McCombe 2011; Nussinovitch 
and Shoenfeld 2012; Golden and Voskuhl 2017; Waubant 2018). The female to male sex 
ratio by year of birth has been increasing for at least 50 years and now exceeds 3·2:1 in 
Canada (p<0.0001) (Orton et al. 2008). 
In their systematic review, Alonso and Hernán found that the female-to-male ratio in 
multiple sclerosis incidence had increased over time. They estimated that in 1955 the 
ratio was 1.4:1 but this had risen to 2.3:1 by 2000 (Alonso and Hernán 2008). The 
increase in the female-to-male ratio has been said to be due to the increased incidence in 
women, and not by a decreased incidence in men (Golden and Voskuhl 2017). One theory 
to explain the increased incidence reported in women was the use of the oral 
contraceptive pill. However, using data from The Royal College of General Practitioners’ 
Oral Contraception Study, Thorogood and Hannaford (1998) found there was not a 
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greatly elevated risk of multiple sclerosis during or after use of combined oral 
contraceptives. 
In a Canadian study involving 5493 multiple sclerosis patients, women with multiple 
sclerosis had earlier menarche than their controls, while men with multiple sclerosis and 
their controls reached puberty at the same time (Ramagopalan et al. 2009). This raises 
questions about a hormonal influence on development of the disease and perhaps 
protective effects of male hormones. However, there are some contradictory findings with 
regard to hormones. Nulliparity, and delayed childbearing, seem to increase the risk of 
multiple sclerosis (Bove and Chitnis 2014). Whereas, an Iranian case-control study of 399 
cases and 541 controls found a protective association between multiple sclerosis and 
older age at menarche (OR = 0.90 95% CI = 0.82–0.98), older maternal age at first 
childbirth (OR = 0.94 95% CI = 0.89 − 0.99) and higher number of parities (OR = 0.61 
95% CI = 0.49 − 0.75) (Salehi et al. 2018).  
In paediatric multiple sclerosis, two peaks of the disease occur. One at 4 years of age and 
the other at 15 years of age. The sex ratio was 1:1 in the 4year olds but had shifted to a 
female dominance at 9 years of age. Puberty typically starts between 9 and 14 years of 
age in boys and 8 and 12 years of age in girls (Waubant 2018). It has been suggested that 
multiple sclerosis onset may be related to hormonal changes associated with puberty and 
the age of puberty has tended to decrease over time (Waubant 2018).  
2.3.2 Obesity and multiple sclerosis and the Mediterranean diet 
In order to be a confounder, obese people would have to eat differently to non-obese 
people. This is quite likely. In addition to confounding, obesity must be considered in 
relation to reverse causation. Patients with multiple sclerosis may become less mobile as 
the disease progresses, which may lead to weight gain. It is possible that comfort eating 
as a response to multiple sclerosis could lead to over-eating and weight gain. 
 
Body Mass Index and Body Mass Index categories  
It is widely accepted that obesity is associated with a low-grade inflammatory state 
Calder et al. (2011), and obesity is a recognised risk factor for multiple sclerosis 
(Vimaleswaran et al. 2013; Gianfrancesco et al. 2017; Olsson Barcellos and Alfredsson 
2017; Correale Farez and Gaitán 2017; Alfredsson and Olsson 2018). A high level of 
evidence from meta-analysis by Liu et al. (2016) supports this. In order to assess the 
effect of reverse causation, it would be necessary to know the level of obesity in multiple 
sclerosis patients prior to their diagnosis. Jelinek (2017) suggests that many of the 
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observational studies associating obesity and multiple sclerosis have not adequately 
accounted for confounding or reverse causation.  
Body Mass Index (BMI) is the most common method of measuring obesity in adults 
because it is cheap and easy to calculate. Munger et al. (2009) used data from 121,700 
women in the Nurses’ Health Study and 116,671 women from the Nurses’ Health Study 
II. Weight and height at 18 years old was used to determine BMI. They found that obesity 
(BMI >30 kg/m2) was associated with a two-fold increased risk of multiple sclerosis 
(Munger et al.2009). It might be suggested that this and other case-control studies on 
obesity are influenced by bias which could potentially be introduced by confounding and 
reverse causation (Mokry et al. 2016). The key question is whether the BMI was high 
before diagnosis or after it. This has been addressed by Hedström Olsson and Alfredsson 
(2012) who conducted a case-control study in Sweden of 1571 multiple sclerosis cases 
and 3371 controls. The authors found that those subjects whose BMI exceeded 27 kg/ at 
age 20 years of age had a two-fold increased risk of developing multiple sclerosis 
compared with normal weight subjects. The conclusion was that BMI during adolescence, 
and not childhood, predicted multiple sclerosis risk. The questionnaire in this study did 
not ask about childhood BMI, but in the medical history section a question about 
diagnosis of overweight and obesity was asked, and if so a date of diagnosis. In this way 
it was possible to determine if obesity was diagnosed in childhood, adolescence or 
adulthood. A further issue that might be raised is recall bias and the validity of weight 
reporting. The authors address this citing the Nurses’ Health Study (Munger et al. 2009), 
which found high correlations between recalled and measured past weight. In the Nurses’ 
Health Study weight was slightly under-reported especially weight at 18 years of age, 
with a mean difference of 1.4 kg. Of course, one might expect nurses to be better at 
reporting their weight than compared to the rest of the population. The suggestion is that 
under-reporting of weight probably does not differ significantly between cases and 
controls (Hedström Olsson and Alfredsson 2012). Langer-Gould et al. (2013) undertook a 
cohort study to research clinically isolated syndrome (CIS) in children enrolled in the 
KPSC Children's Health Study between 2007 and 2009. Body mass index had been 
obtained prior to symptom onset. There were 920,034 (89.2% of eligible patients) who 
had at least one valid weight and height in the 3-year study period. Apart from the lowest 
and highest ends of the socioeconomic spectrum, the KPSC paediatric membership was 
representative of the general paediatric population in Southern California with respect to 
ethnicity, age, gender, and socioeconomic status. The definitions for overweight and 
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obesity in children and adolescents were based on the sex-specific BMI-for-age growth 
charts developed by the Centres for Disease Control and Prevention and WHO definitions 
for overweight and obesity in adults. After exclusions, 913,172 patients were included in 
the final analytical cohort. Results showed 75 children had newly diagnosed CIS. Thirty-
eight (50.7%) children and adolescents with CIS were overweight or obese. After 
statistical analysis they concluded that childhood obesity was independently associated 
with a significantly increased risk of CIS in girls but not boys. An adjusted odds ratio of 
1.58 was found in overweight girls compared to normal and an adjusted odds ratio of 3.76 
in extremely obese girls. The authors postulate that high levels of oestrogen coupled with 
low grade inflammation released by adipose tissue in the obese may accelerate CIS to 
multiple sclerosis onset. The suggestion is that obese boys never reach the androgen 
levels of the girls. Pinhas‐Hamiel et al. (2015) compared 130 adult disabled multiple 
sclerosis patients to the general population. They found disabled multiple sclerosis 
patients had lower rates of obesity assessed by BMI at 18.5%. However, these patients 
had higher rates of increased waist circumference and 56% had central obesity 
determined by waist circumference despite having a lower BMI. A meta-analysis by Liu 
et al. (2016) examined 5 observational studies including 3 case-controls and 2 cohort 
studies. The relative risk (pooled) for overweight and obesity during childhood and 
adolescence when compared with normal weight (body mass index = 18.5-24.9 kg/m2) 
was 1.44 (95% CI 1.22-1.70) and 2.01 (95% CI 1.63-2.48), respectively. The conclusion 
was that higher BMI in childhood and adolescence leads to an increased risk of multiple 
sclerosis. Severe obesity was an even stronger risk. These results were statistically 
significant in females, but not in the males. 
As stated earlier, confounding and reverse causation must be kept in mind when 
considering any association between obesity and multiple sclerosis. In the results section, 
obesity as a confounder is tested statistically. 
 Smoking and multiple sclerosis and the Mediterranean diet 
In order to be a confounder, smokers or previous smokers would have to eat differently to 
never smokers. This is possible, since smoking is an unhealthy life choice and someone 
making an unhealthy life choice might also make an unhealthy eating choice or be less 
likely to make a healthy diet choice such as those in the Mediterranean diet. 
 
2.4.1 Evidence of smoking as a risk factor for multiple sclerosis  
For many years smoking has been suggested as a risk factor for development of multiple 
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sclerosis (Antonovsky et al. 1965; Villard-Mackintosh and Vessey 1993; Ramanujam et 
al. 2015; Gross and Lublin 2017). Much of the evidence comes from large cohort studies 
such as The Oxford Family Planning Association Study.  
The Nurses' Health Study of American women showed a 60% greater multiple sclerosis 
rate among current smokers than among individuals who never smoked. The study also 
showed that the multiple sclerosis rate increased with cumulative smoking exposure, with 
the greatest risk (1.7 times) among smokers who had smoked for 25 years or more. The 
large prospective design of these studies confirms that smoking exposure was evaluated 
prior to a multiple sclerosis diagnosis, thus establishing a temporal relationship. 
A metanalysis by Hawkes et al. (2007) stated that six case-control studies had shown 
similar results to the cohort studies mentioned earlier, that is, the risk of multiple sclerosis 
is increased for those who smoked prior to disease onset. The increased odds ratios, 
ranged from 1.22 95% CI: 1.04,1.48 to 1.51 95% CI: 1.22,1.87, depending on the method 
of analysis. A summary of selected studies and their main outcomes appear in Table 3. 
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Table 3 Selected studies of smoking and multiple sclerosis 95 % CI 1.35–1.63 
 
Study Population size and type Main outcome 
The Oxford Family 
Planning Association Study 
Villard-Mackintosh and 
Vessey (1993). 
Prospective study of more 
than 17,000 British 
women, 63 multiple 
sclerosis cases. 
The risk of multiple 
sclerosis for women 
smoking 15 or more 
cigarettes per day was 
almost twice that of 
women who had never 
smoked relative risk (RR) 
1.8  95% CI: 95% CI: 
0.9,2.2 
The Royal College of 
General Practitioners’ Oral 
Contraception Study 
Thorogood and Hannaford 
(1998) 
Prospective study of 
46,000 British women. 
The risk of multiple 
sclerosis for women 
smoking 15 or more 
cigarettes per day was 
(RR) 1.4 95% CI: 0.9,2.2, 
The Nurses' Health Study I 
and II Hernan Oleky and 
Ascherio (2001). 
121,700 women and 
116,671 US women 
The relative incidence rate 
for current smokers was 
1.6 95% CI: 1.2,2.1, and 
1.2 95% CI: 0.9,1.6 for 
past smokers 
A case-control study in 
Sweden Hedström et al. 
(2013). 
1,798 cases and 3,907 
controls 
Smoking was related to an 
increased risk of multiple 
sclerosis and in a dose 
related manner. Compared 
with never smokers, ‘ever 
smokers’ had an increased 
risk of developing multiple 
sclerosis OR 1.5 95% CI: 
1.35,1.63, 
 
2.4.2 Passive /second hand smoking and multiple sclerosis   
Passive smoking has been associated with almost all the diseases associated with smoking 
as the toxic chemicals found in smoking are also found in second hand smoke.  
In an overview of systematic reviews Cao et al. (2015) highlight the difficulties in 
measuring passive smoking. The type of tobacco smoked, and the volatility of the agents 
make comparisons difficult (Kritz Schmid and Sinzinger 1995). 
Metabolites of tobacco have consistently been used as biomarkers for passive smoking. 
Measurements may be made in blood, urine, saliva, breast milk, amniotic fluid, hair, and 
teeth (Winstanley 2008).  The most commonly used biomarker is cotinine, which is a 
major metabolite of nicotine. It is sensitive enough to distinguish between people not 
exposed to second-hand smoke and those exposed to low, moderate and high levels of 
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second-hand smoke. The half-life of cotinine is around 20 hours, so cotinine levels reflect 
exposure to tobacco smoke in the preceding one or two days. Nicotine can be analysed 
from hair samples and can indicate exposure over a period of months (Winstanley 2008). 
Alternatively, the measurement of urinary trans-muconic acid (Taniguchi et al. 1999) or 
expired carbon monoxide (CO) (Belabbaci et al. 2016) have been used. 
A summary of selected studies and their main outcomes appear in Table 4. 
 
Table 4 Selected studies of smoking and passive smoking and the association with 
multiple sclerosis 
Study Population size and type Main outcome 
Hernan et al. (2001) The Nurses 1 study of 
121,700 women and The 
Nurses II of 116,671 
The relative rate increased 
significantly with 
cumulative exposure to 
smoking. Compared with 
that for women who never 
smoked, the relative 
incidence rate of multiple 
sclerosis was 1.6 (95% CI: 
1.2, 2.1) among current 
smokers and 1.2 (95% CI: 
0.9, 1.6) among past 
smokers after adjustment 
for age, latitude, and 
ancestry. The relative rate 
increased significantly with 
cumulative exposure to 
smoking (p for trend < 
0.05), from 1.1 (95% 
confidence interval: 0.8, 
1.6) for 1-9 pack-years to 
1.5 (95% CI: 1.2, 2.1) for 
10-24 pack-years and 1.7 
(95% CI: 1.2, 2.4) for 25 or 
more pack-years 
 
Ghadirian et al. (2001) 197 multiple sclerosis 
cases and 202 controls 
‘Ever-smokers’ 20-40 
cigarettes per day an odds 
ratio (OR) of 1.9 (95% CI: 
1.2, 3.2) Heavy smokers-40 
per day the odds ratio was 
OR 5.5; 95% CI: 1.7, 17.8) 
Sundström et al. (2008) Cotinine levels of 109 
multiple sclerosis cases 
and 218 matched controls. 
Elevated cotinine was 
associated with an 
increased risk for multiple 
sclerosis 
57 
OR=3.9; 95% CI: 1.3–12 
Hawkes et al. (2007) Metanalysis Increased odds ratios, 
ranged from 1.22 95% CI: 
1.04,1.48 to 1.51 95% CI: 
1.22,1.87 
Hedström et al. (2011) 695 cases, 1635 controls Never-smokers exposed to 
passive smoking had an 
increased risk OR 1.3, 95% 
CI 1.1-1.6 
Abdollahpour et al. (2017) 547 cases and 1057 
controls 






The data have been inconsistent regarding the influence of passive smoking on multiple 
sclerosis.  An extreme example is the effect of maternal smoking on the foetus during 
pregnancy which showed no risk of multiple sclerosis risk in the offspring (Montgomery 
et al. 2008; Ramagopalan et al. 2013). On the other hand, Zhang et al. (2016) undertook a 
meta-analysis based on 20,626 cases from case-control and cohort studies. They included 
four study populations that excluded active smokers and the pooled OR was 1.24 (95% CI 
[1.03–1.49], p = 0.028), indicating that exposure to passive smoking increases the risk of 
multiple sclerosis by 24% compared with unexposed individuals.  
It has been estimated that the risk of multiple sclerosis is increased by approximately 50% 
in cigarette smokers (Handel et al. 2011; Amato et al. 2017). And this risk has been said to 
increase in a dose-related manner (Kamm Uitdehaag and Polman 2014; McKay et al. 2016). 
Smoking and passive smoking are said to pose a considerable and preventable risk of 
acquiring multiple sclerosis (Hedström et al. 2017). Indeed, the suggestion is that in 
Sweden about 20% of all multiple sclerosis cases are attributable to active or passive 
smoking (Hedström et al. 2017). 
 
2.4.3 Smoking in Cyprus    
The association between smoking and multiple sclerosis is strong in observational 
studies, but no studies were found for Cyprus. 
There are large numbers of Cypriots who smoke. Eurostat (2014), suggests that 25.2% of 
Cypriots smoked in 2014. Only Bulgaria 27.3%, Turkey 27.2%, Greece 27% and 
Hungary 25.8% had a higher percentage of the population that smoked. 
These data are similar to those found by Zinonos (2016) who suggest that 26.5% of the 
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Cypriot population smoke. In a study of healthcare staff at Nicosia General Hospital the 
figure was slightly higher. Of 119 doctors and 392 nurses questioned, 28.6% of the doctors 
and 28.1% of the nurses said they currently smoked (Zinonos et al. 2016). By comparison, 
a study of 600 participants published in 2015 found that 37.7% (n=220) had never smoked, 
19% (n=114) were former smokers, 9.2% (n=55) were occasional smokers and 35% 
(n=211) were daily smokers (Lazuras et al. 2015). The figure of 35% for daily smokers is 
10% higher than the Eurostat estimate and amounts to over 1/3 of the adult Cypriot 
population. Cooter et al. (2015) found that the percentage of Cypriot males who smoked 
daily had remained around 38% between 2003 and 2008 (down from 43% in 1989) and this 
percentage was similar in 2014 at 37.3% (Eurostat 2014). However, females who smoked 
daily had risen from 7% in 1989 to 10.5% in 2003 and then 14.3% in 2008 (Cooter et 
al.2015; Farazi et al.2015). It remains around 14% according to the 2014 data (Eurostat 
2014) but there is no explanation why smoking among women doubled between 1989 and 
2008.  Nicolaou et al. (2016) used data from the 2009 Countrywide Integrated Non-
communicable Disease Intervention questionnaire to assess smoking in the Greek Cypriot 
population. There were 3,021 young and middle-aged adults (25-64 years old) in the survey. 
It was found that 50.8 % of adult men and 21.2 % of adult women currently smoked, and 
that just around 50% of the sample either currently smoked or had ever smoked. Since large 
numbers of Cypriots smoke (over 25%), it is not surprising that many teenagers are 
subjected to passive smoking. This could be a major risk factor in acquiring multiple 
sclerosis.  
Multiple sclerosis is approximately twice as common in women than men and has increased 
in prevalence in Cyprus from estimates by Middleton and Dean (1991) of 44.5 per 100 000 
to 198 per 100,000 (Charalambidou Pantzaris and Patrikios 2016). A partial explanation 
could be the rise in smoking among women. 
Smoking amongst Cypriot teenagers is particularly alarming. Cypriot researchers defined 
current smoking, as having smoked cigarettes on one or more days of the past 30 days. 
When 7,294 Middlle school children (12-15year-olds) were surveyed it was found that 
13% of boys and 7% of girls had smoked. When 5,952 high schools (15-18-year-olds) 
teenagers were surveyed, the figures rose to 36% among boys and 23% among girls. 
(Christophi et al. 2008: Christophi et al. 2016). This is in contrast to a 2003 study which 
found 60% of high school male teenagers had ever smoked but only 25% of males had 
smoked in the past 30 days (Bjarnason et al. 2003). The rise of 11% over this 13year time 
period is in contrast with the decline seen in some other countries. What is also 
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interesting is that in 2003 only 9% of high school girls were smokers but by 2016 this had 
risen to 26%. This is almost a three-fold increase. Further data collection in 2016 on 
passive smoking, provided even more worrying results.  More than half of the students 
(53.5%) had at least one parent that smoked, and 84.6% lived in homes where others 
smoked around them. Outside the home, 91% said they were present among other 
smokers (Christophi et al. 2008). 
Between a quarter and a third of Cypriots smoke and most of the regular smokers, smoke 
cigarettes. Many more men smoke than women, but while the male numbers have 
remained similar over a 19year period the number of women smokers has doubled. 
The number of children and adolescents who smoke is high and seems to be increasing, 
especially among girls. It is well- known that teenage smokers progress to adult smokers, 
so this is worrying for future healthcare needs. If smoking does indeed predispose people 
to multiple sclerosis, then the prevalence of multiple sclerosis is likely to increase if 
smoking among Cypriots increases. 
 
 Socioeconomic status and multiple sclerosis and the Mediterranean diet 
In order to be a confounder, people from one socioeconomic group would have to eat 
differently to those from another. This is highly plausible, and results were tested 
statistically to detect confounding. 
Zilber and Kahana (1996) conducted a case-control study which included 93 cases and 94 
matched controls. The study found patients and their parents had higher educational 
levels than controls (p < 0.01) and concluded that less-advantaged socioeconomic status 
were protective against multiple sclerosis, but this observation was only statistically 
significant when living conditions are well below average. A case-control study 
conducted by Kurtzke and Page (1997) recruited 5,305 US veterans. Multiple sclerosis 
cases totalled 80 and 77 were included in the study and matched with controls. The 
socioeconomic data was obtained from military records therefore eliminating recall bias. 
The authors found that higher socioeconomic status was associated with higher risk of 
multiple sclerosis in black and white men and white women (Kurtzke and Page 1997). 
The sub group of black military women with multiple sclerosis was very small and this 
may account for them not having a similar association with socioeconomic status to the 
men.  
There have been several problems with regard to socioeconomic status (SES) association 
and multiple sclerosis over the last 50 or 60 years. First of all is the definition of 
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socioeconomic status which varies considerably from study to study. One definition 
includes the summation of income, education and occupation (Bradley and Corwyn 
2002). The MacArthur Scale of Subjective Social Status was developed in order to make 
sense of a person’s view of their own position on social ladder (Adler and Stewart 2007). 
Obese people have been shown to have an increased risk of multiple sclerosis and obesity 
is associated with lower SES (Mayor 2017) so confounding is likely. There was no strong 
association between SES and multiple sclerosis in a Danish national register study. 
However, there was a tendency towards a reduced risk of multiple sclerosis among 
children of mothers with higher education (Nielsen et al. 2013). This is contrary to earlier 
published data. In a review published in 2015 Berg‐Hansen and Celius state that there is 
still controversy as to whether the risk of multiple sclerosis is affected by socio-economic 
status (SES) (Berg‐Hansen and Celius 2015). A systematic review published in 2015 
found that there were inconsistent associations between high SES and increased multiple 
sclerosis risk. The authors concluded that most studies failed to control for other 
important risk factors for multiple sclerosis (Goulden Ibrahim and Wolfson 2015). 
Further work by Goulden et al. (2016) found that when adjusting for other risk factors 
and taking three countries into account (Norway, Canada and Italy) there was no 
consistent association between parental SES and multiple sclerosis risk, except a 
protective effect of low SES only found only in Canada. Bjørnevik et al. (2016) analysed 
4494 multiple sclerosis patients in a Norwegian registry born between 1930 and 1979. 
The level of education was found to be inversely associated with multiple sclerosis risk 
(p trend < 0.001) with an odds ratio (OR) of 0.73 (95% confidence interval (CI): 0.59–
0.90) when comparing the highest and lowest levels. The conclusion was that the level of 
education was inversely associated with multiple sclerosis risk. Further work by 
Bjørnevik examined education levels in 953 multiple sclerosis patients and 1717 healthy 
controls from Norway. Higher levels of education are associated with decreased multiple 
sclerosis risk (p trend = 0.001) with an OR of 0.53 (95% CI 0.41–0.68) when comparing 
those with the highest and lowest level of education. The risk was slightly reduced when 
adjusted for other risk factors such as smoking. 
Smokers have been shown to have an increased risk of multiple sclerosis, and there are 
more smokers in lower social groups thus confounding the effects of SES on multiple 
sclerosis (Hiscock et al. 2012). Bjørnevik et al. (2016). concluded that a higher level of 
education was associated with lower multiple sclerosis risk. A healthy diet has been 
associated with higher socio-economic status (Tong et al. 2018) which may in part be 
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explained by more disposable income in this group of people. However, this is not true in 
all populations. For example, Yau et al.2019 found diet quality varied across ethnic 
groups and low socioeconomic status was not consistently associated with poor diet 
quality. 
If SES is associated with the risk of multiple sclerosis, (I do not think there is enough 
consistent evidence to say it is) there are several theoretical mechanisms.  SES and diet 
are related (lower SES is often but not always associated with poorer diet). Diet and 
obesity are related, (poorer diet may be associated with increased obesity). SES and 
obesity are related, lower SES may be related to poorer diet and hence higher obesity. 
SES is related to smoking habits (lower SES populations are more likely to smoke) and so 
is possible smoking confounds both the associations of SES with diet and obesity. Any 
associations of SES and the risk of acquiring multiple sclerosis is potentially confounded 
by smoking. 
Other risk factors for multiple sclerosis were considered but deemed unlikely to be 
confounders in this study. These included: skin type and sunlight exposure, latitude, 
vitamin D deficiency, month of year born, infections, inflammatory diseases and genetic 
factors. 
Less likely associations: Lack of exercise, previous surgeries, stress and periodontal 
disease.  
Debunked theories have included: Amalgam fillings, MMR and other vaccinations and 
geographical clusters.  
 
Summary and appraisal of evidence 
It is widely accepted that genetics accounts for 15-30% of the aetiology of multiple 
sclerosis (Wang et al. 2016), and environmental triggers combined with this genetic 
susceptibility most likely initiate the disease in late teenage years and the early years of 
adulthood. Migration studies have supported the notion that multiple sclerosis is due more 
to environmental exposure than genetics (Kurtzke 2013). A latent period exists, and 
disease diagnosis occurs sometime after exposure. Many risks factors have been proposed 
over the years and although there are strong candidates, causative agents remain elusive. 
Evidence of association has mainly been from observational studies and in some studies 
the results are contradictory. While the quality of other studies is on occasions low. 
Viruses 
There is strong evidence for viral triggers especially EBV. Using serology testing, almost 
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all multiple sclerosis cases show past exposure to EBV. The past medical history section 
of the questionnaire therefore asked questions about previous viral infections. 
Smoking 
Smoking is an established risk factor for multiple sclerosis (Hedstrom,Hillert and Olsson 
2013). Large cohort studies and meta-analysis support the view that smoking prior to 
disease onset increased the risk of multiple sclerosis. Hawkes (2007) suggests the OR 
ranged from 1.22 to 1.51. 
In the current study smoking is a potential confounder and needs to be statistically tested 
and interpreted in the results. 
Sex/gender 
Initially, men were affected more than women, but the sex ratio has changed over the 
decades and it is now accepted that women are affected about 3 time more than men, 
(Waubant 2018). Sex/gender is a potential confounder in the current study. 
Vitamin D deficiency 
For many years vitamin D deficiency has been proposed as a risk factor for multiple 
sclerosis. There is strong evidence for this association, supported by several large cohort 
studies including that of Munger et al. (2016) and meta-analysis (Duan et al.2014). 
Questions on vitamin D deficiency were included in the questionnaire of this current 
study as it was a potential confounder. 
Socioeconomic status 
Buchter Dunkel and Li (2012) proposed that the risk of multiple sclerosis could be related 
to lifestyle and purchasing power. Those of a higher high socioeconomic status being 
potentially more at risk. Goulden Ibrahim and Wolfson (2014) state high socioeconomic 
status (SES) is generally associated with better health outcomes but their systematic 
review found any risk of high SES and multiple sclerosis to be inconsistent. Abdollahpour 
et al. (2018) found no association between socioeconomic status and risk of multiple 
sclerosis. 
It has not been possible draw any conclusions from the literature review and the 
association of SES and multiple sclerosis seems to be inconsistent. Perhaps the 
confounding effect of higher smoking levels in lower socioeconomic groups is a factor. 
Diet and the gut microbiota 
Substantial evidence links diet and the gut microbiota (Szychlinska et al. 2019). It has 
been suggested that the gut biome of multiple sclerosis patients is different to the rest of 
the population (Kirby and Ochoa-Repáraz 2018). It is possible that the gut microbiome 
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can interact with the central nervous system through bidirectional signaling (Carabotti et 
al. 2015). While the theoretical link between diet and the risk of acquiring multiple 
sclerosis via changes to the biome is plausible, few studies have addressed this. Many 
dietary studies implicate vitamin D deficiency as a risk for multiple sclerosis. There is a 
paucity of studies in this area of research., whilst there are several reviews and animal 
studies. The following two studies are closely linked to the current study: 
Ghazavi et al. (2019) conducted an age-match case control study in Iran and found a 
higher intake of processed meat OR 2.07 (95% CI:(1.18-3.63) and non-processed meat 
OR1.38 (1.13-1.68)) were found in the cases. Sedaghat et al. (2016) found in a case 
control study (69 case and 140 controls) a Mediterranean type diet was less likely to be 
consumed by multiple sclerosis cases. 
Alcohol 
Consuming alcohol has been suggested as both a risk factor (Pekmezovic et al. 2006) and 
as a protective factor for multiple sclerosis (Hedström Hillert Olsson and Alfredsson 
2014). Wang et al. (2015) reviewed the literature and stated that some cross-sectional 
studies with large sample size had poor responses to the questions on alcohol. They 
concluded that there is insufficient information to suggest an association between 
consuming alcohol and multiple sclerosis. 
Salt 
While animal studies suggest high levels of salt may be associated with a risk of multiple 
sclerosis, there are no human studies to support this association. 
Skin type and sunlight exposure 
Skin type and sunlight exposure have both been proposed as risk factors for acquiring 
multiple sclerosis, but neither are likely to affect diet in cases or controls. 
Latitude 
Several meta-analyses support the view that a latitude gradient of multiple sclerosis 
incidence in Europe exists (Wang Simpson and Taylor 2018) but this may reflect vitamin 
D levels which are affected by seasonal changes in sunlight exposure (Longo et al. 2018). 
Other studies have suggested this latitude gradient has declined for example in Norway 
where Grytten Torkildsen and Myhr (2015) suggest there is no longer evidence of a 
latitude gradient. 
The latitude effect is academic in respect to the current study as all the participants are 
from the same latitude. 
Lack of exercise, previous surgeries, stress and periodontal disease 
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There is little or no evidence to support these theories 
Debunked theories have included: Amalgam fillings, MMR and other vaccinations and 
geographical clusters.  
To recap, the association between diet, or a Mediterranean type diet and the aetiology of 
multiple sclerosis is limited. Few studies have examined this association. However, there 
are many diet studies, and some Mediterranean diet studies suggesting an association of 
diet and cardiovascular disease. To a lesser extent, there is a diet association to colorectal 
cancer. 
This study aims to full some of the gaps in the current knowledge. 
 
 
3 Chapter 3   Aims and objectives 
 
Aims 
The primary aim of this study was to investigate the relationship between a 
Mediterranean dietary pattern and multiple sclerosis in a European population with a 
higher prevalence of the disease than countries of a similar latitude.    
Secondary aims were to investigate the relationship between dietary intake of specific 
food groups (e.g. fruits, vegetables, alcohol) and individual foods (e.g. tomatoes, citrus 
fruit) and multiple sclerosis in this population. 
 
The Null hypothesis tested was that there is no difference in Mediterranean diet pattern 
score, or intake of specific food groups, or foods, between multiple sclerosis cases and 
control participants. 
 
The objectives were: 
• To design and carry out a population-based case-control study in the Republic of 
Cyprus, which has a higher than average prevalence of multiple sclerosis in the 
general population. 
• To measure diet and socio-demographic factors in patients attending for treatment 
of multiple sclerosis compared with “healthy”, age and gender-matched control 
subjects. 
• To assign a Mediterranean diet score to the recorded diets and compare this score 
between multiple sclerosis patients and age-matched controls. 
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• To identify specific food groups and individual foods characteristic of the 
Mediterranean diet and compare intake of these foods between multiple sclerosis 
patients and age-matched controls. 
• To investigate the impact of socio-demographic factors on these relationships. 




4 Chapter 4. Methods  
 
This chapter deals with the methods used to address the aims and objectives of the study 
outlined in Chapter 3. Many authors of case-control studies follow the 22point STROBE 
Checklist because it is considered the gold standard for this type of study (Lynch Popchak 
and Irrgang 2019).  STROBE stands for STrengthening the Reporting of OBservational 
studies in Epidemiology; and was adopted for this study.  The STROBE Checklist is 
shown in Appendix B. This chapter begins with the study design and setting.  It then 
explains the selection of cases and controls for the logistic regression analysis and then 
describes the selection of cases and controls for the age-matched conditional regression 
analysis. Variables and potential confounders are addressed next. Finally, data sources, 
bias, study size, analysis of quantitative variables and statistical methods are described. 
 
 Ethics approval  
The study was completed in compliance with the Declaration of Helsinki for studies 
involving human volunteers.  Study recruitment did not commence until Ethical approval 
was obtained.  Ethical approval was provided by the University of Newcastle upon Tyne 
Faculty of Medical Sciences Research Ethics Committee, reference number 0 1 2 6 9 
granted on 15/5/17 (Appendix E 2).  Local Ethical approval was provided by the Cyprus 
National Bioethics Committee, reference number 0984669 (Appendix E 1). 
All study literature was provided in Greek and English and all volunteers gave written 
informed consent after having the opportunity to ask questions of the research team.  
Participants were told that they could withdraw at any stage of completing the 
questionnaire without needing to provide an explanation and without compromising any 
aspect of their treatment.  
 
 The study design  
This observational study was a population-based case-control study. The study population 
was restricted to the Cypriot population of The Republic of Cyprus, since the Turkish 
occupied third of the island posed language and ethics challenges to the study beyond the 
time-frame available. Exposure to the variable of interest was recorded in both cases and 
controls and any association exposure and disease assessed.  
As stated in chapter 1, multiple sclerosis is a rare disease which is most likely initiated by 
a trigger or triggers in genetically susceptible people and is often diagnosed some years 
after exposure.  A case-control study is a useful study method for a rare outcome or for an 
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outcome that may have a long latent period.  A case-control study can be used to study 
multiple exposures, and associations can be made between exposure and outcome.  Case-
control studies are relatively fast to complete, especially compared with cohort studies.  
 
4.2.1 Participant Inclusion criteria 
Cases and controls were Greek Cypriots recruited from the general population from the 
Republic of Cyprus.  Any person >18yrs old with diagnosed multiple sclerosis or a 
healthy person was eligible to take part.  The study purpose and requirements were 
described to potential participants who also read the study aims (Appendix C).  If 
participants agreed to take part, they signed an informed consent form before entering the 
study (Appendix C)  
Defining a “Greek Cypriot” proved rather difficult in practice. A “Greek Cypriot” is a 
social construct and anyone who considered themselves a “Greek Cypriot” was deemed a 
“Greek Cypriot”.  Anyone born in The Republic of Cyprus was also classed a “Greek 
Cypriot” if their parents deemed themselves a “Greek Cypriot”.   
Some people who met the study definition of “Greek Cypriot” chose to consider 
themselves something other than “Greek Cypriot” and entered that in the ethnicity section 
of the questionnaire.  
 
4.2.2  Participant Exclusion Criteria 
Any potential case or control aged under 18 at the time of the study was excluded. 
Anyone diagnosed with Clinically Isolated Syndrome (CIS) (pre- multiple sclerosis 
symptoms, but not a definitive diagnosis) were not regarded as a multiple sclerosis case 
and were also excluded.  Individuals unable to provide informed consent to take part for 
whatever reason were excluded.  
 
 Recruitment of Cases  
Multiple sclerosis cases were defined using recognised diagnostic criteria and selected by 
convenience sampling due to the small numbers of cases on the island and the timescale 
of the study.  Multiple sclerosis cases were “Greek Cypriot” people aged 18 and over, 
currently living in The Republic of Cyprus with a confirmed diagnosis of multiple 
sclerosis. The diagnosis of multiple sclerosis had to have been made by a consultant 
neurologist using the accepted diagnostic criteria at the time of diagnosis. There was no 
time limit between diagnosis and the time of taking part in the study. 
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Approximately 435 questionnaires were given to patients at The Cyprus Institute of 
Neurology and Genetics (CING) when they attended for their review during a one-year 
period between August 2017 to August 2018.  Completed questionnaires were available 
for 109 cases from this clinic. Some of the self-administered questionnaires n=10 
(approximately10%) were completed on the premises, while the patients waited for 
physiotherapy or another treatment, whereas others were completed at home and brought 
back to the clinic during a subsequent appointment or when the participant was passing 
the clinic.  
In Limassol, 15 questionnaires were given to patients with multiple sclerosis at The Ygia 
Polyclinic Private Hospital.  Four completed questionnaires were obtained for cases from 
this source. 
It is possible that this “clinic-based” recruitment could exclude those multiple sclerosis 
cases which were “least disabled” because they did not seek regular treatment and the 
“most disabled” since they may be house-bound and not able to attend hospital clinics. 
For this reason, in Nicosia, at the Nicosia Multiple Sclerosis Society headquarters, 20 
questionnaires were given throughout the year to patients attending for social functions 
and/or physiotherapy.  A total of 14 multiple sclerosis patients were recruited from this 
location. 
All types of multiple sclerosis were regarded as multiple sclerosis and no distinction was 








































































Over a 12month period 435 questionnaires were given 
to multiple sclerosis patients aged over 18 years with a 
consultant diagnosis. 
400 questionnaires left with a consultant at CING 
Nicosia 
15 questionnaires left with a consultant at Ygia 
Limassol 
20 questionnaires left at The  Multiple Sclerosis 
Society Nicosia (MS Society) 
 
 
127 cases returned the questionnaire 
109 from CING Nicosia 
4 from Ygia Limassol 






















127 cases were 












119 of the 127 
cases gave their 
age 
109 from CING 
4 from Ygia 
6  from MS society 
 









As can be seen, cases were recruited by convenience sampling. While it was attempted to 
recruit cases from clinics and hospitals across the island, this proved more difficult than 
anticipated. Most cases came from CING in Nicosia although some cases may have 
traveled from other towns in Cyprus to CING in Nicosia. 
 Recruitment of Controls 
Controls were people 18 years and over who did not have a diagnosis of multiple 
sclerosis. Recruiting hospital-based controls might have been efficient and cheap to 
undertake, but bias can arise from the illness of the controls.  For the same reason, it was 
decided not to use relatives or spouses of cases as controls.  If relatives had been used, 
there was a risk of “over-matching”.  These people may have had similar environment 
exposure as the cases, and their diet might have been so similar that drawing conclusions 
could be difficult. For example, if a spouse is a control, it is likely they will eat similar if 
not the same meals as the case. Ideally, the controls would have been randomly sampled 
using a postal code method or street number chosen randomly. However, the time-scale 
of the study (2 years from start to finish) and the costs of a postal survey precluded this 
method. 
So, controls were recruited by convenience sampling from coffee shops, offices, schools, 
colleges and family gatherings throughout The Republic of Cyprus.   
Approximately 1100 questionnaires were distributed and after 1 year, 720 had been 
completed (fully or in part) and returned. This represented a response rate of around 65%. 
Matching is popular in case-control studies. Matching may be on any potential 
confounder, for example, age, sex or demographics or a combination of these. Matching 
usually increases the efficiency of the study but may reduce the power by excluding those 
cases and controls that cannot be matched. In some case-control studies it is possible to 
match on both age and sex. Ideally, recruiting cases first would have allowed recruiting 
matched controls on both age and sex, but this was not possible due to the time restraints 
of the study. Case recruitment also proved slower than anticipated.  As a result, in this 
study cases and controls were recruited simultaneously. Age-matching was done by 
matching the 119 cases with age available to 119 controls.  All but 7 cases could be 
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matched exactly by year to one or more controls. The remaining 7 cases were matched to 
controls who were 1 year above or 1 year below the age of the case.  Where more than 
one control had the same year of birth as a case the control was chosen by generating 
random numbers and allocating a random number to each control. The highest number 
was matched with the case of the same age. 
 










































Over a 12month period 1100 questionnaires were given to people aged 
over 18 years without a  diagnosis of multiple sclerosis. 
120  staff and soldiers at the Cyprus army base Limassol (100 returned) 
120 coffee shops Nicosia (100 returned) 
100 staff and students  European University Nicosia (70 returned) 
100 staff and students  Nicosia University Nicosia   (90 returned) 
100 staff  at PWC accountants Nicosia (73 returned) 
100 coffee shops Larnaca (100 returned) 
100 coffee shops Famagusta area (100 returned) 
100 left in the mountain village of Lefkara ( 13 returned) 
60 staff  University Nicosia Medical School  (50 returned) 
60 left for staff at Aretaeio Private Hospital Nicosia (0 returned) 
50 left for staff at Apollonian Private Hospital Nicosia (10 returned) 
30 left for staff at Nicosia General Hospital Nicosia (0 returned) 
30 staff at Bank of Cyprus Nicosia (10 returned) 
10 staff at Alpha Bank Nicosia (8 returned) 
10 staff at Amenti restaurant Larnaca (2 returned) 
10 staff at Napa Star restaurant Ayia Napa (4 returned) 
Total 1110                                                    Total 720 returned             






720 controls returned the questionnaire. 2 had so little data it was 










119 of the 718 
controls aged 
matched to cases 












As previously stated, control recruitment was by convenience sampling. This method of 
recruitment has several potential flaws. While it was attempted to recruit from around the 
island, clearly this was not possible. 
Most of the recruitment was from Nicosia. Statistical analysis was used to test whether 
the demographics of cases and controls were different. 
Using mainly working people and students (banks, universities and coffee shops), 
potential age differences might occur between the 718 controls and the 127 cases in the 
logistic regression analysis. Indeed, this was the case. This potential bias was eliminated 
in the age-matched conditional regression analysis. 
Potential demographic differences between the cases and controls in both analyses were 




Confounding is a type of systematic error which may distort the association between the 
exposure and the outcome. It may account for all or part of an apparent association or it 
may cause an overestimate of the true association (positive confounding) or an 
underestimate of the association (negative confounding). (LaMorte and Sullivan 2014). 
 
According to the Boston University School of Public Health (2013) Three conditions 
must be present for confounding to occur: 
1. The confounding factor must be associated with both the risk factor of interest and 
the outcome. 
2. The confounding factor must be distributed unequally among the groups being 
compared. 
3. A confounder cannot be an intermediary step in the pathway from the exposure of 
interest to the outcome of interest. 
718 controls were 




Having met these conditions, the statistical analysis would be expected to produce a 
difference in association of 10% or more if the variable was a confounder (discussed 
below). 
Matching such as age-matching or sex-matching eliminates each of these potential 
confounders at the design stage. 
In the STROBE “checklist” item 7 suggests “Clearly define all outcomes, exposures, 
predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if 
applicable” While item 12 states “Describe all statistical methods, including those used to 
control for confounding” In the main results item 16 states “Give unadjusted estimates 
and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% 
confidence interval). Make clear which confounders were adjusted for and why they were 
included”. 
The more likely confounders in this study included age, sex (gender), obesity/BMI, 
smoking, alcohol and socioeconomic status. Less likely confounders in this study 
included skin type and sunlight exposure, latitude, vitamin D deficiency, infections, 
inflammatory diseases and genetic factors. 
Sedgwick (2015), suggests potential confounding can be controlled at the design stage or 
adjusted during the statistical analysis. He says the former is more efficient than the latter. 
In this study, latitude and possibly sunlight exposure were removed as confounders at the 
design stage by undertaking the study in a single setting (Cyprus) with a particular 
climate. Confounding by other risk factors was adjusted at the analysis stage by using 
logistic regression (Sedgwick 2013). 
The magnitude of confounding in a case-control study can be quantified by computing the 
percentage difference between the crude and adjusted measures of effect. For example, 
 
The magnitude of confounding = OR (crude) – OR (adjusted) / OR (crude) 
Or  
The magnitude of confounding = OR (crude) – OR (adjusted) / OR (adjusted) 
 
These methods produce slightly different results, but both provide a reasonable measure 
of confounding (LaMorte and Sullivan 2014). A cutoff of 10% is commonly used to 
identify confounders (Lee 2014), but this might not always be appropriate. Lee (2014) 
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undertook a study to examine cutoffs required under different conditions. It was found 
cutoff points for the change-in-estimate criterion varied according to the effect size of the 
exposure–outcome relationship, sample size, standard deviation of the regression error, 
and exposure–confounder correlation. Despite this, in the current study a cutoff of 10% 
was used. 
 
 Missing Data   
There were some missing data from both cases and controls and is addressed in detail 
within the individual questionnaire sections. Missing data can be dealt with in several 
ways. For example, the so-called “Complete case analysis” is where all cases and controls 
with incomplete data are removed from the study. Had anyone with even minor amounts 
of data missing in either analysis been totally removed, for example a person who missed 
out a single question on smoking, there would have been very few cases and controls left. 
The cases and controls who did not give their age were totally excluded from the analysis 
in the age-matched analysis. “Single imputation”, replaces missing data in a variable with 
a value that best represents the mechanism of the missing data. For example, if someone 
says they don’t drink wine and then data on red wine are missing, then it is reasonable to 
replace this value with zero rather than leave it blank. Elsewhere, any missing data in this 
study were left as blank (null) entries. 
 
 The questionnaire  
The whole questionnaire in English is shown in Appendix G. The Food Frequency 
Questionnaire (FFQ) section was derived from The Epic-Norfolk questionnaire (Day et 
al. 1999) and the questions were the same as those used in the Newcastle Thousand 
Families Study (NTFS). The Epic-Norfolk questionnaire has been validated using 
weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and 
carotenoids as biomarkers (Bingham et al. 1997). Katsouyanni et al. (1997) evaluated the 
reproducibility and relative validity of a 190-item semi-quantitative food frequency 
questionnaire (FFQ) in a Greek setting. They concluded there were significant 
correlations between diet and independent biochemical markers which corroborates the 
relative validity of the questionnaire in a Greek population. Unfortunately, there has not 
yet been a validation of the FFQ in a Cypriot setting, although this is planned. In the 
current study, the FFQ was adapted with the help of a local expert, Dr Elena Philippou, 
Associate Professor in Nutrition and Dietetics at the University of Nicosia. For example, 
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branded foods which are not found in Cyprus were omitted and foods such as souvlaki 
(not usually found in UK) and local alcoholic drinks such as Zivania were included. The 
Epic-Norfolk questionnaire had been adapted for the Newcastle Thousand Families Study 
and this template was used in this study. Questions referred to standard servings of foods 
consumed in the last year (see section 4.6.1). 
 The other sections in the questionnaire were also derived from the NTFS which was a 
longitudinal epidemiology study started by Sir James Spence in May and June of 1947.  
There were 1142 babies born in those months and although the study was originally 
planned to follow the babies for a year it continues today (Spence Walton and Miller 
1954; Hind et al. 2019).  The NTFS questionnaire was first used in a follow-up study in 
1997 (Lamont et al. 1998) and again in 2007 (Pearce et al. 2008). 
The questionnaire was divided into two sections: 
1. Collecting information on the frequency and type of foods consumed using a food 
frequency questionnaire (FFQ) 
2. Collecting socio-demographic information including skin type, smoking, alcohol 
intake, and general health. (see appendix for questionnaire in English). 
Details of each section (apart from skin type) are included below. 
Each questionnaire from the cases was given a number and each response was entered in 
the Excel spreadsheet. The controls were treated similarly. The data from the spreadsheet 
was then uploaded to the software. 
4.6.1 Diet 
The questions on diet refer to the frequency of consuming a range of foods eaten during 
the preceding year.  Participants were asked to indicate by ticking the box corresponding 
to their estimate for the frequency they consumed each of the foods listed.  Frequency of 
consumption was scored on a nine-point scale: 
Never or < 1 a month, 1 - 3 x a month, 1 per week, 2 - 4 x 1per week, 5 - 6 x a week, daily, 2 - 3 x a day, 4 - 5 x a day, 6 + a day  
The kinds of food eaten can be grouped to provide a descriptive or characteristic diet 
type/pattern.  This case-control study focussed on associations between multiple sclerosis 
and the Mediterranean diet pattern which has been regarded as a healthy dietary plan 
characterised by higher consumption of plant-based foods such as fruit and vegetables 
76 
and whole grains, and lower consumption of dairy products and low consumption of red 
meat and meat products.  Mediterranean diet scores have been developed to assess how 
close a person’s diet is to the Mediterranean diet.  Several scores exist, and a Modified 
Mediterranean Diet Score was developed for use in this study as described below. 
 
4.6.2 Mediterranean Diet Scores 
The current study used a validated FFQ previously used in the NTFS for a Newcastle 
population, which was taken from the Epic-Norfolk FFQ which was validated for that 
study population.  No validated FFQ currently exist for Cyprus, although one is in the 
process of validation (personal communication 2019). Validation of the Epic-Norfolk 
FFQs came via a complex validation process which used urine analysis, to measure 
nitrogen excretion and compare it to estimated intake.  Although the Epic-Norfolk FFQ 
was not designed to be used to derive a Mediterranean Diet Score, it was considered that 
the data could be incorporated into a Modified Mediterranean Diet Score which will be 
described later.  
 
The MedDietScore developed by Panagiotakos, has been used mainly to assess if 
adherence to a Mediterranean diet reduces the risk of cardiovascular disease. 
Panagiotakos et al. used the weekly consumption of 9 food groups plus olive oil and 
alcohol intake to derive 11 scores as shown in Table 5. The score has been found valid 
and repeatable in many studies and has over 380 citations in the literature. However, it 
has not been validated in Cyprus, although it has been validated in Greece which has 
similar foods to Cyprus. 
 
Table 5 Panagiotakos et al. MedDietScore system (Panagiotakos et al., 2007) 
Frequency (servings per week) and allocated score 
1.Non-refined 
cereals 
Never =0 1-6 =1      7-12 =2     13-18 =3    19-31 =4      >32 =5 
2.Potatoes Never =0 1-4=1 5-8=2 9-12=3 13-18=4 >18=5 
3.Fruits Never =0 1-4=1 5-8=2 9-15=3 16-21=4 >22=5 
4.Vegetables Never =0 1-6=1 7-12=2 13-20=3 21-32=4 >33=5 
5.Legumes Never =0 <1=1 1-2=2 3-4=3 5-6=4 >6=5 




<1=5 2-3=4 4-5=3 6-7=2 8-10=1 >10=0 
8.Poultry <3=5 4-5=4 5-6=3 7-8=2 9-10=1 >10=0 
9.Full fat 
dairy products 




Never=0 Rare=1 <1=2 1-3=3 3-5=4 Daily=5 
11.Alcohol 10 
units=1000ml. 
<300=5 300=4 400=3 500=2 600=1 >700=0 
 
Intake of each food is estimated, and a score allocated from 0-5 (or the reverse) allocated 
to each group according to the position of the food group in the Mediterranean diet 
pyramid. The total MedDietScore is the addition of each group and ranges from 0-55.  
People with the highest scores are considered to adhere more closely to the Mediterranean 
diet. For example, a food such as fruit, that is considered to be typical of the 
Mediterranean diet, is given a score of zero if fruit is never eaten in a week and 5 if it is 
eaten more than 32 times in a week.  
The converse for a food such as red meat, that is not considered to be typical of the 
Mediterranean diet, a score of 5 is given if the red meat is never eaten in a week and 0 if 
it is eaten more than 10 times in a week.  
The scoring system is “not perfect, but a compromise” (Panagiotakos personal 
communication 2019). Alcohol is used as a group, but several different types of alcohol 
such as vodka and beer are not typical of a Mediterranean type diet. Red wine is often 
quoted as typical of the Mediterranean diet but Panagiotakos chose not to use individual 
drinks. The score of 5 for <300 is less than ideal, since small amounts of alcohol get the 
same score as zero alcohol. 
Potatoes are another interesting food category. Potatoes are not normally listed as a 
constituent of the Mediterranean diet. In this scoring system all potatoes are dealt with 
equally. It seems odd that large quantities of French Fries could score a “healthy” 5.  
Finally, the question arises “should all food types be weighted the same?” It might be 
argued that they should not, but one of the benefits of Panagiotakos’ scoring system is its 
ease of use and complex formulae and adjustments would take away this benefit. 
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Below is a brief description of the components of Panagiotakos et al. (2007) 
MedDietScore and how they were applied in the current study: 
1. Non-refined cereals (whole grain bread and pasta, brown rice, etc.). One serving 
was defined as one slice of bread or half cup of rice or pasta per day multiplied by 
7 to give a weekly amount (Panagiotakos et al. 2007).  The FFQ asked for 
frequency of consumption of “one slice” of bread, a “medium serving” or “one 
bowel” of rice or pasta so the quantities are assumed to be similar. 
2. Potatoes are included in the MedDietScore despite the fact they are not part of the 
Mediterranean pyramid which forms the basis of the score.  They are included 
because they are a “good source of vitamins C, B1 and B2, niacin, carbohydrates, 
fiber, potassium and magnesium, which have been associated with cardiovascular 
disease risk markers in previous studies” (Estruch et al.2013).  The FFQ for the 
current study used a “medium” serving as the quantity guide.  
3. Fruits are quantified in the MedDietScore as “1 medium piece of fruit” or “1 small 
apple (80 grams),” Similar measurements were used in the FFQ in this study and 
the strict scientific definition of fruit which included tomatoes and cucumber as 
fruit was used. 
4. Vegetables were scored per 100g in the MedDietScore and in the current study a 
“medium serving” was used. Some individual foods such as capers, mushrooms 
and garlic were evaluated separately and not included in the diet score used here. 
5. Legumes are seeds from plants with seed pods that split in half. Examples include: 
pulses such as lentils, chickpeas, beans, peas, peanuts and carob.  The 
MedDietScore uses servings per week and the “medium serving” used in the 
current FFQ was converted into the same “per week” unit. For the current study, 
peas were categorised as legumes and care was taken not to include a food in 
more than one category.  Tofu from the soy bean and beansprouts from the mung 
bean were also categorised as legumes. 
6. Fish is scored in the MedDietScore by aggregating consumption of all types of 
fish and all ways of cooking, including frying and baking. A low score is allocated 
when low quantities of fish are eaten and vice versa.  
7. For the purposes of scoring red meat consumption, red meat includes meat from 
beef, lamb, goat and pork species. Meat products include sausages and processed 
meat from any species, including poultry. 
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8. Poultry meat is regarded as healthy source of protein by some nutritionists (Farrell 
2013) because of its lower fat content, but in the MedDietScore consumption of 
poultry is scored lower if frequently eaten and higher if never or infrequently 
eaten since poultry is only eaten occasionally in the traditional Mediterranean diet 
pyramid. 
9. Full fat dairy products include milk and products of milk such as cream, cheese 
and full fat yoghurt.  Eggs are not dairy products but are often grouped together 
with dairy products since they are animal bi-products. In this study, eggs and 
avocado (also high in fat) were not included as full fat dairy products. For the 
purpose of this study “dairy” and “dairy products” refer to milk and milk products 
derived from mammals such as cows, goats and sheep. 
10. Olive-oil consumption was measured in the number of days per week olive oil 
was used in cooking and as a dressing. Daily use of olive-oil received a score of 5 
and never a score of 0.  In this study, those who used an alternative fat such as 
vegetable oil, butter or animal fat to cook were regarded as not using olive-oil 
whereas those that reported the use of olive-oil were considered to use it daily. 
This is a potential source of error, but it would be the same in both cases and 
controls. Olive-oil is used extensively on salads in the Mediterranean counties but 
does not feature as a salad dressing in the NTFS questionnaire as a result, olive-oil 
consumption may be artificially lower than it should be in both cases and controls 
in this study, although the amount is likely to be equal in both groups. 
11. Alcohol was calculated in the MedDietScore based on the volume of alcohol 
consumed.  In the NTFS questionnaire and the FFQ used in the current study, 
alcohol was measured in Units, not by volume, with 1 Unit equivalent to 125ml of 
12% alcohol.  For comparison with the MedDietScore, the alcohol scores in this 
study were converted from Units into ml. such that 10 Units= 1250 ml. 
There are certainly limitations in using portion size and controversy still surrounds its use 
(Shim Oh and Kim 2014). Some researchers suggest between-person variations might be 
highly explained by the portion size rather than the frequency (Kim and Choi 2002). 
Unfortunately, there was no pre-testing of how the questionnaire was interpreted in 
relation to portion sizes. This could have been useful. 
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4.6.3 Demographic and Socio-economic Information 
Questions on sex, date of birth, ethnicity, place of birth, current area of residence, highest 
education level, highest qualification, marital status, accommodation ownership, appeared 
in section 1 of the questionnaire.   
Due to regional differences in terminology some adaptations were made to the questions.  
For example, “Gymnasium” is a school not found in the UK but is a lower secondary 
school in Cyprus, and education is compulsory up to this level. The “Apolyterium 
certificate” does not exist in UK but is a type of school leaving certificate.  
The socio-demographic information excluding skin type, smoking, alcohol intake, and 
general health are shown in the descriptive results. The Chi squared test is appropriate for 
descriptive results and was used for 127 cases and 718 controls and 119 cases and 119 
age-matched controls. For the 127 cases and 718 controls, only age was significantly 
different between cases and controls. This confirms age as a potential confounder and 
justifies the age-matching.  
In the results section The Total Medscore score is tested with each demographic factor in 
turn using logistic regression or conditional logistic regression in the age-matched 
analysis. The OR remains unchanged or changed by 2% or less, suggesting none of the 
socio-demographic factors were confounders. 
   
4.6.4 Smoking 
Questions on smoking in this study included current smoking, ever/never smoking, 
exposed to smoke at home and work, inhalation, age when starting quantity per day types 
of cigarettes, cigars, shisha, and reasons for quitting.  If a participant indicated that they 
had never smoked all subsequent missing data from that person was assumed to be no or 
zero.  When a participant indicated they had smoked at some time subsequent missing 
data from that person was left as missing and excluded from the analysis. A “smoking 
status” variable [never smoked, former smoker, current smoker] was created to test for 
confounding of this factor. 
 
All daily quantities of number of cigarettes smoked were converted to weekly values. The 




Alcohol consumption was part of the MedDietScore described by Panagiotakos et al. 
(2007), so these questions were needed in this study. 
 
Questions on alcohol in this study included typical weekly or daily consumption of 
alcohol, types of drinks consumed including spirits, wine, beer, cider and alcoholic drinks 
typical of Cyprus such as Zivania. All answers were converted to weekly Units. One unit 
of alcohol was used as a standard measure in all questions. 
The alcohol questions from the questionnaire in English appear in Appendix G. 
If a participant indicated they never drank alcohol and left all the other questions in this 
section blank, it was assumed that all the answers to the blank questions were zero.  In 
order to fill out the alcohol questions Figure 16 was used as guidance. 
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Figure 15 The Newcastle Thousand Families Study alcohol guidance figure 
 
 
4.6.6 General Health 
Height and weight were self-reported in the questionnaire and were used to calculate 
body mass index (BMI, kg/m2).    BMI categories were classified according to WHO 
guidelines as follows (Nuttall 2015): 
Underweight                               BMI < 18.5 
Normal (healthy weight)                        18.5-25 
Overweight                                             25-30 
Obese                                                   >30 
 
 Statistical Analysis  
Descriptive statistics were used to describe the basic features of the data in the study to 
provided simple summaries about the sample and the measures.  The four major types of 
descriptive statistics used are described below. Data were tested for normality by 
comparing histograms of age. Where the data were not normal, summary data are shown 
as medians with inter-quartile (IQR) range. Summary data for normally distributed data 
are shown as means with standard deviation (SD) Statistical analysis was done using 
STATA 15.1 (StataCorp 15.1 for Mac 2018).  A Chi square test was used to compare 
distribution of estimated intake for cases and controls. 
 
The Logistic regression analysis 
Logistic regression analysis is the analysis of choice for case-control studies, and this 
method was used to compare the risks of various factors for example, diet, with multiple 
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sclerosis. Odds ratios with confidence intervals (CI) and p values were obtained and then 
a dose response was calculated for each variable of interest. A dose response is when 
there is a biological gradient in the association between a variable (for example vegetable 
intake) and the outcome (for example multiple sclerosis). In other words, in a dose 
response, as the amount of vegetable consumption increases, does the likelihood of 
multiple sclerosis change? 
 
4.7.1 The Age-matched conditional regression analysis 
The a priori objective was to age-match controls after cases had been recruited. In this 
way, the potential confounding of age can be controlled at the design stage which is the 
most efficient way of dealing with confounding (Sedgwick 2015). However, recruiting 
cases took longer than expected and time restraints meant that controls needed to be 
recruited unmatched at the same time as recruitment of cases. As recruitment of cases and 
controls came to an end, it became apparent that there was a difference in mean age of 
cases and controls. When comparing the whole dataset, the mean age of the controls (32 
years, SD 12.8, n =686) was much younger than the cases (46 years, SD 14 .1, n = 123).  
Similarly, the median age of controls (27 years, IQR 23-38) was lower than the median 
age of cases (46 years, IQR 3 7-57). With this in mind, it was decided to match cases and 
controls for age using the same year of birth where ever possible. The 119 cases who 
gave their age were matched with 119 controls using the following method. Random 
numbers were generated using STATA 15.1 software and each of the controls was 
allocated a number. The control data were sorted on age, and cases and controls were 
matched on year of birth. When there were two or more controls with the same year of 
birth as the case, the control with the highest random number was used. For example, 
there was 1 case and 27 controls aged 19 years. The control with the highest random 
number was matched with the case. The majority of cases and controls were matched in 
this way. When there was a case but no control of the same year of birth, for example, a 
case aged 69, then an “unused” control born the year before or the year after was used. 
Similarly, when there were 4 cases aged 65 and only 1 control, the extra 3 controls were 
recruited from one year before and one year after. If 2 cases had the same age, then 2 
controls with the highest random numbers were used. All the cases were matched to a 
control born the same year or one year before or one year after. The data from 119 cases 
and 119 controls were analysed using conditional regression analysis. Odds ratios with 
confidence intervals (CI) and p values were obtained and then a dose response was 
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calculated for each variable of interest. Unfortunately, there were not enough controls of 
the same age to allow two controls to be matched with each case.  
Defining “dose response” 
After assessing if cases and controls were exposed to a variable in a binary manner, for 
example ate a food or not, a dose response association was calculated. With a “dose 
response” association, for every step increase in the exposure of interest, there is an 
accompanied stepwise increase or reduction in the likelihood of the outcome (for example 
having multiple sclerosis). 
 
4.7.2 Odds ratios 
 
The odds ratio provides a measure of the association between the exposure and the 
outcome. In a case-control study, the odds ratio estimates the odds of exposure 
among cases compared with controls (Sedgwick 2013). The OR is considered a good 
estimate of the risk in rare diseases such as multiple sclerosis and was used in the current 
study. When there is dichotomous outcome e.g. yes/no an OR calculated by logistic 
regression is the appropriate test to use (Sedgwick 2013). ORs are quoted in case-control 
studies together with the predetermined level of statistical significance (p value) and the 
calculated confidence interval quoted. The 95% confidence interval (CI) is a range of 
values that one can be 95% certain contains the mean. 
When there is matching for age (the so-called age-matched analysis) the OR is calculated 
using conditional logistic regression. 
 
4.7.3 Ordinal variables  
Ordinal variables are similar to categorical variables except ordering is clear. For 
example, in this study, BMI was recorded on a continuous scale then, categorised into 
Underweight, Healthy, Overweight and Obese with the lowest BMI being Underweight 
and the highest Obese.  Therefore, obesity is an ordered categorical (ordinal) variable.      
As another example, some people ate zero apples per week, others ate 7, 14 or 21 per 
week. It was possible to convert these ordinal data into nominal data. For example, ate 
zero apples or ate some apples. In this case the exposure to the variable is described as 











Chapter 5. Results 
 
 
The results of the study are presented in this chapter. Initially, the results were analysed 
with and without matching. Since the results were very similar, only the age-matched 
results are included in this chapter. The un-matched results are now included in Appendix 
A. 
 Section 5.1 includes the descriptive statistics and the results of the demographic 
characteristics of cases and controls are stated and compared. How the missing data 
impacts on the demographic results are stated. The significant difference between age of 
cases and controls is described and the decision to undertake an age-matched conditional 
regression analysis is reported. The methodology chapter covered the age-matched 
conditional regression analysis. Section 5.2 deals with the main focus of the thesis. It 
examines the association between a Mediterranean type diet and multiple sclerosis, using 
a score developed by Panagiotakos (Panagiotakos et al. 2007). The Mediterranean diet 
score adjusted for each potential confounder in turn is then presented. Following this, any 
data on food groups that are part of the Mediterranean diet score are presented. Then, any 
individual foods that may influence the risk of acquiring multiple sclerosis are presented. 
Section 5.3 presents the smoking data, and section 5.4 the alcohol data as standard 
predictors. Section 5.5 presents the impact of the missing data. Section 5.6 deals 
summerises the hypothesis testing. 
 
5.1 Descriptive results 
There were 119 multiple sclerosis cases with a consultant diagnosis who provided their 
age and who returned the questionnaire in the time period of the study (August 31st 2017 
to August 31st 2018). These were matched with 119 controls as described in Chapter 4. A 


















Table 6 Summary of demographic information used in the age-matched analysis.  
 Controls (n=119) n (%) 
Cases 

















Age Matched Matched   
BMI Categories 
Underweight     
Healthy                                       
Overweight 
Obese +severely obese      
Total    
Mean BMI                                                               
 
   4 (3.4) 
69 (59.0) 
  33 (28.2) 
  11 (9.4) 
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23.39 SD 5.15 
 
    8 (7.1) 
  58 (51.3) 
  31(27.4) 
  16 (14.2) 
  
113 
24.68 SD 4.82 
 
  12 (5.2) 
127 (55.2) 
  64 (27.8) 












Place of birth 
Nicosia                            
Limassol     
Larnaca        
Famagusta    
Paphos     
Other eg Greece, UK   
Total      
 
  49 (41.2) 
  24 (20.2) 
  19 (16.0) 
    9 (7.6) 
    2 (1.7) 







  5 (5.2) 
  2 (2.1) 
11 (11.5) 
96  
   
 
  98 (45.6) 
  40 (18.6) 
  32 (14.9) 
  14 (6.5) 
    4 (1.9) 











Place of current 
residency   
Nicosia                            
Limassol     
Larnaca        
Famagusta    




  77 (64.7) 
  23 (19.3) 
  16 (13.5) 
    2 (1.7) 




  60 (57.7) 
  23 (22.1) 
  16 (15.4) 
    3 (2.9) 





  46 (20.6) 
  32 (14.4) 
    5 (2.2) 











Greek Cypriot       Yes 
                              No  
                              Total                           
Maternal ethnicity  
Greek Cypriot       Yes 
                              No  
                              Total                           
Paternal ethnicity  
Greek Cypriot       Yes 
                              No  
                              Total                           
 
 
  114 (95.8) 




















































  88 (75.9) 
  20 (17.2) 
    8 (6.9) 
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  82 (71.3) 
  24 (20.9) 




  44 (19.0) 















    7 (5.9) 
    5 (4.2) 
  78 (65.5) 
  22 (18.5) 
    7 (5.9) 
119 
  
     4 (3.4) 
     7 (6.0) 
   80 (69.0) 
   21 (18.1) 
    7 (6.0) 
116  
 
  11 (4.3) 
  12 (5.1) 
158 (67.2) 
  43 (18.3) 















  40 (37.7) 
  18 (17.0) 
 
  11 (10.3) 
  46 (43.0) 
  29 (27.1) 
   
  27 (12.7) 
  86 (40.4) 








  32 (30.2) 
106 
  21 (19.6) 
107 












Descriptive results for smoking are shown in Table 7. 
 









n  (%) 
 
Current smokers  
        n (%) 
          Total 
Controls 42 (42.9) 15 (12.6) 62 (68.9) 119 
Cases       56 (57.1)  35 (29.4) 28 (31.1) 119 
Total 98 (41.1)      50 (21.0) 90 (37.8) 238 
Pearson chi2(2) =  22.8   p = 0.000 
 
5.2 The Mediterranean diet  
Descriptive table and summaries of a Mediterranean diet score adapted from the 
MedDietScore 
A Mediterranean diet score (Medscore) derived from the MedDietScore (Panagiotakos et 
al, 2007) scoring system was used to assess adherence to the Mediterranean diet as 
described in the methodology chapter. Each of 11 food categories was given a score. The 
maximum total Mediterranean diet score was the sum of the 11 components (10x5) 
+3(olive oil) = 53. The minimum and maximum scores for the cohort were 12 and 50, 
respectively. Cases had a slightly lower mean score of 33.3 (SD 5.24) and ranged from 17 
to 46 while the mean score for the control group was 33.9 (SD 5.74) and ranged from 12 
to 50. There was no statistical significance between the mean Medscore of cases and 
controls (p= 0.26) 
  
Defining “dose response” 
After assessing if cases and controls were exposed to a variable in a binary manner, for 
example ate a food or not, a “dose response” association was calculated. With a “dose 
response” association, for every step increase in the exposure of interest, there is an 
88 
accompanied stepwise increase or reduction in the likelihood of the outcome (for example 
having multiple sclerosis). 
The mean Medscores of the 11 food categories were calculated for the age-matched 








Table 8 Mean Medscores of the 11 food categories in this cohort 
 Controls (n=119) Mean (SD) Cases (n=119) Mean (SD) 
Alcohol 3.40 (2.30) 2.44 (2.51) 
Red meat and products 2.72 (1.76) 2.82 (1.49) 
Poultry 4.77 (0 .76) 4.83 (0 .72) 
 Fish 2.37 (1.48) 2.54 (1.25) 
Non-Refined cereals 2.25 (1.12) 2.00 (1.03) 
Potatoes 3.35 (1.32) 2.97 (1.34) 
Dairy products 3.74 (1.42) 4.08 (1.33) 
Fruit 4.42 (1.00) 4.24 (1.21) 
Vegetables 3.11 (1.27) 2.72 (1.26) 
Legumes 2.99 (1.16) 2.60 (1.04) 
Olive oil 2.21 (1.33) 1.87 (1.46) 
 
The Total Medscore in relation to multiple sclerosis unadjusted and adjusted for sex is 
shown in Table 9 and shows sex is not a confounder, with no change in the odds ratio. 
 
Table 9 The Total Medscore in relation to multiple sclerosis. Unadjusted, and with 
adjustments using conditional regression analysis 
 
Age-matched conditional regression analysis                Total Med Diet Score  OR [95% CI]   p 
Unadjusted     0.91 (0.85, 0.96)   0.001 
Adjusted for sex    0.91 (0.85, 0.97)   0.002 
 
For each unit of the Total Medscore there was a 9% reduction in the likelihood of the 
outcome (multiple sclerosis). 
Potential demographic confounders in relation to the Mediterranean diet score are shown 
in Table 10 and it can be seen these factors are not confounders, since the odds ratio does 
not change by more than 10%. 
 
Table 10 The Total Medscore in relation to demographic potential confounding factors 
adjusted one at a time. 
 
89 
 Total Med Diet Score OR [95% CI]   p 
Unadjusted  0.91 (0.85, 0.96)   0.001 
Adjusted for sex  0.91 (0.85, 0.97)   0.002 
Adjusted for body mass scale  0.90 (0.83, 0.96)   0.002 
Adjusted for ethnicity  0.91 (0.86, 0.97)   0.004 
Adjusted for mother’s ethnicity  0.91 (0.86, 0.97)   0.002 
Adjusted for father’s ethnicity  0.91 (0.85, 0.97)   0.002 
Adjusted for place of birth                  0.91 (0.85, 0.98)   0.01 
Adjusted for current residency  0.89 (0.83, 0.95)   0.001 
Adjusted for Smoking status 0.90 (0.85, 0.97)   0.002 
Adjusted for Regularly exposed to 
smoke                   0.91 (0.85, 0.96)  0.001 
 
Smoking status and being “regularly exposed to smoke” were not confounders since the 
odds ratio does not change by more than 10%. 
Alcoholic drinks as potential confounders are shown in relation to The Total Medscore in 
Table 11. 
Table 11 Alcoholic drinks as potential confounders 
 Total Med Score 
Unadjusted For sex 0.91 (0.85, 0.96)   0.001 
Adjusted for sex 0.91 (0.85, 0.97)   0.002 
Adjusted for and beer, cider per week                            0.94 (0.88, 1.01)   0.08 
Adjusted for units of spirits per week  0.90 (0.84, 0.96)   0.002 
Adjusted for fortified wines per week 0.91 (0.85, 0.97)   0.003 
Adjusted for and wine per week  0.91 (0.85, 0.97)   0.006 
Adjusted for red wine per week  0.91 (0.85, 0.97)   0.004 
Adjusted for white wine per week  0.91 (0.85, 0.97)   0.005 
Adjusted for rose wine per week  0.91 (0.85, 0.97)   0.003 
 
The consumption of alcoholic drinks was not found to be a confounding factor. 
 
The individual food group Medscores were analysed and the results are shown in 
Table12. 
 
Table 12 Individual food group Medscore unadjusted for sex and adjusted for sex 
 
Med score for: Unadjusted OR [95% C.I.   p] Adjusted for sex OR [95% C.I.]   p 
Vegetables 0.77 (0.62, 0.96)   0.02 0.76 (0.61, 0.95)   0.02 
Dairy products 1.21 (0.99, 1.47)   0.06 1.24 (1.01, 1.52)   0.04 
Alcohol 0.83 (0.73, 0.94)   0.002 0.83 (0.73, 0.94)   0.003 
Legumes 0.73 (0.57, 0.93)   0.01 0.72 (0.56, 0.92)   0.01 
Potatoes 0.81 (0.66, 0.98)   0.03 0.81 (0.66, 0.99)   0.04 
Non-refined cereals 0.78 (0.60, 1.02)   0.06 0.79 (0.6, 1.02)   0.07 
Olive oil 0.86 (0.71, 1.04)   0.12 0.87 (0.71, 1.05)   0.14 
Red meat and 
products 1.04 (0.89, 1.23)   0.62 1.04 (0.88, 1.22)   0.66 
Poultry 1.13 (0.80, 1.61)   0.49 1.17 (0.82, 1.68)   0.39 
Fish 1.09 (0.91,1.30)   0.37 1.10 (0.92, 1.32)   0.32 
Fruit 0.86 (0.68, 1.09)   0.21 0.85 (0.67, 1.08)   0.18 
 
90 
The Medscore scores for consumption of vegetables, alcohol, legumes and potato were 
significantly negatively associated with being a multiple sclerosis case and this 
association followed a dose response. In contrast, the Medscore for dairy products was 
significantly positively associated with being a multiple sclerosis case when adjusted for 
sex and this score followed a dose response. 
In summary, a statistically significant association existed between certain food groups 
that contributed to the Mediterranean diet score.  
The individual foods were then examined in a binary association (ate this food or not) and 
for a “dose response” the frequency of consumption was used.  A summary of the 





Table 13 Summary of individual foods with a dose response  
 Unadjusted for sex Adjusted for sex 
  Dose response for a 
1 unit increase 
 Dose response for a 
1 unit increase 
Food OR (95% CI)   
 P 
OR (95% CI)   
 P 
OR (95% CI)   
 p    
OR (95% CI)   
 p 
Beetroot 0.15 (0.04, 0.68) 
0.01 
0.71 (0.55, 0.91)   
0.01 
0.16 (0.04, 0.71)   
0.02 
0.71 (0.55, 0.91)   
0.01 
Grapefruit 0.21 (0.06, 0.75)   
0.02 
0.79 (0.66, 0.94)   
0.01 
0.20 (0.06, 0.71)   
0.01 
0.79 (0.66, 0.95)   
0.01 
Dried pulses 0.22 (0.08, 0.66)   
0.01 
0.83 (0.70, 0.98)   
0.03 
0.22 (0.08, 0.66)   
0.01 




0.14 (0.03, 0.63)   
0.01 
0.90 (0.81, 1.00)   
0.04 
0.13 (0.03, 0.60)   
0.01 





0.15 (0.05, 0.51)   
0.002 
0.88 (0.78, 0.99)   
0.03 
0.15 (0.04, 0.49)   
0.002 
0.88 (0.78, 0.99)   
0.04 
Tomatoes 0.25 (0.05, 1.18)   
0.08 
0.95 (0.91, 1.00)   
0.05 
0.25 (0.05, 1.17)   
0.08 




0.36 (0.13, 0.99)   
0.05 
0.79 (0.63, 1.00)   
0.05 
0.37 (0.13, 1.03)   
0.06 
0.79 (0.62, 1.00)   
0.05 
Tofu 0.38 (0.15, 0.96)   
0.04 
0.37 (0.13, 1.03)   
0.06 
0.38 (0.15, 0.98)   
0.05 
0.37 (0.13, 1.05)   
0.06 
 
As can be seen in Table 13, certain individual foods were significantly negatively 
associated with being a multiple sclerosis case. This association was found to follow a 
dose response with some foods. That is, a linear inverse association exists between the 
consumption of these variables and multiple sclerosis. 
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Consumption of tofu was significantly negatively associated but did not follow a dose 
response. 
The individual foods for the un-matched data are shown in Appendix B when examined 
in a binary association and for a dose response.  
 
Analysis of foods avoided.  
A summary of the results of the foods avoided by cases is shown in Table 15. There were 
34 cases who reported avoiding some foods, and one person avoided all “take-aways”.  






Table 14 Results of foods reported to be avoided by cases 
 
Food Cases Total foods avoided Reason 
Avocado 1 1 Fat 
Beef/red meat/meat 6 10 - 
Broad beans 1 1 Allergy 
Beans 1 3 - 
Black eyed 
peas/beans 2 2 - 
Butter beans 1 1 Indigestion 
Eggs 1 1 - 
Fried food 7 10 - 
Dairy products 3 6 - 
Fat 2 3 - 
Fish 1 1 - 
Mushrooms 1 1 - 
Onions 1 1 - 
Garlic 1 2 - 
Pulses 1 1 - 
Shellfish 1 1 - 
Sugar 1 1 - 
All vegetables 1 1 - 
Wheat 1 1 - 
Total  34 48  
 
One person avoided dairy and fatty food, one person avoided red meat and dairy. Another 
person avoided all fried food and beans. One person avoided red meat and garlic. One 
person avoided pork and all fried food. Another, all fried food and all meat. One person 
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avoided all dairy food, salt and fats. The most commonly avoided foods were beef and 
red meat and fried food with 6 and 7 cases, respectively, reporting that they avoided these 
food types.  Other foods avoided were various types of vegetables, dairy and 
fish/shellfish. 
 
Analysis of foods eaten by cases to help their medical condition 
The results of foods eaten to help their medical condition is shown in Table 15. Only 32 








Table 15 Foods to help with the medical condition 
 
Food Cases 
Bananas, nuts, oats 1 
Chicken, Pulses 1 
Chicken, Salad, Potatoes 1 
Fish 5 
Fish, Nuts, Eggs, Veg 1 
Fruit, Fish, Veg 2 
Grilled food and salad 1 
Meat 1 
Pasta, Rice, White 1 
Salad and Pulses 1 
Salad, Chicken   1 
Veg, beans, salad 1 
Fish, chicken, nut 1 
Fruits, vegetables 10 
Greens vegetables, fish 1 
Salads, salmon 1 
Salmon 1 
Whole grain, chicken 1 
Total 32 
 
5.3 Analysis of smoking data 
Descriptive smoking results appear in section 5.1 and the results of smoking and exposure 
to smoke as potential confounders is reported in the results of the Mediterranean diet 
scores in section 5.2 In this section, smoking status and being “regularly exposed to 
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smoke” are shown not to be confounders since the odds ratio does not change by more 
than 10%. 
 
5.4 Analysis of alcohol consumption data  
 
The type of alcohol consumed per week is shown in Table 16. The binary data refers to 














Table 16 Type of alcohol consumed per week  
 
 Binary age-matched 
Unadjusted for sex OR [95% 
CI]   P 
Binary age-matched and 
adjusted for sex OR [95% CI]   
P 
Units spirits/week 0.67, (0.35, 1.26)   0.21 0.71(0.37, 1.37)   0.31 
Fortified 
wines/week 
1.05e-17 (0.00)   1.00 4.92e-08 (0.00)   0.99 
Beer /cider/week 0.24 (0.13, 0.47) < 0.001 0.24 (0.12, 0.47) < 0.001 
White Wine 0.61 (0.35, 1.09)   0.09 0.63 (0.35, 1.12)   0.12 
Rose Wine 0.29 (0.11, 0.80)   0.02 0.31 (0.11, 0.83)   0.02 
Red Wine 0.52 (0.28, 0.94)   0.03 0.53 (0.28, 1.00)   0.05 
Wine/week 0.61 (0.35, 1.09)   0.09 0.63 (0.35, 1.12)   0.12 
 
There were statistically significant associations between being a case and drinking beer 
/cider, rose wine and red wine. However, spirits and white wine were not statistically 
significant either unadjusted or adjusted for sex. Cases were 76% less likely to drink beer 
and cider, 69% less likely to drink rose wine and 47% less likely to drink red wine. Too 
few people drank fortified wine to provide reliable odds ratios and confidence intervals.  
The results of each alcoholic drink as a potential confounding factor have been described 
in relation to The Medscore in section 5.2. None of the alcohol drinks were considered to 
be confounding factors. 
Cases vs controls 
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The difference in missing data in cases and controls varied depending on the question.  
It was beyond the scope of this thesis to analyse every question in the questionnaire on 
the basis of available or missing data. However, some general remarks can be made using 
the demographics section as an example. Available data for some questions were 
generally high in both cases and controls. For example, sex was known for 100% of cases 
and controls. In the age matched analysis, controls were selected randomly and matched 
to cases on age, so the amount of missing data of cases and controls was unknown until 
analysis. There was no attempt to choose controls with more data. 
Smoking questions 
All of the participants responded to the question if they currently smoke or not or ever 
smoked or not or were regularly exposed to smoking or not. However, when a respondent 
said they currently did not smoke and had never smoked, it can be assumed they did not 
smoke manufactured cigarettes, rolled cigarettes and any type of cigars. Some of these 
respondents had left the section on ways of smoking blank. It has been assumed that these 
responses were null rather than blank. All other blanks were recognised and coded as 
blank responses. As a result, the smoking data are complete in some areas and incomplete 
in others. When quantities were required, or free text spaces for answers were available, 
many more blanks appeared. When the answer was yes or no, respondents were more 
likely to provide an answer. Some questions had considerable amounts of missing data. 
Where no assumptions could be made, gaps were entered as blanks. For example, “filters 
used”. About 1/3 of these data were missing. 
Alcohol  
When asked how much alcohol they consumed per week, many respondents reported zero 
and some left this and other questions blank. For all other questions on wine, beer or 
spirit consumption those people who reported zero initially and left the other questions 
blank were assumed to drink zero units of all types of alcohol per week. 
A Mediterranean diet score and individual foods 
A Mediterranean diet score was calculated for all participants. Missing data on individual 
foods was generally low, so it was still possible to calculate a value for each of the 
categories in the Medscore system.  
Free text questions 
Free text questions generally had few responses.  
5.6 Hypothesis testing  
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The Null hypothesis tested was that there is no difference in Mediterranean diet pattern 
score, or intake of specific food groups, or foods, between multiple sclerosis cases and 
control participants. 
The results presented in this chapter indicate that the Null hypothesis can be rejected, and 
the alternative hypothesis accepted. That is, there are differences in the Mediterranean 
diet pattern score, or intake of specific food groups, or foods, between multiple sclerosis 








Chapter 6 Discussion and Conclusion 
 
The discussion of the results of the study are presented in this chapter. The discussion 
section will relate this study to previous research and highlight the importance of this 
study to others. The implication of these results to clinical practice and preventative 
medicine, where appropriate, will be highlighted. Strengths and limitations will be 
examined, and suggestions for future research will be made. 
 
6.1 Summary of the main findings 
In this case-control study of 718 controls and 127 cases, patients with multiple sclerosis 
when compared with controls, had a lower Mediterranean diet score (MDS). These results 
appear in Appendix A. MDS dose response adjusted for age OR 0.96 [95% CI] (0.93, 
1.00)   p 0.04 
 Similarly, in the aged-matched case-control study of 119 controls and 119 cases, patients 
with multiple sclerosis when compared with controls, had a lower Mediterranean diet 
score. MDS dose response OR 0.91 [95% CI] (0.85, 0.96)   p 0.001. After statistical 
adjustment for each potential confounder in turn, the results of the Mediterranean diet 
score in both analyses remained unchanged and were statistically significant. Cases were 
compared to controls in their consumption of food groups. Medscore scores for 
consumption of vegetables, alcohol, legumes and potato were significantly negatively 
associated with being a multiple sclerosis case and this association was found to follow a 
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dose response for vegetables, alcohol and legumes. Finally, cases were compared to 
controls in their consumption of individual foods. Grapefruit, tomatoes, onions, refined 
breakfast cereal, dried pulses and beetroot consumption were significantly negatively 
associated with being a multiple sclerosis case. This association was found to follow a 
dose response. That is, a linear inverse association existed between the frequency of 
consumption of these foods and the presence of multiple sclerosis.  
One interpretation of this finding is that lower adherence to the Mediterranean diet (as 
indicated by the lower Medscore) has increased the risk of acquiring the disease. This 
idea makes several assumptions. Firstly, that the diet of the multiple sclerosis cases, while 
different now from the controls, was also different in the past before disease diagnosis. 
There is no evidence to support or contradict this. However, the fact that multiple 
sclerosis cases did not indicate a diet change in answers in the questionnaire tends to 
suggest that their diet was likely to be similar if not the same as it was before diagnosis, 
although we cannot be certain of this, as there is no evidence one way or the other. 
Unfortunately, controls were not asked about historical dietary patterns.  
Adult dietary patterns may change over time. Mishra et al. (2006) suggest they do. They 
conducted a longitudinal cohort study of 1265 participants and assessed their diet in 1982, 
1989 and 1999. They found marked changes over time. In this study, it was not possible 
to assess if diet changes had occurred in either cases or controls over time. 
The second assumption is that diet can directly influence the risk of developing multiple 
sclerosis. At the outset, this study tried to explore diet and the risk of developing multiple 
sclerosis, and while statistical evidence supports an association, a study of this type can 
provide no more than an association.  While diet is well documented as a risk factor in 
cardiovascular disease, this has not been established yet in multiple sclerosis. The lower 
adherence to the Mediterranean diet pattern was shown in the diet of cases who were less 
likely to eat some foods and food groups that contribute to the Mediterranean diet. These 
findings remained significant after adjusting for potential confounders such as age and 
sex in the logistic regression analysis, and sex in the age-matched analysis, suggesting 
that diet may be a significant factor in the aetiology of multiple sclerosis development. 
The significant relationship between the Mediterranean diet, certain food groups and 
individual foods may be important in development of the disease in a susceptible 
individual. 
Interpretation of the study findings in the context of the existing evidence in this area and 
suggestions for future work. 
97 
The findings of this study are in broad agreement with those of the only other case-
control study. They are also in broad agreement with those studies of the Mediterranean 
diet and cardiovascular disease and colorectal cancer. As stated earlier, diet has not been 
established yet as a risk factor for multiple sclerosis. This study adds to the current 
knowledge on the topic. 
Further work might include large cohort studies and dietary intervention studies. Future 
work is discussed later in the chapter.  
 
6.2 The Mediterranean diet  
Low grade inflammation has been extensively studied for its association with 
cardiovascular disease, which may have a similar pathophysiology to multiple sclerosis, 
as both involve chronic inflammation. Biomarkers such as C-reactive protein, white blood 
cell counts and circulating fibrinogen have been found to be reliable measures of 
inflammation (Bonaccio et al. 2017). So-called “healthy diets” such as the Mediterranean 
diet are regarded as being associated with lower concentrations of markers of 
inflammation, whereas Western-type diets are often positively associated with 
inflammation markers (Bonaccio et al 2013). The Mediterranean diet is high in 
vegetables, whole grains, fruit and nuts, which have been associated with less oxidative 
stress and lower inflammation. Research has highlighted compounds in these foods that 
might theoretically provide an antioxidant effect if used as supplements. As yet, clinical 
trials of dietary supplements are inconclusive, and supplements are not routinely 
recommended as a measure for preventing cardiovascular disease (Whalen et al. 2016). 
While there are many studies suggesting an inverse association of cardiovascular disease 
and the Mediterranean diet there are very few studies which have examined possible 
relationships between diet and multiple sclerosis. The evidence provided by this case-
control study is that there is a possible association between multiple sclerosis and 
components of the Mediterranean diet. Exposure to the Mediterranean diet was measured 
on a continuous scale using the Mediterranean diet score (Medscore) and a dose-response 
calculated. The results show that for one unit increase of the Medscore, there was a 4% 
reduction in being a multiple sclerosis case. These results are in keeping with the inverse 
relationship between the Mediterranean diet and multiple sclerosis found by Sedaghat et 
al (2016). This implies that individuals with multiple sclerosis are less likely to closely 
follow a Mediterranean type diet than those without the disease, and this is in a step wise 
manner. The possible reasons are discussed below.  
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6.2.1 Age-matching  
The median age of cases (46 years) and controls (27 years) were different, with a 
statistically significant Chi2 p-value. As a consequence, age was judged to be a potential 
confounder. Age-matching (as described in the methods section) eliminated this potential 
confounding, and the results were referred to as “the age-matched analysis”.   
In the age-matched analysis, the Mediterranean diet score was lower in cases than in 
control participants, with a significant inverse linear association.  A one unit increase in 
the Medscore was associated with a 9% reduction in the outcome (being a multiple 
sclerosis case). 
 
6.2.2 Comparison to other studies involving multiple sclerosis 
In both analyses, there were statistically significant results between cases and controls 
with regard to the Mediterranean diet scores. This was also the case when adjustments 
were made for potential confounders such as demographic factors and smoking. Certain 
food groups and individual foods (as seen in the summary tables) also showed significant 
associations. These results are in agreement with the observations of Sedaghat et al 
(2016), who also conducted a case-control study in which they compared the 
Mediterranean diet score of cases and healthy controls and found that those with multiple 
sclerosis were less likely to follow the Mediterranean diet.  Previously, Ghadirian et al. 
(1998) had concluded there was a protective role of fruit, vegetables and grain in the risk 
of acquiring multiple sclerosis and an increased risk with consumption of animal 
products, a dietary pattern which is similar to the Mediterranean diet.  The current study 
is in broad agreement with these results. For example, when adjusted for age, the 
following food group scores; vegetables, legumes and non-refined cereals along with 
alcohol were significantly lower in cases when compared to controls, and dairy products 
significantly higher in cases. In the age-matched analysis, vegetables, alcohol, legumes 
and potatoes were significantly lower in cases when compared to controls. Consumption 
of fish and meats were significantly positively associated with multiple sclerosis, but 
there were no dose response associations 
In the logistic regression analysis, individual foods such as grapefruit, tomatoes, onions, 
refined breakfast cereal, dried pulses and beetroot consumption were significantly 
negatively associated with being a multiple sclerosis case.  
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In the conditional logistic regression analysis, beetroot, grapefruit, dried pulses, oat-based 
cereal, refined breakfast cereal, tomatoes, whole meal pasta and tofu consumption were 
significantly negatively associated with being a multiple sclerosis case. This association 
was found to follow a dose response for all of the above, except for tofu. That is, a linear 
inverse association exists between the consumption of these variables and multiple 
sclerosis. 
 
Reasons for different dietary habits of multiple sclerosis patients 
There is no clear explanation why cases are less likely to follow the Mediterranean diet 
compared with control participants. Indeed, the opposite might be expected. For example, 
Sumowski McDonnell and Bourdette (2017) have suggested that people with multiple 
sclerosis are usually proactive in seeking a healthier diets and lifestyle in order to delay 
disease progression and improve symptoms. So, it might have been expected that cases 
would have a better adherence to the Mediterranean diet than controls, not the other way 
around. 
There are no medical reasons or pharmacological interactions to explain why multiple 
sclerosis cases would be advised against eating the Mediterranean diet. Instead, there is a 
great deal of information in the press to suggest to a patient that the Mediterranean diet is 
a healthy lifestyle option (Fitzgerald et al. 2018), and it might be assumed that on 
diagnosis, multiple sclerosis cases might switch to this healthy option or even be advised 
to adopt a healthy diet option. The results of this study suggest that this does not appear to 
be the case.  
 
6.2.3 Comparison with other studies involving other diseases 
Colon cancer  
The results of previous multiple sclerosis studies and the current study are in broad 
agreement with studies on colon cancer. Adherence to the Mediterranean diet has been 
studied extensively with regard to colon cancer. Schwingshackl et al. (2017) undertook a 
systematic review and meta-analysis of 11 observational studies including 5 case-control 
studies on adherence to the Mediterranean diet and the risk of colorectal cancer. They 
pooled the odds ratios and risk ratios (RR) and concluded that with a higher adherence to 
the Mediterranean diet there was an inverse risk of colorectal cancer (RR 0.82, 95% CI 
0.75 to 0.88). For the 5 case-control studies there was a similar reduction in pooled odds 
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ratio (OR, 0.71, 95% CI 0.57,0.88).  These results suggest that colon cancer patients were 
29% less likely to consume a Mediterranean diet compared with controls. This is in 
keeping, although larger in scale, to the age-matched conditional regression analysis 
results in the current study where cases were 9% less likely to consume a Mediterranean 
diet compared with controls.  The carcinogenesis of colorectal cancer is complex, but a 
simplistic explanation is that it involves chronic inflammation as seen in Crohn’s disease 
and ulcerative colitis. These two diseases are known to increase the risk of colorectal 
cancer.  It is possible that the protective effect of the Mediterranean diet on colorectal 
cancer risk is associated with either the sum of the anti-inflammatory effects of the 
individual foods of the Mediterranean diet or the synergistic effects of the individual 
foods of the Mediterranean diet (Donovan et al. 2017). The gut microbiota is likely to 
play an important role in colorectal cancer. For example, the fermentation of dietary fibre 
resulting in the production of the short chain fatty acid butyrate appears be protective and 
may prevent tumour formation (Fung et al. 2012). Similar protective effects of the diet 
might be involved in the risk of acquiring multiple sclerosis. The elements of the 
Mediterranean diet with the highest anti- inflammatory effects include polyphenolic 
compounds and unsaturated fatty acids plant-based foods, olive oil and fish oil 
(Schwingshackl et al. 2017). These are discussed in more detail with reference to multiple 
sclerosis in a later section. 
 
Cardiovascular disease  
There are a number of studies that suggest there is robust evidence that adherence to the 
Mediterranean diet is protective against cardiovascular events (WHO 1990; Keys 1995; 
Dinu et al. 2017; Asamudo and Okolo 2019).  Sofi (2008) in a meta-analysis of 
prospective cohort studies states that mortality from cardiovascular disease is 9% lower in 
those at-risk patients who adhere to the Mediterranean diet. It is possible that the anti-
inflammatory effects and antioxidants of the constituents of the Mediterranean diet 
synergistically reduce chronic inflammation and oxidative stress (Varadharaj et al. 2017).  
Phenolic compounds found in extra virgin olive oil show antioxidant, anti-inflammatory 
and antimicrobial properties (Cicerale Lucas and Keast 2012), although the 
bioavailability of many phenolic compounds is poor, as discussed in a later section.  
Atherosclerosis involves thickening of the walls of blood vessels in particular, the intima-
media. Foods such as fruits, which have high carotenoid and flavonoid components have 
been shown to be inversely associated with intima-media thickness (Mursu et al. 2007).  
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Lv et al. (2015) suggest citrus fruits contain secondary metabolites such as flavonoids, 
alkaloids, coumarins, limonoids, carotenoids and phenol acids. These may be 
cardiovascular protective and neuroprotective because of their anti-oxidative and anti-
inflammatory effects. The pathogenesis of multiple sclerosis is thought to involve 
inflammatory cytokines, tumour necrosis factor-alpha, interleukin-1β and interleukin-6 
leading to demyelination (Heiss et al. 2001).  Omega 3 fatty acids found in the 
Mediterranean diet are said to inhibit tumour necrosis factor alpha, and interferon-
gamma. There is therefore the potential of the Mediterranean diet to suppress 
demyelination of central nervous system nerve cells which occurs in multiple sclerosis 
(Jahromi et al. 2012).  The Mediterranean diet is also high in dietary fibre (Trichopoulou 
et al. 1995). Fruit, vegetables, legumes, unrefined cereals and nuts all provide a good 
source of fibre to the diet (Maiani et al. 2009).  It has been suggested that dietary fibre 
reduces the of risks of chronic diseases (Trinidad et al. 2010). At least two separate 
mechanisms might be taking place. In cardiovascular disease, fermentable dietary fibre is 
thought to inhibit the enzyme hydroxy-3-methylglutaryl-CoA reductase which is involved 
in LDL-cholesterol production through the production of propionate (Trinidad et al. 
2010).  Another possible mechanism is that dietary fibre is thought to alter the gut biome 
with broader metabolic consequences (Makki et al. 2018). Indeed, the gut biome has been 
at the centre of considerable research in recent years in relation to neuroinflammation 
(Feck et al. 2017).  Riccio and Rossano (2018) suggest that when investigating the 
aetiology of multiple sclerosis the gut microbiome is an important consideration. They 
highlight two particular groups of gut microorganisms. In the first group certain 
microorganisms flourish in a low fibre (Western-style) diet. While in the second group, (a 
more diverse group), the gut microorganisms thrive on a vegetable-based diet. These 
microorganisms are capable of digesting complex oligosaccharides whereas the first 
group are not (Riccio and Rossano 2018). The authors go on to suggest that the people 
who eat a Western diet display a reduced number and diversity of the microorganisms 
that flourish on the vegetable-based diet. They reviewed the gut microorganisms in the 
vegetable-based diet which appear to have protective and anti-inflammatory properties. 
They state amongst other benefits this group of organisms reduce oxidative stress and 
inhibit nuclear factor kappa B which is a proinflammatory transcription factor. It is 
possible that the cases in the current study had different gut microorganisms when 
compared with control subjects based on their diet, although it was not possible to test 
this as faecal samples were not taken for comparison. Oxidative stress is thought to 
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increase the permeability of the blood brain barrier and be in part responsible for the 
pathophysiology of multiple sclerosis (Qureshi et al. 2018). Nuclear factor kappa B is a 
protein that amongst other things, controls cytokine production. If there is irregular 
control of nuclear factor kappa B, proinflammatory signaling may occur and acute 
inflammation becomes chronic. As a result, autoimmune diseases like multiple sclerosis 
can develop (Lawrence 2009). 
It seems plausible that the anti-inflammatory activity of the Mediterranean diet could 
have a protective or ameliorating effect on the inflammatory component of the 
pathophysiology of multiple sclerosis.  
 
6.2.4 The bioavailability of antioxidants    
Plant based foods, olive oil and fish oil are high in phenolic compounds and while 
polyphenols may have theoretical protective antioxidant properties, the bioavailability of 
the 8000+ compounds identified as being present in the diet may well be variable. For 
example, flavonoids have generally low bioavailability (Kawabata Yoshioka and Terao 
2019). Despite the generally low bioavailability of phenolics, Pounis et al. (2016), using 
data from a large population study, concluded the polyphenol content of diet was 
negatively associated with low-grade inflammation biomarkers. In addition to antioxidant 
properties, hydroxytyrosol and tyrosol found in extra virgin olive oil may modulate 
intracellular signalling, scavenge free radicals and down-regulate inflammatory 
mediators.  The gut microbiome also seems to play an important role in affecting the 
bioavailability of phenolic compounds. For example, Karković Marković et al. (2019) 
suggest a complex two-way interaction occurs. The gut microbiota enables 
biotransformation of non-digested phenolic compounds into their catabolic metabolites 
which increases bioavailability. In addition, phenolic compounds may themselves 
modulate the composition of the biome. 
 




When compared with controls, cases were calculated to eat less vegetables in both 
analyses and for one unit increase of the vegetable Mediterranean diet score in the age 
adjusted analysis there was a 17% reduction in the outcome (being a multiple sclerosis 
case). A one unit increase in the vegetable score for a person eating no vegetables per 
week would be simply to eat one serving per week. Or a person eating 1-6 portions a 
week would need to eat 7-12 portions to increase their score by 1 unit. (see Panagiotakos’ 
MedDietScore system). 
In the age-matched analysis the unit change was even higher at around 23% reduction in 
the outcome (being a multiple sclerosis case) for one unit increase of the vegetable 
Mediterranean diet score. There would appear no reason why multiple sclerosis patients 
would deliberately (for health reasons) eat less vegetables than controls. However, it is 
possible that some multiple sclerosis patients may have a physical disability associated 
with the disease. Peeling and preparing vegetables, could make this food preparation 
harder for patients, so this might prevent them from eating as many vegetables, although 
there was no evidence collected in the study to support this idea. Vegetables contain a 
wide variety of minerals, vitamins and fibre. Phytochemicals found in some vegetables 
also have apparent antioxidant properties which are thought to protect against free radical 
damage (Dias 2012). In some chronic diseases such as cardiovascular disease, free 
radicals have been implicated in the disease pathophysiology (Zhang et al. 2015). A diet 
high in vegetables has been shown to be associated with lower risk of cardiovascular 
disease (Mullie and Clarys 2011) due to possible antioxidant effects and it is possible that 
such phytochemicals could be protective against multiple sclerosis.  
 
Dairy products    
Dairy products are a key source of calcium for example, as well as fat soluble vitamins 
such as Vitamin D, but are not typical of the Mediterranean diet. In this study cases were 
found to consume more dairy products than controls, and in a dose dependent manner in 
both analyses undertaken. It is possible that cases chose to consume more dairy products, 
perhaps because they erroneously consider dairy products healthy or beneficial for their 
disease. For example, TV and magazine adverts deliberately portray cows, butter and 
milk in an idyllic countryside setting or backdrop (Borkfelt et al. 2015). 
 
Alcohol    
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In both analyses, the Mediterranean diet score for alcohol consumption was significantly 
lower in cases than controls. For every unit of the Medscore for alcohol, cases were 13% 
less likely to consume alcohol than controls. There are many studies that suggest alcohol 
is detrimental to acquiring multiple sclerosis (Pekmezovic et al. 2006). However, there 
have been other studies that suggest alcohol is potentially protective (Hedström Hillert 
Olsson and Alfredsson 2014) although others have found no correlation between alcohol 
consumption and acquiring multiple sclerosis (Massa O’Reilly Munger and Ascherio 
2013). 
The current study suggests a protective role of alcohol using a Mediterranean diet score 
for alcohol. In other studies, it has been suggested that alcohol consumption and health 
follow a J-shaped curve. For example, low levels of alcohol consumption may be 
beneficial to health, whereas, when the intake level increases to a certain point, excess 
alcohol consumption becomes harmful (Lungaard et al. 2018). Ruitenberg et al. (2002) 
suggested one to three drinks per day significantly lowered the risk of dementia (hazard 
ratio 0·58 [95% CI 0·38–0·90]), giving support to the theory that low levels of alcohol 
consumption may be neuroprotective. 
It is possible that alcohol consumption and acquiring multiple sclerosis also follows a 
similar J-shaped curve.  A j-shaped association was not tested in the current study, but the 
study found a linear relationship. Andersen et al. (2018) found an inverse relationship 
between alcohol consumption in adolescence and acquiring multiple sclerosis which was 
statistically significant in both men and women. For example, women with low alcohol 
consumption had an odds ratio of 0.56 (95% confidence interval 0.47–0.66) compared 
with non-drinking women and women with moderate alcohol consumption (OR = 0.49, 
95% CI: 0.38–0.62) and high consumption (OR = 0.57, 95% CI: 0.38–0.84).  
It is unknown why multiple sclerosis patients in the current study drink less alcohol than 
controls. The question on how much alcohol is consumed now compared with earlier life 
showed less consumption in both analyses for cases but the same in both analyses for 
controls, suggesting cases may have changed their alcohol habit over time. 
It is possible that their drinking reflected the adverse media publicity towards alcohol 
consumption in general in relation to health outcomes. Alternatively, they may have been 
advised by their doctor or dietician in regard to obesity and other health outcomes. 
However, there is no evidence to support either suggestion from the present study. 
 
Alcohol in other diseases 
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In studies of cardiovascular disease, (which may have a similar inflammatory origin to 
multiple sclerosis), Chiva-Blanch et al. (2011) found that red wine was protective on lipid 
profile.  Estruch et al. (2004) suggest red wine decreased hs-CRP which is a marker for 
inflammation. It is possible that red wine, which is typical of the Mediterranean diet, is 
neuroprotective. 
 
Medscore for legumes 
In both analyses, cases ate less legumes than control subjects (by 22% in the logistic 
regression analysis and by 29% in the age-matched analysis). Of the 35 cases who stated 
they avoided certain foods 6 subjects avoided legumes completely. One person cited an 
allergy to broad beans while another suggested they got indigestion from butter beans, but 
no reason was given by the other 4 cases. Martínez-González et al. (2011) state that 
consumption of legumes generally has declined in the Mediterranean region and they 
suggest this may be due to an increase in Westernization of the diet and an increase in 
consumption of the “western diet” in the area (Zhu et al. 2012). 
Legumes are a good source of dietary fibre (Trinidad et al. 2010) which has been 
associated with a healthy lifestyle and to be protective against certain diseases.  For 
example, Fung et al. (2012) suggest that fermentation of dietary fibre is protective against 
tumour formation in the colon due to the effects of butyrate produced during fermentation 
of the fibre. Legumes are said to have a positive effect on control of type 2 
diabetes reducing HbA1C and blood glucose concentrations (Jenkins et al. 2012). 
Legume consumption has been associated with hypertension management and a 
systematic review by Jayalath et al. (2013) concluded that pulses significantly lowered 
blood pressure in people with and without hypertension. It is not certain that multiple 
sclerosis has similar pathophysiology to any of the diseases mentioned but it is plausible 
that any anti-inflammatory effects of the Mediterranean diet would be beneficial in 
multiple sclerosis disease prevention. 
 
Medscore for non-refined cereals (whole grain food) 
In the logistic regression analysis cases are 19% less likely to consume non-refined 
cereals compared with controls. In the age-matched analysis, cases were 22% less likely 
to consume non-refined cereals such as whole grain food compared with controls, but this 
difference was not statistically significant. There is no obvious explanation to explain 
why cases ate this way. These results are similar to those found using different 
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methodology by Jahromi et al. (2012). In a cross-sectional Iranian study, a factor analysis 
was used to identify 7 dietary patterns. In a diet high in whole grains an inverse 
relationship was noted with multiple sclerosis, and the prevalence of multiple sclerosis 
was higher in those who had a diet low in whole grains. Sedaghat et al. (2016) found a 
positive association between refined grains consumption and increased risk of multiple 
sclerosis. 
Medscore for red meat and products 
In the logistic regression analysis, cases were 1.18 times more likely than controls to eat 
red meat and products when the data were unadjusted for age but when adjusted for age 
the statistical significance was lost and there was no statistically significant dose 
response. 
In the age-matched analysis there were no statistically significant results for cases eating 
red meat and products. Baghera et al. (2014) also found no significant difference between 
113 cases and 113 controls with regard to consumption of red meat. In another study 
Black et al. (2019) concluded there was inconclusive evidence associated with red meat 
consumption and the risk of multiple sclerosis. These observations are stark contrast to 
the association of red meat and cardiovascular disease (Wang et al. 2018). It is possible 
the consumption of red meat and products are pro-inflammatory, and this may account for 
the observations in relation to cardiovascular disease but why the data are inconclusive 
with regard to multiple sclerosis is unknown. 
 
Potatoes 
In the logistic regression analysis, there were no statistically significant results for cases 
eating less potatoes than controls. However, in the age-matched analysis, cases were 
about 19% less likely to eat potatoes compared with control subjects.  It has not been 
possible to provide a logical explanation to this result. 
 
6.2.6 Individual Foods 
 
Individual food items avoided by multiple sclerosis patients 
Only 35 cases reported avoiding certain foods as can be seen in Chapter 5 Table 23.  Of 
these, red meat, dairy produce, eggs, fried food and fat accounted for more than half of 
the foods avoided. The reasons for food avoidance were usually not given, but it is 
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possible that they had been advised against eating these “unhealthy foods” by their 
medical team as it is well known these products can influence inflammation.  However, 
as stated earlier there is no evidence to suggest these foods influence multiple sclerosis 
risk. 
 
Individual food items eaten by multiple sclerosis patients to help their condition 
There were 34 cases who reported eating certain foods to help manage their condition. 
There was often more than one food group listed by a person as shown in the results 
section of Chapter 5 Table 26. Around a third of those patients who responded, 
deliberately ate more fish and a third ate more fruit. While two thirds ate more vegetables 
because of their disease. One might assume the deliberate fish consumption was to raise 
omega-3 while the deliberate consumption of fruit and vegetables might have been 
because these foods are regarded by the medical team as “healthy”. There are many 
reports in the press that a “healthy diet” results in less relapses, so it is reasonable to 
assume this could have motivated some multiple sclerosis patients to adopt this eating 
pattern.  It is of interest to understand why more of the patients did not adopt a “more 
healthy lifestyle.”  Despite the deliberate attempt to eat fruit and vegetables by some 
individuals, overall, multiple sclerosis cases were still less adherent to a Mediterranean 
diet pattern than controls.  
Grapefruit 
In both analyses, cases reported eating less grapefruit than control subjects and this 
appears to follow a dose response relationship. There are several possible explanations. 
Grapefruit is known to interact with at least 85 drugs (Bailey et al. 2013) and patients 
taking these drugs are advised to avoid consuming this fruit. There are no documented 
multiple sclerosis medications that interact with grapefruit (personal communication 
2019). However, multiple sclerosis patients who suffer from trigeminal neuralgia might 
be prescribed carbamazepine which is an anti-epileptic drug with success in treating 
nerve pain (Patsalos 2016).  Grapefruit is known to interact with carbamazepine 
increasing the level of the drug, so multiple sclerosis patients taking this drug might have 
been warned against eating grapefruit. 
It is possible that multiple sclerosis patients are on medication in addition to their 
multiple sclerosis medication that interact with grapefruit such as some statins and have 
been advised not to eat it or drink grapefruit juice.  
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The median age of multiple sclerosis patients in this study was about 14 years higher than 
the controls. Older people are more likely to take medication for conditions that are 
affected by grapefruit than younger patients. An example would be older patients are 
more likely to need to take statins for hypercholesterolaemia. This study has adjusted for 
the age effect, and the age-matched analysis showed the same result, so age cannot, on its 
own, explain the difference between cases and controls. Another possibility is that 
grapefruit is neuroprotective. In addition to carbohydrates, proteins, vitamins and 
minerals, grapefruit contains phytochemicals such as flavonoids. These are not essential 
dietary elements but have been shown to be anti-inflammatory (Lv et al. 2015).  
Neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease are 
thought to be driven by a number of factors including oxidative stress (Enogieru et al. 
2018). The antioxidant effect of rutin has been proposed as potentially neuroprotective 
(Budzynska et al.2019), but rutin has poor bioavailability (Faggian et al. 2016) due to a 
combination of poor absorption, high metabolism and rapid excretion (Enogieru et al. 
2018). The literature search suggests that the effect of rutin has not been studied in 
multiple sclerosis despite the pathogenesis in multiple sclerosis being partly due to 
oxidative stress (Gilgun-Sherki Melamed and Offen 2004). Rutin is a glycoside of the 
flavonoid quercetin and is found in many fruits including grapefruit (Enogieru et al. 
2018). If grapefruit is indeed protective, the role of rutin should not be ignored and 
warrants further investigation.  
Tomatoes 
Compared with controls, multiple sclerosis cases ate significantly less tomatoes and in a 
dose response manner. The answers from the “foods avoided” question gave no indication 
that multiple sclerosis patients deliberately avoided eating tomatoes and there are no 
plausible reasons why this might have occurred. 
Tomatoes contain vitamins A, C and K which may hold health benefits for people with 
chronic inflammation. They also contain copper, potassium, manganese and 
molybdenum. They are high in dietary fibre and biotin (vitamin B7). They contain all the 
major carotenoids, namely alpha- and beta-carotene, lutein and lycopene. In particular, 
quantities of lycopene are high. This carotenoid, which is also found in pink grapefruits 
and watermelons (Dasgupta and Klein 2014), has been shown to be a strong antioxidant 
(Riccio and Rossano 2015) and have anti-inflammatory properties (Chen Huang and 
Chen 2019). Lycopene can also be found in all tomato products such as sun-dried 
tomatoes, tomato juice, tomato paste, and ketchup and the processing both concentrates 
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and increases the bioavailability of lycopene (Başaran Bacanlı and Başaran 2017). 
Lycopene levels are higher in the skin than the pulp of the fruit. It is a lipid soluble 
chemical, so when consuming tomatoes or their products with oil, there is better 
absorption from the gut which is mainly by passive diffusion (Başaran Bacanlı and 
Başaran 2017). 
A systematic review and meta-analysis by Cheng et al. (2017) examined the evidence for 
tomato and lycopene supplementation. They concluded that interventions using tomato 
supplement were associated with significant reductions in LDL-cholesterol (p=0.006) and 
improved endothelial function when measured by flow-mediated dilation. In addition, 
they found giving lycopene supplement reduced systolic blood pressure by 5.66 mmHg 
(p=0.002).  
It seems reasonable to suggest, that any antioxidant and anti-inflammatory agent could in 
theory at least, be protective against multiple sclerosis. 
 
Oat based cereal     
In the current study, multiple sclerosis cases ate significantly less oat-based cereal than 
controls, and in a dose response manner. It is possible that some of these patients have 
disease associated diarrhoea or constipation. Hinds (1990) conducted a study of 280 
multiple sclerosis cases and suggested that about 43% had constipation and 51% had 
suffered from faecal incontinence at least once in the previous 3 months. He suggested 
that 68% of the multiple sclerosis cases he studied had some form of bowel dysfunction. 
Perhaps the patients in our study were reluctant to eat high fibre food in case it affected 
their bowel function. Eating oats would often be recommended to improve bowel 
function because of the soluble fibre content. However, there is no evidence to support 
this. Nor was any literature found to suggest that bowel function in multiple sclerosis 
cases might be made worse by eating oat-based cereal.  Indeed, The US National Multiple 
Sclerosis Society suggests eating a high fibre diet to help bowel symptoms. In the present 
study there were no instances when a multiple sclerosis case indicated that they 
deliberately avoided oat-based cereals. 
There were no papers found to link an association between oat-based cereals and multiple 
sclerosis, but the temporal connection can be made of any food with antioxidant and or 




Pulses are the dried seeds of legumes such as beans, peas, lentils and chickpeas (Mudryj 
et al. 2014) and are high in dietary fibre and protein. They are a good source of minerals 
such as iron, calcium, magnesium, zinc and potassium. They contain vitamin C and 
folate. A systematic review of 8 controlled feeding trials by Jayalath et al. (2013) 
concluded that they significantly reduced blood pressure in people with and without 
hypertension. In this study when compared with control subjects, multiple sclerosis cases 
reported eating significantly less dried pulses. Some people with multiple sclerosis can 
have bowel problems. This can take the form of constipation or diarrhoea. It is well 
known that eating beans for example, can cause flatulence (Messina 2014), and it is 
possible that multiple sclerosis patients avoid dried pulses for this reason. The long 
cooking time (Goyal et al. 2018) that pulses need may put some people off using them, 
but this should be similar for control subjects as well as cases. The preparation of dried 
pulses usually takes two steps. Soaking for about 24 hours is followed by cooking for 
between 15 minutes and 2 hours (Margier et al. 2018). It is possible that ill or disabled 
multiple sclerosis patients cannot be bothered with this process. Canned and jarred 
pulses would overcome these problems and it would have been interesting to ask an 
additional question about the reason for people not eating pulses.  Pulses are an important 
component of the Mediterranean diet as an important protein source in place of meat, 
which is recognised as a healthy dietary option (Willett et al. 1995).  However, there is a 
paucity of studies involving consumption of pulses and patients with multiple sclerosis.  
 Awika et al. (2018) suggest pulses and whole grains have health benefits alone and have 
a synergistic effect when consumed together. The “foods avoided” question highlighted 
one case who avoided pulses (without explanation) but this is unlikely to affect the result 




As well as containing fibre and vitamins, beetroot contains betalain pigments which 
have been shown to display antioxidant and anti-inflammatory properties (Clifford et 
al. 2015). Beetroot has been suggested as protective against oxidative stress–related 
disorders such as cardiovascular disease and neurodegenerative disorders (Vulić et al. 
2013).  However, betalains have poor bioavailability (Lechner and Stoner 2019) and 
while betalains have in theory the ability to scavenge free radicals, the bioavailability 
issue has cast doubt on their usefulness at present although it seems plausible that 
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beetroot could be neuroprotective against multiple sclerosis.  In the age-matched 
conditional regression analysis, cases reported eating significantly less beetroot compared 
with controls. As far as is known, there have been no case-control studies in the literature 
suggesting lower beetroot consumption in multiple sclerosis cases compared with 
controls. 
One serious side effect of eating large amounts of beetroot are oxalate kidney stones in 
people prone to kidney stones. It is not known if those with multiple sclerosis in this 
study actively refrained from eating beetroot for this reason, but it seems unlikely. A 
study by Ganesan et al. (2017) suggests that compared with matched controls, patients 
with multiple sclerosis were significantly less likely to have calcium oxalate monohydrate 
stones (39% vs 64%, P < 0.001) and more likely to have calcium phosphate stones (42% 
vs 15%, P < 0.001) and struvite stones (8% vs 3%, P = 0.03). It might be speculated. 
multiple sclerosis cases in this study had misread this article or been misinformed by a 
doctor who had read the article that eating beetroot led to “kidney stones” in multiple 
sclerosis.  However, the answers from the “foods avoided” question gave no indication 
that multiple sclerosis patients deliberately avoided beetroot. 
 
Refined breakfast cereal  
Multiple sclerosis cases reported eating significantly less refined breakfast cereal 
compared with controls.  It would seem counter intuitive that eating less refined breakfast 
cereal would increase the risk of acquiring multiple sclerosis and the data should not be 
interpreted in this way. 
There is some evidence from the “foods avoided” question that some cases have tried to 
eat less fried and “unhealthy” food although none indicated that they were avoiding 
refined breakfast cereal, which is regarded by some as “less healthy” than unrefined 
breakfast cereal.  Refined cereal has been modified by grinding or sifting to removal the 
bran and germ. This adds to the shelf life but results in losses of many “healthy” 
components that in some countries it has been deemed necessary to replace certain lost 
components through mandatory fortification (Mann 2017). It is possible that cases have 
deliberately reduced the consumption of refined breakfast cereal and switched to the 
“healthier” whole grain breakfast cereal. However, there are no data from this study to 




The literature suggests that all onions have antioxidant properties (Borah and Banik 2018) 
with red onions containing the highest amount of antioxidant compounds, in particular 
flavonoids. They are also thought to have anti- cancer and anti-inflammatory properties 
(Roldan et al. 2008). Since multiple sclerosis is an inflammatory disease it is possible to 
make a temporal connection with any anti-inflammatory compounds that may be 
protective and that there might be health benefits of consuming onions might be 
protective against multiple sclerosis When compared with controls, multiple sclerosis 
patients ate significantly less onions than control subjects, in a dose response manner, 
although the number of participants who did not eat onions was very small and so 
statistical calculations should be viewed with caution. One possible explanation is that 
cases may have been advised against eating onions by a doctor or dietician. However, 
there are no documented reasons why someone would advise this, and there is no 
indication in the literature to suggest any interactions between consumption of onions and 
multiple sclerosis medications.  
 
6.3 Smoking  
Smoking is a recognised potential confounder in the study of cardiovascular disease, 
which may have a similar inflammatory pathogenesis to multiple sclerosis.  Smoking 
fulfilled part of condition 1 of being a confounder in this study (a confounder is defined 
in Chapter 2 page 26). That is, smoking is shown to be associated with multiple sclerosis 
(Gross and Lublin 2017). However, it is more difficult to associate smoking with eating a 
Mediterranean diet.  It could be argued that a person who follows an unhealthy lifestyle 
choice (smoking), is less likely to follow a healthy dietary choice (the Mediterranean 
diet).  To determine if smoking was a confounder in the current study, condition 2 was 
applied as described in Chapter 2. Adjustments were made statistically to determine if 
smoking was distributed unequally among the groups being compared.  In the study, 
current smoking incidence was high in both cases and control subjects but was 
significantly less amongst cases than control subjects. This might give the impression that 
current smoking might be in some way be protective. For example, the odds ratio was OR 
0.32 (0.20, 0.52) p<0.001 (see Appendix A).  This suggests that cases were 68% less 
likely to be current smokers than were control subjects. There is a plausible reason for 
this result. On being diagnosed, many multiple sclerosis patients may have given up 
smoking. This is suggested with the “ever-smoked” (ie current plus former smokers) 
result, where there was no statistically significant difference in the numbers who had ever 
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smoked between cases and controls. Unfortunately, there were no data collected in the 
questionnaire as to when former smokers stopped smoking in relation to their diagnosis of 
multiple sclerosis. To summarise, current smoking was high amongst both cases and 
control subjects but was higher amongst control subjects. When “ever-smokers” were 
compared, there was no statistically significant difference between either group. When 
the Medscore diet score was adjusted for smoking status or exposure to smoke, there were 
no differences in the odds ratio. So, for this study smoking was not a confounding factor. 
 
6.4 Demographic characteristics  
 
Summary  
The definition of a confounding factor is described and discussed in chapters 1 and 4 and 
defined in chapter 2 page 26. Although there were several potential confounding factors, 
the only confounding factor found to be significant in this study was age.  Age was 
associated with both the risk factor of interest and the outcome, and it was distributed 
unequally between the groups being compared. It was not an intermediary step in the 
pathway from the exposure of interest to the outcome of interest, so age fulfilled the three 
conditions of being a confounding factor. 
Median age was found to be significantly different between cases and control subjects. 
Adjustment was therefore made for age in the logistic regression analysis. Obviously, the 
age-matched conditional regression analysis removed age as a confounding factor.  
 
Condition 1 of the “definition of a confounder” requires the confounding factor to be 
associated with both the risk factor of interest and the outcome. Skin type and previous 
diseases do not fulfil this condition. While both variables are possible risk factors of 
multiple sclerosis, neither can be linked temporally with the Mediterranean diet, so have 
been removed from the discussion. 
Condition 2 requires that the confounding variable is distributed unequally among the 
groups being compared. Other potential confounders such as sex, educational attainment, 
were tested as adjustments in the Medscore diet score but were found not to be 
confounding factors as they had no or little effect on the Medscore diet score.  
 
6.4.1 Sex/Gender  
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While the variable “sex” fulfilled condition 1 of being a confounder, that is, it was 
associated with the outcome of interest (the sex ratio worldwide is about 3:1, women to 
men) and it is plausible that females could eat a different diet to males, it did not fulfil 
condition 2 in this study. To satisfy this condition, the distribution of the variable would 
need to be unequal between cases and controls. In this study, that was not the case. 
Females were about 2/3 of both cases and control subjects.  With this in mind, the 
discussion on sex has been omitted. 
 
6.4.2  Age  
The mean age of the multiple sclerosis cases was 46.8 years (SD 13.7) while the mean 
age of the control subjects was 32.4 years (SD 12.8). The age distribution of the control 
subjects was not uniform, being skewed towards the younger age range, whereas the ages 
of cases were normally distributed.  
Questionnaires were collected from cases and controls simultaneously by convenience 
sampling and the mean (then median) age of each group determined afterwards at the 
analysis stage.  With hindsight, more older controls could have been recruited using a 
more targeted approach if the cases had been recruited first and analysis started.  
However, the time restrictions and a delay in getting case information for this study 
prevented this. 
The average age at diagnosis of multiple sclerosis in Cyprus is 35 years, according to the 
principal consultant at the Cyprus Institute of Neurology (Personal communication) but 
no accurate data exist as there is not a multiple sclerosis registry or universal 
computerised hospital records system yet in Cyprus. 
The age of cases ranged from 19 to 81 years while the range for control subjects was 
similar, ranging from 18 to 87 years.  Since there were over 700 controls, it would have 
been possible to remove large numbers of young controls from the analysis to bring the 
median age of controls to nearer 47 years.   
However, a priori, age was considered a potential confounding factor, and the initial 
analysis confirmed that this was the case, so it was decided to adjust all the logistic 
analysis for age statistically.  
 
6.4.3 Socioeconomic status  
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Socioeconomic status was regarded as a potential confounding factor since it has been 
suggested as a risk factor for multiple sclerosis in a number of previous studies, although 
the evidence is conflicting (Leibowitz et al. 1966; Kurtzke and Page 1997; Berg‐Hansen 
and Celius 2015). Low socioeconomic status and poor sanitary conditions have been 
suggested as being protective against multiple sclerosis but was shown to be statistically 
significant only when living conditions were well below average (Zilber and Kahana 
1996). However, another study found that low socioeconomic status increased the risk for 
multiple sclerosis in certain ethnic groups such as black and white men and white women 
(Briggs Green and Weintraub 2015). 
Cyprus has the second highest number of people in Europe who have completed tertiary 
education (The Republic of Cyprus Statistical Service 2017). 
In this study, there were no statistical relationships between housing status, marital status, 
highest qualification obtained and the risk of being a multiple sclerosis case or not. When 
the Mediterranean diet score data were adjusted for socioeconomic status there were no 
confounding effects observed. 
 
6.4.4 Body Mass Index and Body Mass Index categories  
There is strong evidence from observational studies to suggest that obesity is a risk factor 
for multiple sclerosis (Correale Farez and Gaitán 2017; Alfredsson and Olsson 2018) and 
meta-analysis supports this (Liu et al. 2016). In this study, which relied on self-reported 
weight and height, obesity was more common in cases than control subjects (13% 
compared with 9.5%). As can be seen from the results in chapter 5, cases had a higher 
mean BMI than control subjects which was statistically significant. However, there was 
no statistically significant difference between groups when body mass index categories 
were compared or when obesity data were adjusted for age. 
Self-reported weight may be lower than that measured using accurate scales and similarly 
self-reported height higher than that determined using a measure (Gorber et al. 2007). It is 
also likely that reporting differed between males and females (Birrell Pearce Francis and 
Parker 2005). This could make the BMI values calculated for subjects in this study lower 
than the true value.  However, since there is no evidence that self-reporting would be 
different between cases and control subjects, the comparison is still valid. 
It is possible that the effect of the disease process in multiple sclerosis could reduce 
mobility and hence increase weight gain as the disease advances. It is also possible that 
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the median age difference between cases and controls could partly explain the mean BMI 
difference as older people tend to put on weight with age as activity/exercise reduces with 
age. This is more likely than the minimal effect of slightly slower metabolism observed in 
multiple sclerosis (Godard 2016). 
When the Mediterranean diet score data were adjusted for BMI, there were no 
confounding effects observed. 
 
6.5 Strengths and limitations of the study  
6.5.1 Strengths  
The study design is considered a strength and followed standard practice. For example, 
case-control studies are appropriate for rare diseases and multiple sclerosis is a rare 
disease. To the author’s knowledge this is the first known case-control study examining 
the relationship between adherence of the Mediterranean diet and the risk of acquiring 
multiple sclerosis in Cyprus, and indeed Europe.  Other than one case-control study in 
Iran, it is only the second known study investigating possible relationships between 
adherence to the Mediterranean diet and risk of multiple sclerosis in the world.  
Using two main methods of data analysis is also considered a strength. The logistic 
regression analysis with adjustments for potential confounding factors such as age and 
sex, is a strength.  The age-matched analysis was carried out because it avoided a major 
bias, which would have been a major limitation.  When the age-matched analysis was 
incorporated into the study design, the study became stronger. The analyses using both 
logistic regression and conditional logistic regression are robust approaches. The study 
used a validated FFQ based on the Epic-Norfolk FFQ which has been used in many 
circumstances. The questionnaire was self-administered which avoids interviewer bias. 
Participants were allowed to answer food questions on a continuum for example a food 
item might be eaten daily, weekly or monthly. All answers were converted to weekly 
scores. Another strength is that a local nutritional expert provided information to support 
the local context of the study. The local expert helped ensure that foods typical of Cyprus 
were included in the FFQ and that English brands that are not found in Cyprus were 
identified and excluded. The FFQ was also translated by a professional translator into 
Greek and another translator translated that Greek version back to English to ensure 
accuracy of translation.  The final FFQ was printed with every question in both English 
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and Greek.  The questionnaire was relatively short and could be completed without any 
help in about 15 - 20 minutes. Using a single investigator can be time consuming, but it 
prevents potential errors associated with multiple investigators such as inputting data 
differently. Another strength is that the study is reproduceable. For example, the FFQ 
could be used on another Greek speaking island such as Crete (with appropriate ethics 
approval). Another strength is that there was clear case definition. Cases had a consultant 
diagnosis using the McDonald criteria revised 2107. Furthermore, the STROBE 
guidelines for observational studies were followed for this case-control study. 
 
 
6.5.2 Limitations  
One potential limitation was control selection. It was not possible to assess to what extent 
controls were representative of the background population. While every effort was made 
to collect control data from across the island, it was not possible to ensure this was 
representitive. However, case and control demographics were not statistically different in 
the analyses. 
The recruitment of cases and control subjects might have suffered from selection bias. 
Due to the small number of cases on the island, and the way they could be contacted 
because of the lack of a registry, cases were selected by convenience sampling in hospital 
clinics. This could be a limitation since some multiple sclerosis cases may be so unwell 
that they find regular attendance at a clinic more difficult and other multiple sclerosis 
cases might be in a phase of remission so don’t feel they need attending. Control subjects 
were also selected by convenience sampling because of the timescale of the study as 
mentioned in the methods chapter. Like other case-control studies, recall bias was a 
possible limitation. It is possible that cases and controls recalled their diets differently. In 
multiple sclerosis, cognitive impairment occurs late in the disease so this should not have 
been a problem in the current study although data on time since diagnosis was not 
collected. The aim at case selection was to avoid enrolling patients who could not make 
an informed decision about participation and consent. However, it was not possible to 
measure cognition, and it is possible that cases were less able to recall dietary details than 
controls.  It is also possible that cases altered their diet upon diagnosis or answered 
questions differently to the way they would before diagnosis. The low numbers of cases 
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who answered the questions on “foods avoided” and “foods eaten deliberately because of 
the disease”, tends to suggest this was not the case.  
The use of any score to assess Mediterranean diet adherence as a method of assessing a 
dietary eating pattern is limited by subjectivity (Sofi 2008) and comparisons with any of 
the other 48 scores available is difficult. Another weakness is that only a comparison of 
“Mediterranean diet adherence” or “foods eaten” between these cases and control subjects 
was possible, since in this study, no measurements of nutrient intake were made. 
Comparisons to other studies can only be made in general terms.  In this context reverse 
causation is a possible limitation. This when the disease (outcome) increases the 
likelihood of the exposure. For example, multiple sclerosis patients might avoid a food 
because of their condition. 
The problems of multiple testing also require consideration. When multiple simultaneous 
tests occur in a study like the current study, each test has the potential to produce a 
significant result alone. As more tests (in this study 100s) are analysed, it becomes 
increasingly likely that cases and control subjects will differ due to random sampling 
error alone.  Type 2 errors (or false positives) can occur. Corrections for this potential 
error were not performed in this study, since the number of hypotheses were small 
(Streiner and Norman 2011). 
 
6.6 Conclusion and Recommendations 
 
The null hypothesis in this study was:  multiple sclerosis cases when compared with 
control subjects, have neither a higher nor lower Mediterranean diet score.  Since cases 
had a lower Mediterranean diet score and this was statistically significant, it was possible 
to reject the null hypothesis and accept the alternative hypothesis.  The Mediterranean 
diet is a dietary pattern high in plant-based foods and fruit, while low in dairy and red 
meat products. There is evidence to suggest the Mediterranean diet is a healthy diet which 
seems to be protective against cardiovascular disease and colorectal cancer. This current 
study adds additional evidence that this healthy dietary pattern is lower in multiple 
sclerosis cases compared with control subjects. This raises the question “Can a diet such 
as the Mediterranean diet, be a useful intervention for primary prevention of multiple 
sclerosis?” Future intervention studies might help answer this. 
The current study also examined whether food groups within the Mediterranean diet 
pattern were associated with multiple sclerosis risk.  In cardiovascular disease and 
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colorectal cancer research, there has been a shift away from studying food groups and 
individual foods, towards diet as a whole. This might be due to a belief that it is the 
synergistic effect of the components of the diet that are beneficial. This may well be true, 
but this study found that certain food groups within the Mediterranean diet were 
consumed less by cases than by control subjects.  For example, cases ate less vegetables, 
ate less legumes, ate less whole grain food and drank less alcohol than control subjects. In 
addition, cases ate more dairy products than control subjects.  Cases also ate more red 
meat and products than control subjects, but this difference was not statistically 
significant.  Within food groups some individual foods were of interest as cases 
consumed less grapefruit, tomatoes, oat-based cereal, dried pulses, beetroot, onions and 
refined breakfast cereal than control subjects.  These food groups and individual foods 
warrant further investigation in the future. However, it is likely that some reverse 
causation exists. It was not possible to determine where this was occurring, although the 
discussion of individual foods highlights some potential areas.  
The results from this case-control study suggest patients with multiple sclerosis eat a 
dietary pattern less like the Mediterranean diet and a vegetable-based diet is less likely to 
be eaten by multiple sclerosis patients than controls. It is recommended that a plant-based 
diet be considered as a primary prevention measure subject to future intervention studies. 
 
 6.6.1 Suggestions for future research 
 
Other Mediterranean diet scores 
As stated earlier, there are many other Mediterranean diet scores in existence (Zaragoza-
Martí et al 2018). It will be possible to use the same data collected from this study and 
derive other Mediterranean diet scores by only slightly modifying the information already 
at hand. If similar results were obtained using different Mediterranean diet scores, this 
would add weight to the view that a Mediterranean type diet is protective against multiple 
sclerosis. If contradictory results were obtained, then it would cast doubt on this idea. 
 
Large cohort studies 
Large cohort studies can add valuable information to the study of a rare disease such as 
multiple sclerosis. The Oxford Centre for Evidence-based Medicine (2011) suggests that 
the level of evidence of well-designed large cohort studies is Level II or III depending on 
the effect. This is more powerful evidence than a case-control study which is considered 
Level IV.  However, following large cohorts of patients forward over long periods of time 
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can be challenging and expensive. Unfortunately, studies of this type have a long 
timescale and attrition is often high. The numbers of multiple sclerosis cases needed 
overall would be very large. 
 
Dietary intervention studies 
Randomised intervention clinical trials can provide more powerful evidence (Level II) 
than cohort studies and can be used to imply causation. Dietary intervention studies can 
be full studies or proof of concept studies. In the latter, as it possible to design a relatively 
short study that involves less patient recruitment. A group of perhaps 100 multiple 
sclerosis cases could be randomly allocated to two groups, one group who would receive 
a Mediterranean type (plant-based) diet and the second group who would consume a 
“Western” or control diet.  Unfortunately, attrition might be high in such a study, as it is 
difficult to get people to adhere to a diet for a long period. Yearly MRI results (among 
other measures) would be needed for comparison to see if there were differences in new 
lesions and disease progression.  
 
Principal components analysis (PCA) 
Principal components analysis (PCA) is a statistical method of converting observations of 
variables that may be correlated into linearly uncorrelated variables called principal 
components. For example, with the current data food patterns may be empirically derived. 
Indeed, this method was considered and started, but abandoned due to time constrains. 
 
6.6.2  Relevance of the study to health planning in Cyprus. 
It is uncertain the exact cost of the health treatment for a multiple sclerosis patient in 
Cyprus, but in a UK study, the annual mean cost per patient varied with disease severity 
from 11,400 GBP for mild cases to 36,500 GBP for severe cases (Kobelt et al. 2017).  
Cyprus has a population of about 850,000 and the estimated prevalence of the disease is 
198 per 100,000 (Charalambidou et al. 2016.) This is far higher than a previous study in 
1997 which estimated 44.5 per 100,000 (Dean et al. 1997) and is much higher than the 
rest of Europe at this latitude. If it were assumed that Cyprus were to have 1600 multiple 
sclerosis patients needing treatment costing 11,000 Euros per year, this would equate to 
an annual cost of over 17 million Euros. 
The potential for severe disability, the reduction in quality of life and the financial burden 
to the individual and the state, provides the impetus to find ways of reducing incidence in 
121 
both Cyprus and elsewhere. With this in mind, modifying modifiable risk factors such as 
diet could lead to health benefits for the individual Cypriot and reduce the financial 
burden to the state. So far, however, the evidence is not clear enough to warrant widescale 
dietary interventions, so more research is needed with perhaps a registry and high-quality 
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7 The Appendices 
7.1.1.1 Appendix A  
7.1.1.2 This section deals with the results of the unmatched data. 
Descriptive results 
There were 127 multiple sclerosis cases with a consultant diagnosis (uptake 21.2%) who returned the questionnaire in the time period of the 
study (August 31st 2017 to August 31st 2018). During the same period 718 control subjects (uptake 60.2%) returned the questionnaire. A 
summary of the demographic data for the whole population can be seen in Table 1. Data on gender were available for all cases and controls 
(n=845). The 127 cases were composed of 83 females and 44 males with approximately a 2:1 female to male ratio in the return of 














Table 1 Summary of demographic information collected. Part1 
 Controls (n=718) n (%) 
Cases 



















Inter quartile range (IQR) 
 
27 years (n=686) IQR 
23-38 
 
46 years (n=123) IQR 
37-57 
 
29 years (n=809) IQR 
24-43 
 
 p=< 0.001 
BMI Categories 
Underweight     
Healthy                                       
Overweight 
Obese       
Total    
Mean BMI                                                               
 
  57 (8.3) 
418 (61.1)  
143 (20.9) 
  66 (9.7)  
684    
23.61 SD 5.18                        
 
    8 (6.7) 
  60 (50.0) 
  36 (30.0) 
  16 (13.3) 
120    
24.61 SD 4.43                                         
 
  65 (8.1) 
478 (59.5) 
179 (22.3) 






Place of birth 
Nicosia                            
Limassol     
Larnaca        
Famagusta    
Paphos     
Other eg Greece, UK   
Total      
 
 391 (54.6)  
 111 (15.5)   
 105 (14.7)    
   29 (4.1)   
   11 (1.5) 
   69 (9.6) 
 716 
 
  50 (50.0) 
  19 (18.8) 
  13 (12.9 
    5 (5.0) 
    2 (2.0) 
  12 (11.9)   





  34 (41.6) 
  13 (15.9) 






p = 0.85. 
Place of current 
residency   
Nicosia                            
Limassol     
Larnaca        
Famagusta    
Paphos     







  11 (1.5) 
    6 (0.8) 
    5 (0.7) 
 
715                     
 
 
  62 (56.9) 
  26 (23.9) 
  16 (14.7) 
    3 (2.8) 
    2 (1.8) 
    0 (0.0) 
 






  14 (17.0) 
    8 (0.1) 







p = 0.11 
Ethnicity 
Greek Cypriot       Yes 
                              No  
                              Total                           
Maternal ethnicity  
Greek Cypriot       Yes 
                              No  
                              Total                           
Paternal ethnicity  
Greek Cypriot       Yes 














































                              Total                           
 







  33 (4.7) 
 
707                                         
   9 (7.4)   
 





   7 (5.8)   
 
121                                             





788 (95.2)  
 
  40 (4.8) 
 














  68 (9.7) 
699 
 
  86 (71.1) 
  25 (20.7) 


















  58 (8.2) 
  23 (3.3) 
232 (32.9) 
384 (54.5) 
    8 (1.1) 
705 
  
    4 (3.2) 
    8 (6.5) 
  83 (66.9) 
  23 (18.6) 
    6 (4.8) 
124 
 
  62 (7.5) 
  31 (3.7) 
315 (38.0) 
407 (49.1) 
























22 (19.8)  
111                         
   
 
  79 (10.6) 
310 (41.4)  
196 (26.2) 
164 (21.9) 





In the logistic regression analysis data, from 127 cases and 718 controls were used.  There were no cases or controls with every single 
question answered in full.  In the age-matched analysis, 119 cases had provided age, and these were matched with 119 controls as described 
in Chapter 4. 
Details of how missing data were treated appear in the methods section in Chapter 4 and the discussion of the impact on the study of missing 
data is dealt with in the discussion section in Chapter 6.  
All missing data in the demographic factor section of the questionnaire were left blank when uploaded to the statistical software. As an 










n (% data available) (n=718) 
Cases 









Age 686 (95.5) 123 (96.9) 
BMI Categories 





Place of birth 




101 (79.5)                   
Place of current 




715 (99.6)                 
 
 
109 (85.3)                      
Ethnicity 
                              Total                           
Maternal ethnicity  
                              Total                           
Paternal ethnicity  







707 (98.5)                                     
 
 
121 (95.3)                    
 
 
122 (96.1)                      
 
 




















111 (87.4)                                                              
 
There was no significant difference between the missing data of cases and controls, except for place of birth, which didn’t impact on the 
Mediterranean diet results. 
Age was recorded for 809/845 people (95.74%), with similar percentage of cases and controls providing this information. Age ranged 
between 18 and 87 years old for controls and 19 and 81 for cases. The mean age of the cohort was 34.7 years (SD 14) and the median age 29 
years (IQR 24-43). The age of the controls was not normally distributed, being skewed towards the younger ages, so the median was used. 
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The whole cohort median age was 29 years, but the median age of cases was 46 years and of controls 27 years. The results showed that age 
was significantly different between cases and controls (p<0.001). 
Of the four cases who were included as “Greek Cypriots” but declared themselves as “other”, two were born outside Cyprus but gave both 
parents as “Greek Cypriots”. The other two both gave both parents as “other” but neither filled in their place of birth. The sixteen controls 
who were included as “Greek Cypriots” but declared themselves as “other”, gave both parents as “other” or left the answer blank. They 
stated they were born outside Cyprus or left the answer blank.  
All other categories in the demographic data showed no statistically significant association between cases and controls. 
Analysis of the demographic information showed that only age was statistically different between cases and controls in the logistic 
regression analysis.  The effect of demographic data results are shown as potential confounders in the Mediterranean diet score analysis later. 
 
The Mediterranean diet  
Descriptive table and summaries of a Mediterranean diet score adapted from the MedDietScore 
A Mediterranean diet score (Medscore) derived from the MedDietScore (Panagiotakos et al, 2007) scoring system was used to assess 
adherence to the Mediterranean diet as described in the methodology chapter. Each of 11 food categories was given a score. The maximum 
total Mediterranean diet score was the sum of the 11 components (10x5) +3(olive oil) = 53. The minimum and maximum scores for the 
cohort were 12 and 50, respectively. Cases had a slightly lower mean score of 33.3 (SD 5.24) and ranged from 17 to 46 while the mean score 
for the control group was 33.9 (SD 5.74) and ranged from 12 to 50. There was no statistical significance between the mean Medscore of 
cases and controls. 
Defining “dose response” 
After assessing if cases and controls were exposed to a variable in a binary manner, for example ate a food or not, a dose response 
association was calculated. With a “dose response” association, for every step increase in the exposure of interest, there is an accompanied 
stepwise increase or reduction in the likelihood of the outcome (for example having multiple sclerosis). 
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The mean medscores of the 11 food categories were calculated for the whole cohort and separately for the age-matched cohort. These appear 
in Table 3  
 
Table 3 Mean medscores of the 11 food categories in the analysis using 718 controls and 127 cases 
 Controls (n=718) Mean (SD) Cases (n=127) Mean (SD) 
Alcohol 3.49 (2.28) 2.44 (2.51) 
Red meat and products 2.36 (1.77) 2.85 (1.49) 
Poultry 4.45 (1.28) 4.83 (0 .71) 
 Fish 2.38 (1.41) 2.58 (1.27) 
Non-Refined cereals 2.18 (1.21) 1.97 (1.02) 
Potatoes 3.38 (1.39) 2.99 (1.34) 
Dairy products 3.62 (1.57) 4.12 (1.31) 
Fruit 4.09 (1.20) 4.27 (1.19) 
Vegetables 2.99 (1.34) 2.77 (1.27) 
Legumes 2.94 (1.23) 2.61 (1.07) 
Olive oil 2.10 (1.38) 1.89 (1.46) 
 
 
Table 4 The Total Medscore in relation to multiple sclerosis. Unadjusted, and with adjustments using Logistic regression analysis  
 
 Total Med Diet Score  OR [95% CI]   p 
Dose response unadjusted 0.98 (0.95, 1.01)   0.26 
Dose response Adjusted for age 0.96 (0.93, 1.00)   0.04 
Dose response Adjusted for sex 0.98 (0.95, 1.01)   0.25 
Dose response Adjusted for age and sex 0.96 (0.93, 1.00)   0.04 
 
Statistically significant results were obtained. For each unit of the Total Medscore in the logistic regression analysis adjusted for age, there 
was a 4% reduction in the likelihood of the outcome (multiple sclerosis). 
 












Table 5 Logistic regression analysis Dose response of the total Medscore with adjustments of potential demographic confounding factors 
 
 Total Med Score 
OR [95% CI]   p 
Unadjusted 0.98 (0.95, 1.01)   0.26 
Adjusted for age 0.96 (0.93, 1.00)   0.04 
Adjusted for sex 0.98 (0.95, 1.01)   0.25 
Adjusted for age and sex 0.96 (0.93, 1.00)   0.04 
Adjusted for age and Body mass scale 0.96 (0.92, 1.00)   0.06 
Adjusted for age and Ethnicity 0.96 (0.93, 1.00)   0.06 
Adjusted for age and mother’s ethnicity 0.96 (0.92, 1.00)   0.04 
Adjusted for age and father’s ethnicity 0.96 (0.92, 1.00)   0.04 
Adjusted for age and place of birth 0.97 (0.93, 1.01)   0.10 
Adjusted for age and current residency 0.96 (0.92, 1.00)   0.04 
Adjusted for age and level of education 0.96 (0.93, 1.00)   0.07 
Adjusted for age and highest qualification 0.96 (0.92, 1.00)   0.05 
Adjusted for age and marital status 0.96 (0.92, 1.00)   0.02 
Adjusted for age and housing status 0.96 (0.92, 1.00)   0.03 
 
 
The results of alcohol consumption as potential confounders are shown in the Table 6 below. 
 
 
 Table 6  Logistic regression analysis of the dose response of the total Medscore with adjustments for alcoholic drink consumption as 
potential confounding factors 
 
 Total Med Score 
OR [95% CI]   p 
Unadjusted 0.98 (0.95, 1.01)   0.26 
Adjusted for age 0.96 (0.93, 1.00)   0.04 
Adjusted for sex  0.98 (0.95, 1.01)   0.25 
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Adjusted for age and sex  0.96 (0.93, 1.00)   0.04 
Adjusted for age and beer, cider per week  0.99 (0.95, 1.03)   0.49 
Adjusted for age and units of spirits per week  0.97 (0.92, 1.00)   0.07 
Adjusted for age and fortified wines per week  0.96 (0.93, 1.00)   0.05 
Adjusted for age and wine per week  0.96 (0.92, 1.00)   0.03 
Adjusted for age and Red wine per week  0.96 (0.92, 1.00)   0.07 
Adjusted for age and White wine per week  0.96 (0.92, 1.00)   0.10 
Adjusted for age and Rose wine per week  0.97 (0.93, 1.00)   0.07 
 
The Medscore does not change by more than 10% when adjusted for alcohol, so the consumption of alcoholic drinks were not confounding 
factors. 
Food group Medscores were analysed and are shown in Table 7. 
 
 Table 7 Dose response of The Mediterranean Diet Scores of food groups 
 
Total Med Score 
 Dose response 
unadjusted OR 
[95% CI]   P 
Dose response 
adjusted for age 
OR [95% CI]   P 
Dose response 
adjusted for sex 
OR [95% CI]   P 
Dose response 
adjusted for age 
and sex OR [95% 
CI]   P 
Vegetables 0.89 (0.77, 1.02) 
0.10 
0.83 (0.70, 0.98) 
0.03 
0.89 (0.77, 1.02) 
0.09 
0.83 (0.70, 0.98) 
0.03 
Dairy Products 1.28 (1.11, 1.49) 
.001 
1.24 (1.05, 1.46) 
0.01 
1.28 (1.10, 1.49) 
.001 
1.24 (1.05, 1.47) 
0.01 
Alcohol 0.84 (0.78, 0.90) 
<0.001 
0.87 (0.80, 0.95) 
0.001 
0.84 (0.77, 0.90) 
<0.001 
0.87 (0.80, 0.94)   
<0.001 
Legumes 0.78 (0.66, 0.93) 
0.004 
0.78 (0.64, 0.95) 
0.01 
0.78 (0.66, 0.93) 
0.004 




0.85 (0.72, 1.01) 
0.07 
0.81 (0.66, 0.98) 
0.03 
0.85 (0.72, 1.01) 
0.07 
0.81 (0.67, 0.98) 
0.03 
Olive oil  0.90 (0.79, 1.03) 
0.13 
0.92 (0.80, 1.07) 
0.27 
0.90 (0.79, 1.03) 
0.13 
0.92 (0.80, 1.07)    
0.27 
Red meat and 
products 
1.18 (1.06, 1.33) 
0.004 
1.04 (0.91, 1.18) 
0.60 
1.19 (1.06, 1.33) 
0.003 
1.03 (0.91, 1.18)    
0.62 
Poultry 1.49 (1.15, 1.94) 
0.003 
1.30 (0.98, 1.71) 
0.07 
1.49 (1.15, 1.94) 
0.003 
1.30 (0.98, 1.71)    
0.07 
Fish 1.11 (0.97, 1.27) 
0.13 
1.13 (0.97, 1.30) 
0.12 
1.11 (0.97, 1.27) 
0.14 
1.13 (0.97, 1.31) 
0.11 
Potatoes 0.81 (0.71, 0.94) 
0.004 
0.86 (0.74, 1.01) 
0.07 
0.81 (0.71, 0.93) 
0.004 
0.86 (0.74, 1.01)    
0.07 
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Fruit 1.14 (0.96, 1.35) 
0.13 
0.94 (0.78, 1.13) 
0.49 
1.14 (0.96, 1.35) 
0.14 
0.94 (0.78, 1.13)    
0.50 
 
In the logistic regression analysis adjusted for age, the Medscore scores for consumption of vegetables, alcohol, legumes and potato were 
significantly negatively associated with being a multiple sclerosis case. This association was found to follow a dose response for vegetables, 
alcohol and legumes. The Medscore for non-refined cereals when adjusted for age was significantly negatively associated with being a 
multiple sclerosis case and followed a dose response. Medscores for red meats and meat products as well as poultry meat were significantly 
positively associated with being a multiple sclerosis case but did not follow a dose response. In contrast, the Medscore for dairy products was 
significantly positively associated with being a multiple sclerosis case and this score followed a dose response when adjusted for sex. 
In summary, a statistically significant association existed between certain food groups that contributed to the Mediterranean diet score.  
The individual foods were examined in a binary association (ate this food or not) using logistic regression unadjusted and for a dose response 
for the “dose response,” frequency of consumption was used.  
 
Table 8 Summary of individual foods with a statistically significant dose response and the binary logistic regression results unadjusted, 
adjusted for age adjusted for sex and adjusted for age and sex 
 
Food Binary logistic regression Unadjusted OR [95% CI]   P 
Binary logistic regression 
Adjusted for age OR [95% 
CI]   P 
Binary logistic regression 
Adjusted for sex OR [95% 
CI]   P 
Binary logistic regression 
Adjusted for age and sex OR 
[95% CI]   P 
Dose response Adjusted for 
age and sex OR [95% C.I.]   P 
Grape Fruit 0.35 (0.18, 0.65) 0.04 0.46 (1.05, 1.08) 0.04 0.35 (0.18, 0.65)   0.001 0.46 (0.22, 0.96) 0.04 0.87 (0.77, 1.00) 0.05 
Tomatoes      0.41 (0.19, 0.92) 0.03 0.29 (0.11, 0.73) 0.008 0.41 (0.19, 0.92) 0.03 0.29 (0.12, 0.73) 0.01 0.96 (0.92, 1.00) 0.05 
Onions  0.43 (0.18, 0.99) 0.05 0.32 (0.12, 0.86) 0.02 0.43 (0.18, 0.99)   0.05 0.32 (0.12, 0.86) 0.02 0.90 (0.82, 0.98) 0.02 
Refined breakfast 
cereal 0.19 (0.11, 0.34) < 0.001 0.31 (0.16, 0.61) 0.001 0.19 (0.11, 0.34) < 0.001 0.31 (0.16, 0.61) 0.001 0.90 (0.82, 0.99) 0.04 
Dried Pulses 0.23 (0.13, 0.41) <0.001 0.36 (0.18, 0.70) 0.003 0.23 (0.13, 0.41) < 0.001 0.36 (0.18, 0.70) 0.003 0.84 (0.72, 0.99) 0.04 
Beetroot 0.37 (0.20, 0.68) 0.002 0.44 (0.21, 0.92) 0.03 0.36 (0.19, 0.68) 0.001 0.97 (0.62, 1.51) 0.89 0.75 (0.59, 0.95) 0.02 
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Grapefruit, tomatoes, onions, refined breakfast cereal, dried pulses and beetroot consumption were significantly negatively associated with 
being a multiple sclerosis case. This association was found to follow a dose response. That is, a linear inverse association existed between the 
frequency of consumption of these foods and the presence of multiple sclerosis. Whole meal pasta and tofu consumption were significantly 
negatively associated with being a multiple sclerosis case but did not follow a dose response. Consumption of some individual foods such as 
fish and meats were significantly positively associated with multiple sclerosis. However, there were no dose response associations with any 
of these positively associated foods.  
 
Analysis of smoking data 
Current smoking was high among cases (30/127) 23.6% and controls (352/718) 49.0% but cases were less likely to be current smokers 
compared with controls and this was statistically significant in all analyses.  
Exposure to smoke was high among cases and controls. There were 51 of 127 multiple sclerosis cases who were regularly exposed to smoke 
(40.2%), while 54.6% (392 of 718) controls were regularly exposed to smoke. These results included those exposed to smoke from people 
smoking in the home and at the workplace (as happens despite the smoking law prohibiting this) and social interaction with people who were 
smoking for example at outdoor cafes and bars. There was a significant association using Pearson Chi2 test =   9.02   p = 0.003 but there was 
no significant difference between cases and controls being regularly exposed to smoke with logistic regression analysis adjusted for age and 
sex, OR 0.85 (0.56, 1.30) [95% CI] p=0.46. 
 
Analysis of alcohol consumption data  
The amount of alcohol consumed per week was documented as units per week and is presented in table 9 below. 
 







age and sex OR 
[95% CI] P 
Binary Adjusted 
for age OR 
[95%CI] P 
Binary Adjusted 
for sex OR [95% 
CI] P 
Binary Adjusted 
for age and sex 
OR [95% CI] P 
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Units spirits/week 16.95 0.46 0.47 (0.29, 0.74) 0.001 
0.63 (0.38, 1.04) 
0.07 
0.46 (0.29, 0.74) 
0.001 
0.46 (0.30, 0.72)   
0.001 
Fortified 
wines/week 4.16      0.39 
0.17 (0.02, 1.22) 
0.08 
0.12 (0.02, 0.90) 
0.04 
0.17 (0.02, 1.21) 
0.08 
0.12 (0.02, 0.89)    
0.04 
Beer /cider/week 34.32    0.01 0.29 (0.18, 0.45) < 0.001 
0.27 (0.16, 0.44) < 
0.001 
0.28 (0.18, 0.45) < 
0.001 
0.26 (0.16, 0.43) 
<0.001 
White Wine 7.53      0.82 0.51 (0.28, 0.91) 0.02 




0.48 (0.26, 0.90)    
0.02 
Rose Wine 13.24    0.21 0.26 (0.12, 0.58) 0.001 
0.34, (0.14, 0.80) 
0.01 
0.27 (0.12, 0.58) 
0.001 
0.33 (0.14, 0.79)    
0.01 
Red Wine 13.80    0.39 0.87 (0.56, 1.34) 0.52 
0.76 (0.47,1.22) 
0.26 
0.86 (0.56, 1.33) 
0.49 
0.76 (0.47, 1.23)   
0.26 
Wine/week 5.91    0.97 0.84 (0.57, 1.25) 0.38 
0.94 (0.61, 1.45) 
0.77 
0.84 (0.57, 1.26) 
0.40 




In the binary logistic regression analysis adjusted for age and sex, there was a statistically significant association between cases and units of 
spirits/week, fortified wines/week, beer /cider/week, white wine and rose wine consumed per week and cases of multiple sclerosis. However, 
there was no statistically significant association with red wine or wine per week and cases of multiple sclerosis.  
Cases were around 88% less likely to drink fortified wines and 73% less likely to drink beer/cider. Cases were around 51% less likely to 
drink white wine and around 67% less likely to drink rose wine (adjusted for age and sex). The numbers of alcohol drinkers were small in 
both cases and controls. 
 
The results of each alcoholic drink as a potential confounding factor have been described in relation the Medscore. None of the alcohol 
drinks were found to be potential confounding factors. 
 
Missing Data   
Details of how missing data were treated are described in the methods section in Chapter 4 and the discussion of the impact on the study of 
missing data is dealt with in the discussion section in Chapter 6. In the logistic regression analysis data from 127 cases and 718 controls were 
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used. There were no cases or controls with every single question answered in full, so decisions were made on how to deal with the missing 
data.  
Cases vs controls 
The difference in missing data in cases and controls varied depending on the question. As an example, when asked about foods which were 
avoided, 359/718 (50%) controls answered compared to 41/127 (32.3%) cases, so for cases there were approximately 18% more data missing 
for this question.  As an example of low response rate, when asked about the name of the salt substitute used, 73/845 (8.6%) of controls 
answered while 9/127 (7.1%) of cases did. Again, cases had slightly more data missing but the results were closer in this instance. 
It was beyond the scope of this thesis to analyse every question in the questionnaire on the basis of available or missing data. However, some 
general remarks can be made using the demographics section as an example. Available data for some questions were generally high in both 
cases and controls. For example, gender was known for 100% of cases and controls. Age was known for 95.5% of controls and 96.9% of 
cases, marital status was answered for 98.2% of controls and 97.6% of cases.   
 
Smoking questions 
All of the participants responded to the question if they currently smoke or not or ever smoked or not or were regularly exposed to smoking 
or not. However, when a respondent said they currently did not smoke and had never smoked, it can be assumed they did not smoke 
manufactured cigarettes, rolled cigarettes and any type of cigars. Some of these respondents had left the section on ways of smoking blank. It 
has been assumed that these responses were null rather than blank. All other blanks were recognised and coded as blank responses. As a 
result, the smoking data are complete in some areas and incomplete in others. When quantities were required, or free text spaces for answers 
were available, many more blanks appeared. When the answer was yes or no, respondents were more likely to provide an answer. Some 
questions had considerable amounts of missing data. Where no assumptions could be made, gaps were entered as blanks. For example, 




When asked how much alcohol they consumed per week, 199 respondents reported zero and 2 left the question blank. For all other questions 
on wine, beer or spirit consumption these 199 people were assumed to drink zero units of all types of alcohol per week. 
A Mediterranean diet score and individual foods 
A Mediterranean diet score was calculated for all participants. Missing data on individual foods was generally low so it was still possible to 
calculate a value for each of the categories in the Medscore system.  
However, when asked about foods which were avoided, only 400/845 answered (47.3%), leaving 52.7% data missing. 
When asked about the amount of food eaten, some questions also had a very poor response. For example, when asked about Souvla eaten, 
only 50/845 answered (5.9%) so there were 94.1% data missing. Calculations on the amount of Souvla eaten were therefore not attempted. 
Another example of a very poor response was the amount of grilled meat eaten. This was answered by 53/845 (6.3%) so there was 93.7% 




Free text questions 
Free text questions generally had poor responses with much missing data. For example, when asked about salt substitute used only 82/845 
(9.7%) answered and when asked about herbal remedies taken 136/845 (16.1%) answered. 
 Hypothesis testing  
The Null hypothesis tested was that there is no difference in Mediterranean diet pattern score, or intake of specific food groups, or foods, 
between multiple sclerosis cases and control subjects. 
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The results presented in this chapter indicate that the Null hypothesis can be rejected, and the alternative hypothesis accepted. That is, there 




7.2.1.1 Appendix B 
Table 1 showing the association of individual foods and the likelihood of being consumed or not by cases, unadjusted. Determined by binary 
logistic regression. Dose response unadjusted 
Food Binary (ate this fruit or not) OR [95% C I] 
unadjusted   p Dose response OR [95% C I] unadjusted… p 
Fruit   
Apples 0.37 (0.14,1.00)      0.05  1.00 (0.97, 1.04)    0.89                                
Avocado 0.30 (0.16, 0.56)   <0.001 0.97 (0.89, 1.03)    0.25     
Bananas 0.52 (0.22, 1.24)     0.14                  1.02 (0.99, 1.05)    0.26 
Grapefruit 0.35 (0.18, 0.65)     0.001                                                  0.88 (0.78, 1.00)    0.04 
Grapes 0.32 (0.15, 0.68)     0.003                                                  0.97 (0.91, 1.02)    0.22                                     
Marrow 0.55 (0.22, 1.40)     0.29                                                 1.01 (0.97, 1.05)    0.80                                
Melon 0.46 (0.22, 0.94)     0.03                                              1.03 (0.95, 1.04)    0.72                                 
Oranges 0.49 (0.22, 1.13)     0.09 1.00 (1.00, 1.05)    0.50                                     
Peaches 0.35 (0.17, 0.71)     0.04                                                0.99 (0.95, 1.03)    0.68                                     
Pears 0.30 (0.14, 0.67)     0.003                                                   0.97 (0.93, 1.02)    0.20   
Peas  0.54 (0.24, 1.22)     0.14                                                0.84 (0.71, 0.99)    0.04 
Strawberries 0.40 (0.19, 0.82)     0.01                                                  1.01 (0.96, 1.03)    0.88                                          
Sweet peppers 0.28 (0.14, 0.57)   <0.001                                                 0.90 (0.81, 0.99)    0.03                                        
Tomatoes 0.41 (0.19, 0.92)     0.03                                                   0.90 (0.96, 1.02)    0.43                                       
Dried fruit 0.34 (0.17, 0.68)     0.02                                                  1.00 (0.96, 1.03)    0.81 
Tinned fruit 0.27 (0.15, 0.46)   <0.001                                                  0.82 (0.66, 1.01)    0.07                                       
Fish   
Fried fish in batter 3.53(2.12, 5.88)    <0.001                                                        0.96 (0.86, 1.06)    0.41                                     
Fish fingers  2.99 (1.87, 4.78)   <0.001                                                        0.91 (0.78, 1.07)    0.25                               
White fish  2.62 (1.55, 4.43)   <0.001      0.97 (0.89, 1.06)    0.48                                    
Oily fish  3.50 (1.89, 6.48)   <0.001                                                      0.98 (0.91, 1.06)    0.68                                       
Shell fish 2.94 (1.77, 4.91)   <0.001                                                        0.98 (0.91, 1.04)    0.47                                      
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Fish roe  3.53 (2.21, 5.64)   <0.001     1.00 (0.95, 1.06)    0.91                                       
Vegetables   
Beetroot 0.37 (0.20, 0.68)     0.002                                                   0.81 (0.67, 0.97)    0.02 
Broccoli 0.30 (0.15, 0.63)     0.001                                                0.92 (0.84, 1.01)    0.95                                         
Brussels sprouts 0.27 (0.15, 0.49)   <0.001                                                     0.82 (0.69, 0.99)    0.04 
Cabbage 0.21 (0.11, 0.41)   <0.001                                                     0.93 (0.87, 1.01)    0.07                                         
Capers 0.42 (0.22, 0.78)     0.01 0.92 (0.84, 1.02)    0.12                                         
Carrots 0.40 (0.15, 1.06)     0.07                                                   0.98 (0.94, 1.02)    0.32                                         
Cauliflower 0.40 (0.19, 0.82)     0.01 0.93 (0.84, 1.03)    0.17                                        
Charcoal grilled 
veg 
1.06 (0.13, 8.89)     0.06                                             0.74 (0.56, 0.98)    0.04       
Leeks 0.28 (0.15, 0.52)   <0.001                                                   0.90 (0.84, 1.11)    0.27                                         
Onions  0.43 (0.18, 0.99)     0.05                                                   0.95 (0.90, 1.00)    0.10                                         
Green salad 0.55 (0.22, 1.40)     0.21                                                    0.98 (0.95, 1.02)    0.36 
Parsnips 0.26 (0.14, 0.48)   <0.001                                                 0.84 (0.65, 1.08)    0.17                                     
Spinach 0.34 (0.15, 0.77)     0.01                                                    0.89 (0.78, 1.01)    0.67                                     
Sweetcorn 0.21 (0.11, 0.43)   <0.001                                                   0.87 (0.77, 0.98)    0.02                                       
Watercress 0.29 (0.17, 0.48)   <0.001                                                  0.69 (0.47, 1.00)    0.05                                        
Dairy products   
Single cream 0.44 (0.22, 0.85)     0.02                                               0.80 (0.61, 1.04)   0.10 
Clotted cream 0.35 (0.20, 0.63)   <0.001                                               0.76 (0.54, 1.07)   0.12 
Low fat yoghurt 0.48 (0.23, 1.00)     0.05                                                0.92 (0.84, 1.00)   0.06 
Full fat yoghurt 0.48 (0.23, 1.00)     0.05                                                   0.92 (0.82, 1.03)   0.15 
Desserts 0.32 (0.17, 0.60)   <0.001 0.77 (0.62, 0.96)   0.02 
Cheese 1.06 (0.24, 4.80)     0.94                                                 0.95 (0 .90 1.01)   0.13 
Eggs 0.45 (0.16, 1.29)     0.14                                                  0.85 (0.76, 0.95)   0.01 
Quiche 0.56 (0.34, 0.90)     0.02                                                  0.79 (0.61, 1.04)   0.09 
Salad cream 0.27 (0.15, 0.51)   <0.001                                              0.93 (0.85, 1.02)   0.13 
French dressing 0.28 (0.16, 0.49)   <0.001                                                                        0.97 (0.90, 1.04)   0.36                                   
Butter 0.23 (0.11, 0.50)   <0.001                                                 0.98 (0.93, 1.04)   0.45 
Margarine 0.28 (0.14, 0.56)   <0.001                                                  1.01 (0.95, 1.06)   0.85                                    
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Low fat spread 0.33 (0.17, 0.64)     0.001                                                 0.98 (0.92, 1.04)   0.47                                        
Very low fat spread 0.31 (0.17, 0.58)   <0.001                                                   0.94 (0.86, 1.03)   0.16 
Red Meat   
Beef  1.80 (0.98, 3.29)       0.06                                                    0.92 (0.83, 1.01)   0.09                                    
Beef burgers  2.15 (1.26, 3.68)       0.01 0.95 (0.89, 1.03)   0.20                                     
Bacon 2.84 (1.72, 4.69)     <0.001                                             0.93 (0.81, 1.05)   0.24           
Pork 1.66 (0.84, 3.28)       0.15      0.94 (0.87, 1.02)   0.15 
Lamb 3.08 (1.83, 5.19)     <0.001     0.85 (0.72, 1.00)   0.05            
Ham 2.38 (1.43, 3.98)       0.001          0.89 (0.80, 1.00)   0.05     
Corned beef 4.25 (2.65, 6.84)     <0.001       0.77 (0.59, 1.01)   0.05      
Sausages 4.49 (2.60, 7.74)     <0.001          0.98 (0.89, 1.07)   0.64     
Souvlaki 10.45 (1.43, 76.22)   0.02         0.69 (0.53, 0.89)   0.004           
Souvla 1.96 (0.25, 15.32)     0.52    0.39 (0.21, 0.72)   0.002 
Charcoal grilled 
meat 
1.06 (0.13, 8.89)       0.96     0.66 (0.49, 0.90)   0.01 
Grilled roasted 
meat 
1.48 (0.62, 3.52)       0.38  0.83 (0.74, 0.93)   0.002 
Other foods   
Beansprouts 0.24 (0.13, 0.44)   <0.001         0.92 (0.82, 1.04)    0.18    
Coleslaw 0.29 (0.16, 0.55)   <0.001          0.97 (0.91, 1.04)    0.36  
Garlic 0.29 (0.15, 0.57)   <0.001                      0.92 (0.84, 1.01)    0.09         
Dried pulses 0.23 (0.13, 0.41)   <0.001 0.83 (0.70, 0.98)    0.03 
Baked beans 0.47 (0.22, 1.04)     0.06                     0.93 (0.83, 1.04)    0.19   




Tofu 0.29 (0.17, 0.50)   <0.001                           0.26 (0.09, 0.82)    0.02    
White Meat   
Chicken 2.28 (0.97, 5.37)     0.06                     0.95 (0.90, 1.00)    0.06                            
Cereal   
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Whole meal Bread 0.32 (0.17, 0.68)     0.002               0.99 (0.96, 1.02)    0.55 
Cream Crackers 0.35 (0.19, 0.63)   <0.001                    0.99 (0.93, 1.05)    0.74 
Crispbread 0.44 (0.22, 0.91)     0.03              1.00 (0.96, 1.05)    0.99 
Oat based cereal 0.32 (0.17, 0.61)   <0.001                 0.93 (0.87, 1.00)    0.04                 
Refined breakfast 
cereal 
0.19 (0.10, 0.34)   <0.001             0.85 (0.76, 0.94)    0.002               
Carbohydrates   
Potatoes 0.37 (0.15, 0.92)     0.03                     0.93 (0.85, 1.02)    0.14       
Chips 0.49 (0.23, 1.08)     0.08                            0.93 (0.84, 1.03)    0.17 
Roast potatoes 0.79 (0.26, 2.38)     0.68                       0.87 (0.75, 1.02)    0.08 
Potato salad 0.49 (0.23, 1.08)     0.08                         0.77 (0.60, 0.99)    0.04 
White rice  0.94 (0.27, 3.28)     0.93                          0.87 (0.77, 0.99)    0.03 
Brown rice 0.36 (0.20, 0.63)   <0.001                        0.79 (0.64, 0.98)    0.03 
White green pasta 0.30 (0.14, 0.65)     0.002  0.86 (0.75, 0.98)    0.03       
Whole meal pasta 0.39 (0.21, 0.74)     0.004                    0.74 (0.59, 0.91)    0.01 
Lasagne 0.32 (0.16, 0.62)     0.001                  0.73 (0.53, 0.99)    0.04 
Pizza 0.38 (0.16, 0.90)     0.03                  0.69 (0.51, 0.94)    0.02 
Food Binary (ate this fruit or not) adjusted for age OR [95% C I]    p 
Dose response adjusted for ageOR [95% C 
I] p 
Fruit   
Apples 0.21 (0.07, 0.66)   0.01 0.99 (0.96, 1.03) 0.68 
Avocado 0.37 (0.18, 0.73)   0.01 0.97 (0.90, 1.06) 0.51 
Bananas 0.53 (0.19, 1.52)   0.24 1.03 (1.00, 1.06) 0.09 
Grapefruit 0.46 (0.22, 0.96)   0.04 0.87 (0.77, 1.00) 0.05 
Grapes 0.35 (0.14, 0.85)   0.02 0.96 (0.9, 1.02)   0.14 
Marrow 0.32 (0.10, 0.98)   0.05 1.00 (0.95, 1.04) 0.82 
Melon 0.41 (0.18, 0.97)   0.04 1.00 (0.95, 1.04) 0.82 
Oranges 0.34 (0.14, 0.86)   0.02 1.01 (0.97, 1.04) 0.78 
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Peaches 0.35 (0.15, 0.82)   0.02 0.99 (0.95, 1.04) 0.77 
Pears 0.24 (0.09, 0.63)   0.004 0.97 (0.91, 1.02) 0.22 
Peas  0.45 (0.17, 1.21)   0.12 0.92 (0.79, 1.06) 0.24 
Strawberries 0.33 (0.14, 0.76)   0.01 1.01 (0.97, 1.05) 0.72 
Sweet peppers 0.28 (0.12, 0.66)   0.004 0.90 (0.82, 1.00) 0.06 
Tomatoes 0.29 (0.11, 0.73)   0.01 0.96 (0.92, 1.00) 0.05 
Dried fruit 0.47 (0.21, 1.09)   0.08 1.00 (0.95, 1.04) 0.75 
Tinned fruit 0.42 (0.22, 0.79)   0.01 0.85 (0.68, 1.06) 0.14 
Fish   
Fried fish in batter 5.31 (2.98, 9.46) <0.001 1.01 (0.93, 1.10) 0.78 
Fish fingers  3.95 (2.34, 6.67) <0.001 0.99 (0.89, 1.10) 0.84 
White fish  2.93 (1.65, 5.21) <0.001 1.02 (0.94, 1.10) 0.67 
Oily fish  3.76 (1.94, 7.28) <0.001 1.01 (0.94, 1.09) 0.75 
Shell fish 3.95 (2.23, 6.99) <0.001 1.01 (0.95, 1.07) 0.75 
Fish roe  4.29 (2.56, 7.19) <0.001 1.03 (0.98, 1.09) 0.25 
Vegetables   
Beetroot 0.44 (0.21, 0.92)   0.03 0.75 (0.59, 0.95) 0.02 
Broccoli 0.42 (0.18, 0.99) 0.05 0.97 (0.90, 1.04) 0.39 
Brussels sprouts 0.43 (0.22, 0.84) 0.01 0.92 (0.79, 1.07) 0.28 
Cabbage 0.29 (0.13, 0.63) 0.002 0.94 (0.87, 1.02) 0.17 
Capers 0.43 (0.20, 0.91) 0.03 0.94 (0.84, 1.04) 0.21 
Carrots 0.31 (0.10, 0.96) 0.04 0.98 (0.94, 1.03) 0.42 
Cauliflower 0.38 (0.16, 0.87) 0.02 0.96 (0.88, 1.06) 0.44 
Charcoal grilled veg 0.50 (0.06, 4.27) 0.52 0.73 (0.54, 1.00) 0.05 
Leeks 0.39 (0.19, 0.81) 0.01 0.96 (0.83, 1.11) 0.60 
Onions  0.32 (0.12, 0.86) 0.02 0.90 (0.82, 0.98) 0.02 
Green salad 0.56 (0.19, 1.72) 0.32 0.96 (0.92, 1.00) 0.10 
Parsnips 0.37 (0.18, 0.75) 0.01 0.84 (0.61, 1.15) 0.28 
Spinach 0.24 (0.09, 0.61) 0.003 0.91 (0.80, 1.04) 0.16 
Sweetcorn 0.32 (0.14, 0.73) 0.01 0.93 (0.84, 1.02) 0.12 
Watercress 0.37 (0.21, 0.67) 0.001 0.74 (0.53, 1.04) 0.09 
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Dairy products   
Single cream 0.76 (0.35, 1.67) 0.50 0.99 (0.82, 1.17) 0.83 
Clotted cream 0.64 (0.32, 1.26) 0.20 0.98 (0.81, 1.19) 0.88 
Low fat yoghurt 0.70 (0.30, 1.68) 0.43 0.95 (0.87, 1.04) 0.27 
Full fat yoghurt 0.74 (0.31, 1.76) 0.49 0.91 (0.80, 1.04) 0.18 
Desserts 0.59 (0.28, 1.23) 0.16 0.89 (0.73, 1.07) 0.22 
Cheese 0.93 (0.17, 5.02) 0.93 0.90 (0.84, 0.98) 0.01 
Eggs 0.38 (0.11, 1.31) 0.13 0.89 (0.79, 0.99) 0.04 
Quiche 0.74 (0.43, 1.29) 0.29 0.93 (0.74, 1.16) 0.51 
Salad cream 0.43 (0.21, 0.90) 0.02 0.98 (0.90, 1.06) 0.56 
French dressing 0.53 (0.28, 1.02) 0.06 1.00 (0.94, 1.06) 0.95 
Butter 0.37 (0.15, 0.92) 0.03 1.00 (0.94, 1.07) 0.89 
Margarine 0.44 (0.20, 0.99) 0.05 1.02 (0.96, 1.09) 0.45 
Low fat spread 0.51 (0.23, 1.13) 0.10 1.00 (0.93, 1.07) 0.98 
Very low fat spread 0.50 (0.24, 1.04) 0.06 0.98 (0.90, 1.05) 0.52 
Red Meat   
Beef  2.96 (1.50, 5.83) 0.002  1.00 (0.91, 1.10) 0.93 
Beef burgers  3.04 (1.69, 5.47) <0.001 1.00 (0.94, 1.05) 0.92 
Bacon 3.91 (2.23, 6.84) <0.001 0.99 (0.88, 1.10) 0.79 
Pork 1.97 (0.94, 4.15)   0.07 0.99 (0.92, 1.06) 0.75 
Lamb 3.73 (2.12, 6.56) <0.001      0.94 (0.80, 1.09) 0.39 
Ham 3.25 (1.83, 5.77) <0.001      0.94 (0.84, 1.06) 0.32 
Corned beef 5.48 (3.21, 9.34) <0.001      0.88 (0.67, 1.16) 0.37 
Sausages 5.00 (2.76, 9.02) <0.001      1.01 (0.93, 1.11) 0.77 
Souvlaki 7.40 (1.00, 54.84) 0.05 0.80 (0.62, 1.04) 0.09 
Souvla 2.02 (0.24, 17.04) 0.52 0.49 (0.27, 0.87) 0.02 
Charcoal grilled meat 0.80 (0.78, 8.28)  0.85 0.77 (0.57, 1.04) 0.09 
Grilled roasted meat 0.92 (0.36, 2.33)  0.86 0.93 (0.81, 1.07) 0.31 
Other foods   
Beansprouts 0.31 (0.15, 0.61) 0.001 0.93 (0.83, 1.04) 0.18 
Coleslaw 0.34 (0.17, 0.70) 0.003 0.95 (0.87, 1.03) 0.21 
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Table 3 The association of individual foods and the likelihood of being consumed or not by cases, adjusted for sex. Determined by binary 
logistic regression. Dose response adjusted for sex 
Garlic 0.35 (0.16, 0.78) 0.01 0.91 (0.81, 1.01) 0.08 
Dried pulses 0.36 (0.18, 0.70) 0.003 0.84 (0.72, 1.00) 0.04 
Baked beans 0.38 (0.15, 0.94) 0.04 0.92 (0.80, 1.07) 0.27 
Mushrooms 0.45 (0.17, 1.23) 0.12 0.88 (0.77, 1.00) 0.05 
Veg. derived Protein    
Tofu 0.54 (0.29, 0.98) 0.04 0.52 (0.24, 1.13) 0.10 
White Meat   
Chicken 2.16 (0.88, 5.30) 0.09 0.98 (0.94, 1.03) 0.49 
Cereal   
White bread 1.00 (0.38, 2.64) 0.99 0.96 (0.93, 1.00) 0.06 
Whole meal Bread 0.61 (0.28, 1.37) 0.23 0.99 (0.95, 1.03) 0.58 
Cream Crackers 0.72 (0.36, 1.41) 0.33 1.01 (0.95, 1.07) 0.73 
Crispbread 0.94 (0.41, 2.19) 0.89 1.00 (0.95, 1.05) 0.96 
Oat based cereal 0.46 (0.22, 0.94) 0.04 0.94 (0.87, 1.00) 0.07 
Refined breakfast cereal 0.31 (0.16, 0.60) 0.001 0.90 (0.82, 1.00) 0.04 
Carbohydrates   
Potatoes 0.25 (0.09, 0.73) 0.01 0.97 (0.89, 1.06) 0.49 
Chips 1.08 (0.43, 2.70) 0.87 1.00 (0.93, 1.08) 0.95 
Roast potatoes 0.83 (0.24, 2.83) 0.76 0.94 (0.82, 1.08) 0.39 
Potato salad 0.71 (0.28, 1.76) 0.46 0.85 (0.65, 1.10) 0.21 
White rice  1.32 (0.30, 5.83) 0.72 0.95 (0.86, 1.05) 0.29 
Brown rice 0.54 (0.28, 1.06) 0.07 0.93 (0.79, 1.09) 0.37 
White green pasta 0.34 (0.14, 0.85) 0.02 0.94 (0.84, 1.04) 0.24 
Whole meal pasta 0.45 (0.22, 0.93) 0.03 0.83 (0.68, 1.02) 0.07 
Lasagne 0.54 (0.24, 1.20) 0.13 0.90 (0.71, 1.15) 0.39 
Pizza 0.55 (0.20, 1.50) 0.24 0.89 (0.70, 1.12) 0.30 
Food Binary (ate this fruit or not) adjusted for sex OR [95% C I]    p Dose response adjusted for sex OR [95% C I] p 
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Fruit   
Apples 0.38 (0.14, 1.01)   0.05                 1.00 (0.97, 1.03)   0.93 
Avocado 0.30 (0.16, 0.56) <0.001                            0.96 (0.89, 1.03)   0.25 
Bananas 0.52 (0.22, 1.25)   0.14 1.02 (0.99, 1.04)   0.26 
Grapefruit 0.35 (0.18, 0.65)   0.001 0.88 (0.78, 0.99)   0.03 
Grapes 0.32 (0.15, 0.68)   0.003 0.97 (0.91, 1.02)   0.21 
Marrow 0.55 (0.22, 1.40)   0.21 1.00 (0.97, 1.04)   0.83 
Melon 0.46 (0.23, 0.95)   0.04 1.00 (0.97, 1.05)   0.74 
Oranges 0.49 (0.21, 1.13)   0.09 1.03 (1.00, 1.05)   0.06 
Peaches 0.35 (0.17, 0.71)   0.004 1.00 (0.95, 1.05)   0.65 
Pears 0.30 (0.14, 0.67)   0.003 0.97 (0.92, 1.02)   0.19 
Peas  0.54 (0.24, 1.22)   0.14 0.84 (0.71, 0.99)   0.04 
Strawberries 0.40 (0.19, 0.83)   0.01 1.00 (0.96, 1.03)   0.86 
Sweet peppers 0.27 (0.13, 0.56) <0.001                            0.90 (0.81, 0.99)   0.03 
Tomatoes 0.41 (0.18, 0.92)   0.03 0.99 (0.96, 1.02) <0.001 
Dried fruit 0.34 (0.17, 0.68)   0.002 0.99 (0.96, 1.03)   0.76 
Tinned fruit 0.27 (0.15, 0.46) <0.001                            0.81 (0.65, 1.01)   0.06 
Fish   
Fried fish in batter 3.53 (2.12, 5.88) <0.001 0.95 (0.86, 1.06) 0.39 
Fish fingers  2.99 (1.87, 4.78) <0.001 0.91 (0.78, 1.07) 0.24 
White fish  2.62 (1.55, 4.43) <0.001 0.97 (0.88, 1.06) 0.46 
Oily fish  3.50 (1.88, 6.49) <0.001 0.98 (0.91, 1.06) 0.67 
Shell fish 2.94 (1.77, 4.91) <0.001 0.98 (0.91, 1.04) 0.48 
Fish roe  3.53 (2.21, 5.63) <0.001 1.00 (0.95, 1.06) 0.93 
Vegetables   
Beetroot 0.36 (0.19, 0.68)  0.001 0.81 (0.67, 0.97) 0.02 
Broccoli 0.30 (0.14, 0.62)   0.001 0.92 (0.83, 1.01) 0.09 
Brussels sprouts 0.27 (0.15, 0.49) <0.001 0.82 (0.68, 0.98) 0.03 
Cabbage 0.21 (0.11, 0.41) <0.001 0.93 (0.87, 1.01) 0.07 
Capers 0.41 (0.22, 0.77)   0.01 0.92 (0.83, 1.02) 0.11 
Carrots 0.40 (0.15, 1.06)   0.07 0.98 (0.94, 1.02) 0.30 
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Cauliflower 0.39 (0.19, 0.82)   0.01 0.93 (0.84, 1.03) 0.17 
Charcoal grilled veg 1.05 (0.12, 8.77)   0.97 0.73 (0.55, 0.97) 0.03 
Leeks 0.28 (0.15, 0.52) <0.001 0.90 (0.74, 1.09) 0.26 
Onions  0.43 (0.18, 0.99)   0.05 0.95 (0.90, 1.01) 0.09 
Green salad 0.55 (0.22, 1.41)   0.21 0.98 (0.95, 1.02) 0.37 
Parsnips 0.25 (0.14, 0.47) <0.001 0.83 (0.64, 1.08) 0.16 
Spinach 0.34 (0.15, 0.77)   0.01 0.88 (0.78, 1.00) 0.06 
Sweetcorn 0.21 (0.11, 0.43) <0.001 0.87 (0.77, 0.98) 0.02 
Watercress 0.29 (0.17, 0.48) <0.001 0.68 (0.46, 0.99) 0.05 
Dairy products   
Single cream 0.44 (0.22, 0.85)   0.02 0.80 (0.61, 1.04) 0.10 
Clotted cream 0.35 (0.20, 0.63) <0.001 0.76 (0.54, 1.06) 0.11 
Low fat yoghurt 0.48 (0.23, 1.01)   0.05 0.92 (0.84, 1.01) 0.06 
Full fat yoghurt 0.47 (0.22, 1.00)   0.05 0.92 (0.82, 1.03) 0.15 
Desserts 0.32 (0.17, 0.60) <0.001 0.77 (0.62, 0.96) 0.02 
Cheese 1.08 (0.24, 4.88)   0.92 0.95 (0.90, 1.01) 0.13 
Eggs 0.45 (0.16, 1.28)   0.14 0.85 (0.76, 0.95) 0.01 
Quiche 0.55 (0.34, 0.90)   0.02 0.80 (0.61, 1.03) 0.08 
Salad cream 0.27 (0.15, 0.51) <0.001 0.93 (0.85, 1.02) 0.13 
French dressing 0.28 (0.16, 0.49) <0.001 0.97 (0.92, 1.04) 0.35 
Butter 0.23 (0.11, 0.50) <0.001 0.98 (0.92, 1.04) 0.45 
Margarine 0.28 (0.14, 0.55) <0.001 1.01 (0.95, 1.06) 0.85 
Low fat spread 0.33 (0.17, 0.64)   0.001 0.98 (0.92, 1.04) 0.47 
Very low fat spread 0.31 (0.17, 0.58) <0.001 0.94 (0.86, 1.03) 0.16 
Red Meat   
Beef  1.79 (0.97, 3.28)   0.06 0.92 (0.83, 1.01) 0.09 
Beef burgers  2.14 (1.25, 3.67)     0.01 0.95 (0.88, 1.03)   0.20 
Bacon 2.84 (1.72, 4.70)   <0.001 0.92 (0.81, 1.05)   0.22 
Pork 1.64 (0.83, 3.26)     0.16 0.94 (0.86, 1.02)   0.14 
Lamb 3.08 (1.83, 5.20)   <0.001 3.08 (1.83, 5.20) <0.001 
Ham 2.38 (1.42, 3.97)     0.001 0.89 (0.79, 1.00)   0.05 
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Corned beef 4.26 (2.65, 6.85)   <0.001 0.76 (0.58, 1.00)   0.05 
Sausages 4.52 (2.61, 7.80)   <0.001 0.97 (0.89, 1.07)   0.60 
Souvlaki 10.40 (1.43, 75.88) 0.02 0.68 (0.53, 0.88)   0.003 
Souvla 1.94 (0.25, 15.15)   0.53 0.38 (0.20, 0.70)   0.002 
Charcoal grilled meat 1.06 (0.13, 8.86)     0.96 0.65 (0.48, 0.89)   0.007 
Grilled roasted meat 1.47 (0.62, 3.51)     0.39 0.83 (0.73, 0.93)   0.002 
Other foods   
Beansprouts 0.24 (0.13, 0.43) <0.001 0.92 (0.82, 1.04) 0.17 
Coleslaw 0.29 (0.15, 0.54) <0.001 0.97 (0.90, 1.03) 0.33 
Garlic 0.29 (0.15, 0.56) <0.001 0.92 (0.83, 1.01) 0.08 
Dried pulses 0.23 (0.13, 0.41) <0.001 0.83 (0.70, 0.98) 0.03 
Baked beans 0.47 (0.22, 1.04)   0.06 0.93 (0.83, 1.04) 0.18 
Mushrooms 0.38 (0.16, 0.90)   0.03 0.85 (0.75, 0.96) 0.01 
Veg. derived Protein    
Tofu 0.29 (0.17, 0.49) <0.001 0.27 (0.09, 0.82) 0.02 
White Meat   
Chicken 2.27 (0.18, 5.34) 0.06 0.95 (0.90, 1.00) 0.06 
Cereal   
White bread 0.43 (0.18, 0.99)   0.05 0.99 (0.95, 1.02) 0.45 
Whole meal Bread 0.34 (0.17, 0.69)   0.002 0.99 (0.96, 1.02) 0.55 
Cream Crackers 0.35 (0.19, 0.63)   0.001 0.99 (0.93, 1.05) 0.73 
Crispbread 0.45 (0.22, 0.92)   0.03 1.00 (0.95, 1.05) 0.97 
Oat based cereal 0.32 (0.17, 0.61) <0.001 0.93 (0.86, 0.99) 0.03 
Refined breakfast cereal 0.19 (0.11, 0.34) <0.001 0.85 (0.76, 0.94) 0.001 
Carbohydrates   
Potatoes 0.37 (0.15, 0.91)   0.03 0.93 (0.85, 1.02) 0.13 
Chips 0.50 (0.23, 1.09)   0.08 0.93 (0.84, 1.03) 0.16 
Roast potatoes 0.80 (0.27, 2.40)   0.69 0.87 (0.75, 1.01) 0.07 
Potato salad 0.49 (0.23, 1.08)   0.08 0.77 (0.60, 0.99) 0.04 
White rice  0.97 (0.28, 3.38)   0.96 0.87 (0.77, 0.99) 0.03 






Table 4 The association of individual foods and the likelihood of being consumed or not by cases, adjusted for age and sex. Determined by 
binary logistic regression. Dose response adjusted for age and sex. 
White green pasta 0.30 (0.14, 0.65)   0.002 0.86 (0.75, 0.98) 0.03 
Whole meal pasta 0.39 (0.21, 0.74)   0.004 0.74 (0.59, 0.91) 0.005 
Lasagne 0.31 (0.16, 0.62)   0.001 0.72 (0.53, 0.98) 0.04 
Pizza 0.38 (0.16, 0.90)   0.03 0.69 (0.51, 0.94) 0.02 
Food Binary (ate this fruit or not) OR [95% C I] Adj 
for age and sex    P 
Dose response OR [95% C I]  Adj for age and 
sex   P 
Fruit   
Apples 0.21 (0.07, 0.64)    0.01            0.99 (0.96, 1.03)    0.71                                   
Avocado 0.37 (0.18, 0.74)    0.01                                                   0.97 (0.90, 1.06)    0.52                                       
Bananas 0.53 (0.19, 1.52)    0.24     1.03 (1.00, 1.06)    0.08 
Grapefruit 0.46 (0.22, 0.96)    0.04                                                  0.87 (0.77, 1.00)    0.05                                         
Grapes 0.34 (0.14, 0.84)    0.02                                                    0.96 (0.90, 1.02)    0.15                                       
Marrow 0.32 (0.10, 0.98)    0.05                                                    1.00 (0.95, 1.04)    0.82                                        
Melon 0.39 (0.17, 0.88)    0.02                                                    1.00 (0.95, 1.04)    0.84                                      
Oranges 0.34 (0.14, 0.85)    0.02  1.00 (0.97, 1.04)    0.75                                       
Peaches 0.35 (0.15, 0.82)    0.02                                                   0.99 (0.95, 1.04)    0.78                                        
Pears 0.24 (0.09, 0.62)    0.003                                                    0.97 (0.91, 1.02)    0.23                                     
Peas  0.45 (0.17, 1.21)    0.11                                                    0.92 (0.79, 1.06)    0.25 
Strawberries 0.32 (0.14, 0.75)    0.01                                                   1.01 (0.97, 1.05)    0.71                                          
Sweet peppers 0.28 (0.12, 0.67)    0.004                                                  0.91 (0.82, 1.00)    0.06                                        
Tomatoes 0.29 (0.12, 0.73)    0.01                                                   0.96 (0.92, 1.00)    0.05                                         
Dried fruit 0.48 (0.21, 1.10)    0.08                                                   0.99 (0.95, 1.04)    0.78 
Tinned fruit 0.42 (0.22, 0.80)    0.01                                                   0.85 (0.68, 1.06)    0.15                           
Fish   
Fried fish in batter 5.3 (2.99, 9.52)     <0.001                                                          1.01 (0.93, 1.10)    0.76                                        
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Fish fingers  3.98 (2.35, 6.73)   <0.001                                                        0.99 (0.89, 1.10)    0.85                                  
White fish  2.95 (1.66, 5.24)   <0.001      1.02 (0.94, 1.10)    0.66                                       
Oily fish  3.77 (1.95, 7.31)   <0.001                                                          1.01 (0.94, 1.09)    0.74                                        
Shell fish 3.98 (2.25, 7.04)   <0.001                                                          1.01 (0.95, 1.07)    0.76                                       
Fish roe  4.30 (2.56, 7.21)   <0.001                                                        1.04 (0.98, 1.09)    0.23                                          
Vegetables   
Beetroot 0.97 (0.62, 1.51)   0.89                                                  0.75 (0.59, 0.95)   0.02 
Broccoli 0.42 (0.18, 1.00)    0.05                                                   0.97 (0.90, 1.05)   0.40                                         
Brussels sprouts 0.96 (0.62, 1.50)    0.87                                                0.92 (0.79, 1.07)   0.29 
Cabbage 0.29 (0.13, 0.64)    0.002                                                   0.94 (0.87, 1.03)   0.17                                        
Capers 0.43 (0.21, 0.92)    0.03                                                   0.94 (0.84, 1.04)   0.22                                         
Carrots 0.31 (0.10, 0.96)    0.04                                                   0.98 (0.94, 1.03)    0.43                                           
Cauliflower 0.38 (0.17, 0.90)    0.02                                                   0.97 (0.88, 1.06)    0.46                                         
Charcoal grilled veg 0.37 (0.18, 0.76)    0.01                                                  0.73 (0.53, 1.00)    0.05                                        
Leeks 0.40 (0.19, 0.82)    0.01                                                   0.96 (0.84, 1.11)    0.62                                        
Onions  0.32 (0.12, 0.86)    0.02                                                   0.90 (0.82, 0.98)    0.02                                         
Green salad 0.56 (0.18, 1.72)    0.31                                                   0.96 (0.92, 1.01)    0.10 
Parsnips 0.37 (0.18, 0.76)    0.01                                                 0.84 (0.61, 1.16)    0.29                                         
Spinach 0.24 (0.09, 0.62)    0.003                                                    0.91(0.80, 1.04)     0.16                                     
Sweetcorn 0.32 (0.14, 0.74)    0.01                                                 0.93 (0.84, 1.02)    0.12                                       
Watercress 0.38 (0.21, 0.68)    0.001                                                  0.75 (0.53, 1.05)    0.09                                        
Dairy products   
Single cream 0.77 (0.35, 1.69)    0.51                                              0.98 (0.82, 1.17)   0.85 
Clotted cream 0.65 (0.33, 1.28)    0.21                                                 0.99 (0.82, 1.20)   0.90 
Low fat yoghurt 0.71 (0.30, 1.69)    0.44                                               0.95 (0.87, 1.04)   0.25 
Full fat yoghurt 0.93 (0.60, 1.44)    0.73 0.91 (0.80, 1.04)   0.18  
Desserts 0.59 (0.28, 1.25)    0.17  0.89 (0.73, 1.07)   0.22 
Cheese 0.91 (0.17, 4.93)    0.91   0.90 (0.84, 0.98)   0.01 
Eggs 0.38 (0.11, 1.32)    0.13                                                   0.88 (0.79, 0.99)   0.04 
Quiche 0.75 (0.44, 1.29)    0.30                                                 0.93 (0.74, 1.16)   0.52 
Salad cream 0.43 (0.21, 0.90)    0.03 0.98 (0.90, 1.06)   0.56 
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French dressing 0.54 (0.28, 1.03)    0.06  0.98 (0.90, 1.06)   0.56 
Butter 0.37 (0.15, 0.92)    0.03 1.01 (0.94, 1.07)   0.89 
Margarine 0.45 (0.20, 1.00)    0.05 1.01 (0.94, 1.07)   0.89 
Low fat spread 0.52 (0.24, 1.14)    0.10 1.02 (0.96, 1.09)   0.45 
Very low fat spread 0.51 (0.25, 1.06)    0.07                0.98 (0.90, 1.05)   0.52 
Red Meat   
Beef  3.00 (1.52, 5.93)    0.002 1.00 (0.92, 1.10)   0.93   
Beef burgers  3.06 (1.70, 5.51) <0.001 1.00 (0.94, 1.06)   0.93  
Bacon 4.00 (2.26, 6.92) <0.001                                               0.99 (0.88, 1.10)   0.80          
Pork 1.99 (0.95, 4.19)   0.07   0.99 (0.92, 1.06)   0.76 
Lamb 3.78 (2.15, 6.65) <0.001    0.94 (0.81, 1.09)   0.39          
Ham 3.27 (1.84, 5.80) <0.001        0.94 (0.84, 1.06)   0.33            
Corned beef 5.52 (3.23, 9.41)   0.001       0.88 (0.67, 1.16)   0.37          
Sausages 5.07 (2.80, 9.17) <0.001        1.01(0.93, 1.11)    0.75      
Souvlaki 7.37 (1.00, 54.56) 0.05          0.80 (0.62, 1.04)   0.09        
Souvla 2.01 (0.24, 16.90) 0.52     0.48 (0.27, 0.87)   0.02 
Charcoal grilled meat 0.82 (0.08, 8.54)   0.87    0.77 (0.56, 1.04)   0.09 
Grilled roasted meat 0.92 (0.36, 2.33)   0.86   0.93 (0.81, 1.07)   0.31 
Other foods   
Beansprouts 0.31 (0.16, 0.62)   0.001        0.93 (0.83, 1.04)   0.18       
Coleslaw 0.34 (0.17, 0.70)   0.004                               0.95 (0.88, 1.03)   0.22       
Garlic 0.35 (0.16, 0.79)   0.01   0.91(0.81, 1.01)    0.08         
Dried pulses 0.36 (0.18, 0.70)   0.003                        0.84 (0.72, 0.99)   0.04        
Mushrooms 0.45 (0.17, 1.22)   0.11                          0.88 (0.77, 1.00)   0.05 
Veg. derived Protein    
Tofu 0.53 (0.29, 0.97)   0.04                           0.53 (0.24, 1.14)   0.10         
White Meat   
Chicken 2.14 (0.87, 5.27)   0.10                            0.98 (0.94, 1.03)   0.48 
Cereal   
White bread 1.00 (0.38, 2.65)   1.00                   0.96 (0.93, 1.00)   0.06 
Whole meal Bread 0.62 (0.28, 1.38)   0.24     0.99 (0.95, 1.03)   0.57 
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Table 5 Age-matched analysis Conditional Logistic Regression unadjusted and adjusted for sex of individual foods together with dose 
response 
Cream Crackers 0.71 (0.36, 1.40)   0.33                    1.01 (0.95, 1.07)   0.72 
Crispbread 0.95 (0.41, 2.20)   0.90                   1.00 (0.95, 1.06)   0.93 
Oat based cereal 0.45 (0.22, 0.95)   0.04  0.94 (0.87, 1.01)   0.07               
Refined breakfast cereal 0.31 (0.16, 0.61)   0.001       0.90 (0.82, 0.99)   0.04            
Carbohydrates   
Potatoes 0.25 (0.09, 0.74)   0.01                         0.97 (0.89, 1.06)   0.50      
Chips 1.09 (0.43, 2.72)   0.86                           1.00 (0.93, 1.08)   0.92 
Roast potatoes 0.82 (0.24, 2.82)   0.76                          0.94 (0.83, 1.08)   0.40 
Potato salad 0.71(0.29, 1.78)    0.47                         0.85 (0.65, 1.10)   0.22 
White rice  1.28 (0.29, 5.67)   0.75                          0.95 (0.86, 1.05)   0.29 
Brown rice 0.55 (0.28, 1.07)   0.08                        0.93 (0.80, 1.09)   0.37 
White green pasta 0.35 (0.14, 0.86)   0.02 0.94 (0.84, 1.04)   0.24       
Whole meal pasta 0.46 (0.22, 0.94)   0.03      0.83 (0.68, 1.02)   0.07      
Lasagne 0.55 (0.25, 1.22)   0.14                         0.90 (0.71, 1.15)   0.40 
Pizza 0.55 (0.20, 1.52)   0.25                        0.89 (0.71, 1.11)   0.31 
 Unadjusted for sex Adjusted for sex 
Food Odds Ratio (95% CI) p Dose response Odds 
Ratio 
Odds Ratio (95% CI) p Dose response Odds 
Ratio [95% C I] p                                                      
Fruit     
Apples 0.33 (0.07, 1.65)  0.18 0.99 (0.94, 1.04) 0.65 0.30 (0.06, 1.53)  0.15 0.99 (0.95, 1.04) 0.69 
Avocado 0.25 (0.08, 0.75)  0.01 0.92 (0.81, 1.05) 0.23 0.26 (0.09, 0.76)  0.02 0.92 (0.81, 1.05) 0.21 
Bananas 1.63e-18   0.00    1.00 1.02 (0.97, 1.07) 0.41 1.75e-07  0.00      0.99 1.02 (0.97, 1.07) 0.44 
Grapefruit 0.21 (0.06, 0.75)  0.02 0.79 (0.66, 0.94) 0.01 0.20 (0.06, 0.71)  0.01 0.79 (0.66, 0.95) 0.01 
Grapes 0.20 (0.04, 0.91)  0.04 0.95 (0.88, 1.02) 0.15 0.19 (0.04, 0.88)  0.03 0.95 (0.88, 1.02) 0.18 
Marrow 0.40 (0.08, 2.06)  0.27 1.02 (0.96, 1.08) 0.50 0.38 (0.07, 1.98)  0.25 1.02 (0.96, 1.08) 0.60 
Melon 0.20 (0 .04, 0.91) 0.04 0.99 (0.93, 1.04) 0.65 0.19 (0.04, 0.88)  0.03 0.99 (0.94, 1.05) 0.70 
Oranges 0.25 (0.05, 1.18)  0.08 1.01 (0.97, 1.06) 0.58 0.24 (0.05, 1.14)  0.07 1.02 (0 .97, 1.07) 0.55 
Peaches 0.27 (0.08, 0.98)  0.05 0.97 (0.92, 1.03) 0.34 0.28 (0.08, 1.01)  0.05 0.98 (0.93, 1.03) 0.37 
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Pears 0.11 (0.01, 0.88)  0.04 0.96 (0.89, 1.02) 0.19 0.10 (0.01, 0.81)  0.03 0.96 (0.90, 1.02) 0.21 
Peas  0.14 (0.02, 1.16)  0.07 0.86 (0.69, 1.07) 0.18 0.12 (0.02, 1.01)  0.05 0.85 (0.67, 1.08) 0.17 
Strawberries 0.18 (0.04, 0.82)  0.03 0.99 (0.95, 1.04) 0.81 0 .18 (0.04, 0.81) 0.03 1.00 (0.95, 1.04) 0.85 
Sweet peppers 1.22e-17   0.00    1.00 0.88 (0.77, 1.01) 0.07 9.17e-08      0.0   0.99 0.88 (0.76, 1.01) 0.06 
Tomatoes 0.25 (0.05, 1.18)  0.08 0.95 (0.91, 1.00) 0.05 0.25 (0.05, 1.17) 0.08 0.95 (0.91, 1.00) 0.05 
Dried fruit 0.11 (0.01, 0.88)  0.04 0.97 (0.92, 1.02) 0.19 0.11 (0.01, 0.90) 0.04 0.97 (0.92, 1.02) 0.23 
Tinned fruit 0.32 (0.13, 0.79)  0.01 0.87 (0.70, 1.08) 0.20 0.31 (0.12, 0.78) 0.01 0.86 (0.69, 1.08) 0.21 
Fish     
Fried fish in batter 6.43 (2.90, 14.26) <0.001          1.02 (0.87, 1.21) 0.79 6.54 (2.94, 14.57) <0.001 1.02 (0.86, 1.20) 0.84 
Fish fingers  3.90 (1.95, 7.81)   <0.001 1.10 (0.82, 1.46) 0.53 3.89 (1.94, 7.80)  <0.001 1.11 (0.83, 1.49) 0.47 
White fish  2.20 (1.04, 4.65)     0.04 0.99 (0.86, 1.14) 0.88 2.24 (1.06, 4.74)    0.04 0.99 (0.85, 1.14) 0.86 
Oily fish  3.83 (1.56, 9.41)     0.003 0.97 (0.86, 1.10) 0.66 3.96 (1.61, 9.78)    0.003 0.97 (0.86, 1.10) 0.64 
Shell fish 3.88 (1.78, 8.43)     0.001 0.97 (0.90, 1.05) 0.43 3.96 (1.81, 8.65)    0.001 0.97 (0.90, 1.04) 0.36 
Fish roe  5.00 (2.34, 10.68) <0.001 1.04 (0.93, 1.17) 0.45 4.93 (2.3, 10.55)  <0.001 1.04 (0.94, 1.16) 0.45 
Vegetables     
Beetroot 0.15 (0.04, 0.68) 0.01 0.71 (0.55, 0.91) 0.01 0.16 (0.04, 0.71) 0.02 0.71 (0.55, 0.91) 0.01 
Broccoli 0.30 (0.08, 1.09) 0.07 0.93 (0.83, 1.05) 0.24 0.30 (0.08, 1.09) 0.07 0.93 (0.83, 1.05) 0.24 
Brussels sprouts 0.29 (0.11, 0.80) 0.02 0.84 (0.68, 1.04) 0.11 0.30 (0.11, 0.82) 0.02 0.84 (0.67, 1.05) 0.12 
Cabbage 0.14 (0.03, 0.63) 0.01 0.90 (0.79, 1.02) 0.11 0.15 (0.03, 0.64) 0.01 0.90 (0.79, 1.03) 0.13 
Capers 0.31 (0.10, 0.94) 0.04 0.91 (0.80, 1.04) 0.15 0.31 (0.10, 0.96) 0.04 0.91 (0.80, 1.04) 0.16 
Carrots 0.20 (0.02, 1.71) 0.14 0.97 (0.92, 1.03) 0.31 0.19 (0.02, 1.63) 0.13 0.97 (0.91, 1.03) 0.27 
Cauliflower 0.22 (0.05, 1.03) 0.05 0.99 (0.83, 1.18) 0.88 0.23 (0.05, 1.09) 0.06 0.98 (0.81, 1.17) 0.79 
Charcoal grilled veg 8.10e-16   0.00   1.00 0.65 (0.41, 1.05) 0.08 4.26e-07  0.00     0.99 0.68 (0.43, 1.07) 0.09 
Leeks 0.27 (0.09, 0.80) 0.02 1.10 (0.77, 1.59) 0.60 0.27 (0.09, 0.81) 0.02 1.09 (0.75, 1.57) 0.66 
Onions  8.10e-16   0.00   1.00 0.89 (0.80, 0.98) 0.02 7.51e-08  0.00     0.99 0.89 (0.80, 0.98) 0.02 
Green salad 0.50 (0.09, 2.73) 0.42 0.96 (0.91, 1.01) 0.12 0.42 (0.08, 2.38) 0.33 0.96 (0.91, 1.01) 0.10 
Parsnips 0.19 (0.06, 0.64) 0.01 0.84 (0.60, 1.20) 0.34 0.19 (0.06, 0.66) 0.01 0.85 (0.60, 1.21) 0.37 
Spinach 0.11 (0.01, 0.88) 0.04 0.81 (0.65, 1.01) 0.06 0.11 (0.01, 0.84) 0.03 0.81 (0.65, 1.01) 0.06 
Sweetcorn 0.08 (0.01, 0.64) 0.02 0.93 (0.83, 1.03) 0.17 0.08 (0.01, 0.65) 0.02 0.93 (0.83, 1.04) 0.18 
Watercress 0.19 (0.07, 0.56) 0.002 0.68 (0.44, 1.06) 0.09 0.19 (0.07, 0.57) 0.003 0.69 (0.45, 1.07) 0.10 
Dairy products     
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Single cream 0.21 (0.06, 0.75) 0.02 0.97 (0.71, 1.32) 0.84 0.45 (0.14, 1.47) 0.19 0.99 (0.72, 1.35) 0.92 
Clotted cream 0.50 (0.20, 1.23) 0.13 0.95 (0.68, 1.33) 0.75 0.50 (0.20, 1.25) 0.14 0.95 (0.68, 1.34) 0.78 
Low fat yoghurt 0.88 (0.32, 2.41) 0.80     0.96 (0.89, 1.03) 0.24 0.81 (0.29, 2.26) 0.69 0.95 (0.88, 1.03) 0.19 
Full fat yoghurt 0.75 (0.26, 2.16) 0.60 0.94 (0.82, 1.07) 0.34 0.78 (0.27, 2.25) 0.64 0.93 (0.81, 1.06) 0.27 
Desserts 0.31 (0.10, 0.94) 0.04 0.94 (0.80, 1.09) 0.40 0.29 (0.10, 0.91) 0.03 0.92 (0.79, 1.08) 0.33 
Cheese 1.00 (0.14, 7.10) 1.00 0.91 (0.84, 0.99) 0.04 0.87 (0.12, 6.32) 0.89 0.90 (0.82, 0.98) 0.02 
Eggs 0.40 (0.08, 2.06) 0.27         0.88 (0.76, 1.02) 0.08 0.40 (0.08, 2.06) 0.27 0.86 (0.74, 1.00) 0.05 
Quiche 0.74 (0.37, 1.47) 0.39        0.89 (0.67, 1.17) 0.40 0.75 (0.38, 1.51) 0.42 0.89 (0.67, 1.17) 0.40 
Salad cream 0.20 (0.06, 0.69) 0.01 0.98 (0.90, 1.07) 0.71 0.20 (0.06, 0.68) 0.01 0.98 (0.90, 1.07) 0.70 
French dressing 0.38 (0.16, 0.93) 0.03        1.03 (0.91, 1.17) 0.59 0.40 (0.17, 0.96) 0.04 1.04 (0.92, 1.17) 0.51 
Butter 0.10 (0.01, 0.78) 0.03        1.06 (0.94, 1.20) 0.31 0.09 (0.01, 0.73) 0.02 1.06 (0.94, 1.19) 0.38 
Margarine 0.18 (0.04, 0.82) 0.03         1.02 (0.94, 1.11) 0.58 0.18 (0.04, 0.80) 0.02 1.02 (0.93, 1.11) 0.70 
Low fat spread 0.58 (0.23, 1.48) 0.26       1.00 (0.92, 1.09) 0.94 0.58 (0.23, 1.48) 0.26 1.00 (0.91, 1.09) 0.92 
Very low fat spread 0.39 (0.14, 1.08) 0.07         0.95 (0.86, 1.04) 0.27 0.39 (0.14, 1.11) 0.08 0.94 (0.85, 1.04) 0.20 
Red Meat     
Beef  3.00 (1.28, 7.06)     0.01        0.98(0.87, 1.11)  0.77 3.75 (1.68, 8.37)    0.001 0.98 (0.87, 1.11) 0.79 
Beef burgers  3.50 (1.60, 7.68)     0.002     1.00 (0.92, 1.08) 0.98 3.75 (1.68, 8.37)     0.001 1.00 (0.92, 1.08) 0.97 
Bacon 4.63 (2.15,9.93)    <0.001    1.06 (0.89, 1.25) 0.52 4.78 (2.21, 10.33) <0.001    1.07 (0.90, 1.27) 0.45 
Pork 2.00 (0.90, 4.45)     0.09         0.99 (0.89, 1.09) 0.77 1.99 (0.89, 4.43)     0.09 0.98 (0.89, 1.08) 0.67 
Lamb 3.20 (1.57,6.51)      0.001       0.79 (0.61, 1.02) 0.07 3.49 (1.68, 7.24)     0.001 0.80 (0.62, 1.04) 0.10 
Ham 3.89 (1.87, 8.09)   <0.001     0.97 (0.88, 1.07) 0.56 3.97 (1.90, 8.30)    <0.001 0.97 (0.88, 1.08) 0.60 
Corned beef 5.88 (2.78, 12.43) <0.001    1.07 (0.67, 1.70) 0.79          6.05 (2.84, 12.92)  <0.001      1.09 (0.68, 1.73) 0.73 
Sausages 5.86 (2.63, 13.06) <0.001     1.32 (0.79, 2.21) 0.29        6.16 (2.74, 13.88)  <0.001     1.38 (0.81, 2.34) 0.23 
Souvlaki 1.16e+17    0.00      1.00           0.80 (0.57, 1.13) 0.21 e              0.00          0.99       0.81 (0.58, 1.14) 0.23 
Souvla 8.10e-16     0.00      1.00           0.61 (0.33, 1.14) 0.12 1.10e-09   0.00         1.00        0.61 (0.33, 1.13) 0.11 
Charcoal grilled 
meat 8.10e-16      0.00     1.00 0.81 (0.56, 1.15) 0.24 4.26e-07  0.00     0.99 0.80 (0.56, 1.14) 0.21 
Grilled roasted meat 1.00 (0.32, 3.10)     1.00 0.98 (0.81, 1.17) 0.79 0.93 (0.30, 2.93) 0.90 0.97 (0.81, 1.16) 0.73 
Other foods     
Beansprouts 0.31 (0.12, 0.85)     0.02 0.93 (0.81, 1.06) 0.28 0.32 (0.12, 0.89) 0.03 0.93 (0.81, 1.07) 0.30 





Garlic 0.23 (0.07, 0.89)    0.03         0.93 (0.82, 1.06) 0.30 0.26 (0.07, 0.93) 0.04 0.94 (0.82, 1.07) 0.34 
Dried pulses 0.22 (0.08, 0.66)   0.01 0.83 (0.70, 0.98) 0.03 0.22 (0.08, 0.66) 0.01 0.83 (0.70, 0.98) 0.03 
Mushrooms 0.17 (0.02, 1.38)   0.10 0.86 (0.73, 1.02) 0.08 0.18 (0.02, 1.52) 0.12 0.85 (0.72, 1.01) 0.07 
Veg. derived 
Protein      
Tofu 0.38 (0.15, 0.96)   0.04           0.37 (0.13, 1.03) 0.06 0.38 (0.15, 0.98) 0.05       0.37 (0.13, 1.05) 0.06 
White Meat     
Chicken 2.33 (0.90, 6.07)   0.08            1.01 (0.93, 1.09) 0.88 2.26 (0.87, 5.91) 0.10 1.00 (0.92, 1.09) 0.99 
Cereal     
White bread 0.86 (0.29, 2.55)   0.78         0.97 (0.29, 2.55) 0.10 0.86 (0.29, 2.56) 0.78 0.97 (0.93, 1.01) 0.10 
Whole meal Bread 0.64 (0.25, 1.64)   0.35            0.99 (0.95, 1.04) 0.72 0.62 (0.24, 1.62) 0.33 0.99 (0.95, 1.04) 0.71 
Cream Crackers 0.79 (0.36, 1.73)   0.55        1.01 (0.94, 1.08) 0.87 0.79 (0.36, 1.75) 0.57 1.01 (0.94, 1.08) 0.79 
Crispbread 0.67 (0.24, 1.87)   0.44        0.98 (0.93, 1.03) 0.38 0.68 (0.24, 1.91) 0.46 0.98 (0.93, 1.03) 0.43 
Oat based cereal 0.14 (0.03, 0.63)   0.01       0.90 (0.81, 1.00) 0.04 0.13 (0.03, 0.60) 0.01 0.90 (0.82, 1.00) 0.05 
Refined breakfast 
cereal 0.15 (0.05, 0.51) 0.002 0.88 (0.78, 0.99) 0.03 0.15 (0.04, 0.49) 0.002      0.88 (0.78, 0.99) 0.04 
Carbohydrates         
Potatoes 8.10e-16      0.00 1.00        0.97 (0.87, 1.08) 0.58 5.76e-08    0.00  0.99        0.98 (0.88, 1.09) 0.66 
Chips 0.60 (0.14, 2.51) 0.48 1.03 (0.90, 1.17) 0.69 0.53 (0.13, 2.27) 0.39        1.03 (0.90, 1.17) 0.66 
Roast potatoes 0.50 (0.09, 2.73) 0.42 1.03 (0.82, 1.29) 0.82 0.47 (0.09, 2.61) 0.39        1.03 (0.82, 1.30) 0.79 
Potato salad 0.29 (0.06, 1.37) 0.12 0.85 (0.60, 1.21) 0.37 0.26 (0.05, 1.28) 0.10        0.84 (0.59, 1.18) 0.31 
White rice  0.67 (0.11, 3.99) 0.66 0.95 (0.84, 1.07) 0.38 0.55 (0.09, 3.43) 0.52        0.94 (0.83, 1.06) 0.30 
Brown rice 0.20 (0.06, 0.69) 0.01 0.85 (0.66, 1.10) 0.22 0.20 (0.06, 0.71) 0.01        0.85 (0.66, 1.10) 0.22 
White green pasta 0.13 (0.02, 1.00) 0.05 0.94 (0.76, 1.15) 0.54 0.10 (0.01, 0.83) 0.03        0.93 (0.75, 1.14) 0.47 
Whole meal pasta 0.36 (0.13, 0.99) 0.05 0.79 (0.63, 1.00) 0.05 0.37 (0.13, 1.03) 0.06       0.79 (0.62, 1.00) 0.05 
Lasagne 0.30 (0.08, 1.09) 0.07 0.93 (0.65, 1.32) 0.68 0.30 (0.08, 1.09) 0.07       0.92 (0.65, 1.31) 0.65 
Pizza 0.29 (0.06, 1.38) 0.12 0.80 (0.57, 1.11) 0.18 0.25 (0.05, 1.24) 0.09       0.80 (0.58, 1.11) 0.18 
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7.2.1.2 Appendix C 
The STROBE “checklist” has been reproduced here. 
STROBE Statement—Checklist of items that should be included in reports of case-




Title and abstract 1 (a) Indicate the study’s design with a commonly used 
term in the title or the abstract 
(b) Provide in the abstract an informative and 
balanced summary of what was done and what was 
found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the 
investigation being reported 
Objectives 3 State specific objectives, including any prespecified 
hypotheses 
Methods 
Study design 4 Present key elements of study design early in the 
paper 
Setting 5 Describe the setting, locations, and relevant dates, 
including periods of recruitment, exposure, follow-up, 
and data collection 
Participants 6 (a) Give the eligibility criteria, and the sources and 
methods of case ascertainment and control selection. 
Give the rationale for the choice of cases and controls 
(b) For matched studies, give matching criteria and the 
number of controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, 
potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and 
details of methods of assessment (measurement). 
Describe comparability of assessment methods if there 
is more than one group 
Bias 9 Describe any efforts to address potential sources of 
bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in 
the analyses. If applicable, describe which groupings 
were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those 
used to control for confounding 
(b) Describe any methods used to examine subgroups 
and interactions 
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(c) Explain how missing data were addressed 
(d) If applicable, explain how matching of cases and 
controls was addressed 
(e) Describe any sensitivity analyses 
Results 
Participants 13* (a) Report numbers of individuals at each stage of 
study—e.g. numbers potentially eligible, examined for 
eligibility, confirmed eligible, included in the study, 
completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive data 14* (a) Give characteristics of study participants (e.g. 
demographic, clinical, social) and information on 
exposures and potential confounders 
(b) Indicate number of participants with missing data 
for each variable of interest 
Outcome data 15* Report numbers in each exposure category, or 
summary measures of exposure 
Main results 16 (a) Give unadjusted estimates and, if applicable, 
confounder-adjusted estimates and their precision 
(e.g., 95% confidence interval). Make clear which 
confounders were adjusted for and why they were 
included 
(b) Report category boundaries when continuous 
variables were categorized 
(c) If relevant, consider translating estimates of 
relative risk into absolute risk for a meaningful time 
period 
 
Other analyses 17 Report other analyses done—e.g. analyses of subgroups and 
interactions, and sensitivity analyses 
 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of 
potential bias or imprecision. Discuss both direction and 
magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity of analyses, results from 
similar studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study 
results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the 
present study and, if applicable, for the original study on which 




7.2.1.3 Appendix D 1 Consent Form in English 
 
You are being asked to participate in a research study. Please take your time to review this 
consent form and discuss any questions you may have with the study staff. This consent 
may contain words that you do not understand.  Please ask Dr Johnson to explain any 
words or information that you do not clearly understand.      
8 Purpose of Study 
The study aims to establish which environmental factors are a risk of acquiring Multiple 
Sclerosis among Cypriots. 
 
 Study Procedures 
Participation in this study will only be during the time when the questions are being 
asked.  You can stop participating at any time. 
 Confidentiality 
 Information gathered in this research study may be published or presented in 
public forums, however, your name and other identifying information will not be 
used or revealed  
 Voluntary Participation/ Withdrawal from the Study 
You may refuse to answer individual questions.  
 Questions 
You are free to ask any questions that you may have about this research study and your 
rights as a research participant.  If any questions come up during the study please ask 
Dr.Paul Johnson. 
Do not sign this consent form unless you have had a chance to ask questions and have 
received satisfactory answers to all your questions. 
Legal Rights 
You are not waiving any of your legal rights by signing this consent form nor releasing the 
investigator from their legal or professional responsibility.   
8.5.1 Statement of Consent 
I have read the Participant Information Sheet and 
this consent form. I have had the opportunity to discuss this research study with Dr.Paul 
Johnson.  I have had my questions answered in a way I understand. I understand that my 
participation in this study is voluntary and that I may choose to withdraw at any time.  I 
freely agree to participate in this research study. I understand that information regarding 
my personal identity will be kept confidential.  
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By signing this consent form, I have not waived any of the legal rights that I have as a 
participant in this study.   
I consent to the following as part of this study:   
a) Filling in the research questionnaire                                          Yes    No 
    
b)  Having my data included in medical journal articles, conference  
     presentations, etc. however my name and other identifying information  
     will not be used or revealed.                                                             Yes         No 
_____________________________________   
________________________ 





8.5.1.1 Appendix D2 Consent Form in Greek 
 
     Έντυπο Συγκατάθεσης 
 
Καλείστε να συμμετάσχετε σε μια ερευνητική μελέτη. Παρακαλώ όπως αφιερώσετε τον 
κατάλληλο χρόνο για να μελετήσετε το έντυπο συγκατάθεσης και να συζητήσετε τυχόν 
ερωτήσεις με το προσωπικό της μελέτης. 
Αυτό το έντυπο συγκατάθεσης μπορεί να περιέχει λέξεις που δεν καταλαβαίνετε. 
Παρακαλώ ζητήστε από τον Δρ.Johnson να σας εξηγήσει οποιεσδήποτε λέξεις ή 
πληροφορίες δεν καταλαβαίνετε.      
Σκοπός Μελέτης  
Η μελέτη στοχεύει στο να διαπιστώσει ποιοι περιβαλλοντικοί παράγοντες αποτελούν 
κίνδυνο εμφάνισης σκλήρυνσης κατά πλάκας στους Κύπριους. 
 
 Διαδικασία Μελέτης 
Η συμμετοχή στη μελέτη αυτή θα διαρκεί μόνο κατά την περίοδο που υποβάλλονται οι 
ερωτήσεις. Μπορείτε να σταματήσετε να συμμετέχετε ανά πάσα στιγμή. 
 
 Εμπιστευτικότητα 
 Οι πληροφορίες που θα συγκεντρωθούν στην μελέτη αυτή μπορούν να 
δημοσιευθούν ή να παρουσιαστούν σε δημόσια φόρουμ, ωστόσο το όνομά σας και 
άλλες πληροφορίες ταυτοποίησης δεν θα χρησιμοποιηθούν ούτε θα αποκαλυφθούν. 
 
 Εθελοντική Συμμετοχή / Απόσυρση από τη Μελέτη 
Έχετε το δικαίωμα να αρνηθείτε να απαντήσετε σε μεμονωμένες ερωτήσεις. 
 
 Ερωτήσεις 
Είστε ελεύθεροι να θέσετε οποιαδήποτε ερωτήματα έχετε σχετικά με τη μελέτη αυτή 
καθώς και για τα δικαιώματά σας ως συμμετέχοντας/συμμετέχουσα στην έρευνα. Εάν 
προκύψουν οποιαδήποτε ερωτήματα κατά τη διάρκεια της μελέτης, παρακαλώ όπως 
ρωτήστε τον Δρ.Paul Johnson. 
Μην υπογράψετε αυτήν τη φόρμα συγκατάθεσης εάν δεν είχατε την ευκαιρία να υποβάλετε 
τυχόν ερωτήσεις και δεν έχετε λάβει ικανοποιητικές απαντήσεις σε αυτές. 
 
Νόμιμα δικαιώματα 
Υπογράφοντας αυτό το έντυπο συγκατάθεσης, δεν παραιτείστε από τα νόμιμα δικαιώματά 
σας, ούτε απαλλάσσετε τον ερευνητή από τη νομική ή επαγγελματική ευθύνη του.  
 
Η μελέτη αυτή έχει εγκριθεί από την Επιτροπή Δεοντολογίας Έρευνας της Σχολής 
Ιατρικών Επιστημών, μέρος της Επιτροπής Δεοντολογίας  Έρευνας του Newcastle 
University. Η επιτροπή αυτή περιλαμβάνει μέλη τα οποία είναι εσωτερικά της Σχολής, 
καθώς και ένα εξωτερικό μέλος. Η μελέτη αυτή εξετάστηκε από τα μέλη της επιτροπής, τα 
οποία πρέπει να παρέχουν αμερόληπτες συμβουλές και να αποφεύγουν σημαντικές 
συγκρούσεις συμφερόντων.  
8.10.1 Δήλωση συγκατάθεσης 
Έχω διαβάσει το Δελτίο Πληροφοριών Συμμετεχόντων και το παρόν Έντυπο 
συγκατάθεσης. Είχα την ευκαιρία να συζητήσω την παρούσα ερευνητική μελέτη με τον 
Δρ.Paul Johnson. Τα ερωτήματά μου έχουν απαντηθεί με κατανοητό τρόπο. Κατανοώ ότι 
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η συμμετοχή μου σε αυτή τη μελέτη είναι εθελοντική και ότι μπορώ να επιλέξω να 
αποσυρθώ ανά πάσα στιγμή. Συμφωνώ με ελεύθερη βούληση να συμμετάσχω σε αυτή τη 
μελέτη. Κατανοώ το ότι οι πληροφορίες σχετικά με την προσωπική μου ταυτότητα θα 
παραμείνουν εμπιστευτικές.  
Ως μέρος αυτής της μελέτης, δηλώνω την συγκατάθεση μου ως προς τα πιο κάτω: 
α) Συμπλήρωση του ερωτηματολογίου της έρευνας                                          Ναι      
 Όχι     
β) Να συμπεριληφθούν τα δεδομένα μου σε άρθρα ιατρικών περιοδικών, παρουσιάσεις, 
συνέδρια κλπ., ωστόσο το όνομά μου και άλλες πληροφορίες ταυτοποίησης δεν θα 
χρησιμοποιηθούν ούτε θα αποκαλυφθούν.                                                                     
 Ναι       Όχι 
______________________  __________ 
Υπογραφή συμμετέχοντα            Ημερομηνία    
 
_________________________ 




8.10.1.1 Appendix E 1 Participant Information Sheet in English 
 
Study name 
A Case-Control study of Multiple Sclerosis among in Cyprus 
 
You are invited to take part in a research study. Before you decide you need to understand 
why the research is being done and what it would involve for you. Please take time to read 
the following information carefully. Ask questions if anything you read is not clear or would 
like more information. Take time to decide whether or not to take part.   
 
This is a questionnaire based study. 
 
9 What is the purpose of the study? 
The study aims to establish which environmental factors are a risk of acquiring Multiple 
Sclerosis among Cypriots. 
 
Why have I been invited? 
You have been chosen because you are a Cypriot. This study is not for people of other 
nationalities. 
Some people are chosen because they have Multiple Sclerosis. These are the cases. 
Others are chosen because they don’t have Multiple Sclerosis. These are the controls. 
The environmental factors that the control group have been exposed to will be compared 
to those of the people with Multiple Sclerosis. 
 
Do I have to take part? 
No. Your participation in the research is entirely voluntary. If you have Multiple Sclerosis 
your current and future treatment will be unaltered whether or not, you take part. If you 
do not have Multiple Sclerosis any other medical treatment you receive now or need in 
the future will not be affected either. 
 
What will happen to me if I take part? 
You will be asked to fill in a questionnaire that will ask about food and lifestyle. 
It will take between 10-15 minutes. You will only be asked to fill this in once and won’t 
be contacted for any other information. 
 
Expenses and payments? 
There is no payment for this study. 
 
What will I have to do? 
Fill in a questionnaire. 
 
What are the possible disadvantages and risks of taking part? 
There are none. 
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What are the possible benefits of taking part? 
There are no direct benefits available for you. However, your participation will help 
enrich our current understanding of the epidemiology, pathophysiology and burden of 
Multiple Sclerosis in the Cypriot population. This is something that will be extremely 
useful for devising targeted prevention programmes that will be more efficient and cost-
effective, thus reducing the burden of the disease on the society and at the same time 
saving money from the National Health System of Cyprus. 
 
What if there is a problem? 
This is unlikely but if you have a concern about any aspect of this study, you should ask to 
speak to the researcher Dr Paul Johnson who will do his best to answer your questions or 
you may email:    Johnson.p@unic.ac.cy 
 
If you remain unhappy and wish to complain formally you can do this to Dr Alexandros 
Heraclides  by email to:   heraclides.a@unic.ac.cy 
 
Will my taking part in the study be kept confidential? 
All questionnaires will be anonymised, and participants will be identified by a specific 
study number. Only the principal investigator will have access to the patient’s name and 
this information will be kept, password-protected, in a separate file in the principal 
investigator’s computer only. No other person will be able to link participant names to 
any information collected from the questionnaire.  
 
All electronic information (the database) of the research project will be securely stored in 
a password-protected electronic file. Only the principal investigator will be aware of the 
password, which will be changed every 3 months.  
 
Completed questionnaires will be locked in a safe locker in the study coordinator’s office 
at CING immediately after data collection. Once the transfer from the paper 
questionnaires to the electronic dataset is completed, all questionnaires will be safely 
stored in a locked metallic drawer. No person other than the study principal investigator 
will have access to these questionnaires. All computers containing study data, will be 
safely locked at the CING premises when not in operation.  
 
 
All information which is collected about you during the course of the research will be kept 
strictly confidential, and any information about you which leaves the 
hospital/surgery/university will have your name and address removed so that you cannot 
be recognised.  
 
What will happen to the results of the research study? 
Any published material will be anonymized so you cannot be identified. 
 
Who is organising or sponsoring the research? 
This research is organised by Dr Paul Johnson the principal investigator. There is no 
funding or sponsorship. 
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9.1.1.1 Appendix E 2 Participant Information Sheet in Greek 
 
Δελτίο Πληροφοριών Συμμετεχόντων 
Όνομα μελέτης 
Μια μελέτη ασθενών-μαρτύρων για την Σκλήρυνση Κατά Πλάκας σε Ελληνοκύπριους 
στην Κύπρο. 
 
Καλείστε να λάβετε μέρος σε μια ερευνητική μελέτη. Προτού αποφασίσετε πρέπει να 
καταλάβετε γιατί γίνεται η έρευνα και τι ποια θα είναι η δική σας ανάμειξη. Παρακαλώ 
αφιερώστε λίγο χρόνο για να διαβάσετε προσεκτικά τις παρακάτω πληροφορίες. Υποβάλετε 
ερωτήσεις εάν κάτι που διαβάζετε δεν είναι σαφές ή επιθυμείτε περισσότερες πληροφορίες. 
Πάρτε τον χρόνο σας για να αποφασίσετε αν θα συμμετάσχετε ή όχι.  
 
H μελέτη αυτή είναι βασισμένη σε ερωτηματολόγιο. 
 
 • Ποιος είναι ο σκοπός της μελέτης; 
Η μελέτη στοχεύει στο να διαπιστώσει ποιοι περιβαλλοντικοί παράγοντες αποτελούν 
κίνδυνο εμφάνισης Σκλήρυνσης Κατά Πλάκας στους Κύπριους. 
 
Γιατί έχω καλεστεί να συμμετάσχω; 
Έχετε επιλεγεί επειδή είστε Ελληνοκύπριος/α. Αυτή η μελέτη δεν απευθύνεται σε άτομα 
άλλων εθνικοτήτων. 
Μερικά άτομα έχουν επιλεγεί επειδή έχουν Σκλήρυνση Κατά Πλάκας. Αυτοί αποτελούν 
την ομάδα ασθενών.  
Άλλα άτομα έχουν επιλεγεί επειδή δεν έχουν Σκλήρυνση Κατά Πλάκας. Αυτοί 
αποτελούν την ομάδα «μαρτύρων». 
Οι περιβαλλοντικοί παράγοντες στους οποίους έχουν εκτεθεί τα άτομα της ομάδας 
ελέγχου, θα συγκριθούν με εκείνους των ατόμων με Σκλήρυνση Κατά Πλάκας . 
 
Πρέπει να λάβω μέρος; 
Όχι. Η συμμετοχή σας στην έρευνα είναι εντελώς εθελοντική. Εάν έχετε Σκλήρυνση Κατά 
Πλάκας, η παρούσα και η μελλοντική σας θεραπεία θα είναι αναλλοίωτη, ανεξάρτητα από 
το αν συμμετέχετε ή όχι στην μελέτη. Εάν δεν έχετε Σκλήρυνση Κατά Πλάκας, δεν θα 
επηρεαστεί οποιαδήποτε άλλη ιατρική θεραπεία που λαμβάνεται τώρα, ή που μπορεί να 
χρειαστεί να λάβετε στο μέλλον. 
 
Τι θα μου συμβεί εάν λάβω μέρος; 
Θα σας ζητηθεί να συμπληρώσετε ένα ερωτηματολόγιο που θα ρωτά για τις διατροφικές 
συνήθειες και τον τρόπο ζωής σας. 
Θα σας πάρει 10-15 λεπτά. Θα σας ζητηθεί να συμπληρώσετε τη φόρμα αυτή μόνο μία 
φορά και δεν θα επικοινωνήσουμε μαζί σας για οποιαδήποτε άλλη πληροφορία. 
 
Έξοδα και πληρωμή;  Δεν υπάρχει πληρωμή για τη μελέτη αυτή. 
 
Τι θα πρέπει να κάνω;   Να συμπληρώσετε ένα ερωτηματολόγιο.  
 
Ποια είναι τα πιθανά μειονεκτήματα και οι κίνδυνοι συμμετοχής; Δεν υπάρχουν.  
 
Ποια είναι τα πιθανά οφέλη συμμετοχής; 
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Δεν υπάρχουν άμεσα οφέλη για εσάς. Παρ ’όλα αυτά, η συμμετοχή σας θα βοηθήσει στον 
εμπλουτισμό της υφιστάμενης γνώσης για την επιδημιολογία, την παθοφυσιολογία και την 
επιβάρυνση της σκλήρυνσης κατά πλάκας στον κυπριακό πληθυσμό. Αυτό είναι κάτι που 
θα είναι εξαιρετικά χρήσιμο για την επινόηση στοχευμένων προγραμμάτων πρόληψης, τα 
οποία θα είναι πιο αποτελεσματικά και οικονομικά αποδοτικά, μειώνοντας έτσι την 
επιβάρυνση της νόσου στην κοινωνία και ταυτόχρονα εξοικονομώντας χρήματα από το 
Εθνικό Σύστημα Υγείας της Κύπρου. 
 
Τι γίνεται αν υπάρξει κάποιο πρόβλημα; Αυτό είναι απίθανο, αλλά εάν έχετε κάποια 
ανησυχία για οποιαδήποτε πτυχή αυτής της μελέτης, θα πρέπει να ζητήσετε να μιλήσετε 
με τον ερευνητή Δρ. Paul Johnson ο οποίος θα κάνει ότι μπορεί για να απαντήσει στις 
ερωτήσεις σας, ή να στείλετε ηλεκτρονικό μήνυμα στη διεύθυνση: Johnson.p@unic.ac.cy 
 
Αν μείνετε δυσαρεστημένοι και επιθυμείτε να διαμαρτυρηθείτε επίσημα μπορείτε 
απευθυνθείτε στον Δρ. Αλέξανδρο Ηρακλείδη μέσω ηλεκτρονικού ταχυδρομείου στη 
διεύθυνση: heraclides.a@unic.ac.cy 
 
Θα είναι εμπιστευτική  η συμμετοχή μου στη μελέτη; 
Όλα τα ερωτηματολόγια θα μετατραπούν σε ανώνυμα και οι συμμετέχοντες θα 
αναγνωρίζονται από έναν συγκεκριμένο αριθμό μελέτης. Μόνο ο κύριος ερευνητής θα 
έχει πρόσβαση στο όνομα του ασθενούς και οι πληροφορίες αυτές θα φυλάσσονται, 
προστατευμένες με κωδικό πρόσβασης, σε ξεχωριστό αρχείο, μόνο στον υπολογιστή του 
κύριου ερευνητή. Κανένα άλλο άτομο δεν θα μπορεί να συνδέσει ονόματα 
συμμετεχόντων με οποιαδήποτε πληροφορία που θα συλλεχθεί από το ερωτηματολόγιο. 
 
Όλες οι ηλεκτρονικές πληροφορίες (η βάση δεδομένων) του ερευνητικού έργου θα 
αποθηκευτούν με ασφάλεια σε ηλεκτρονικό αρχείο με κωδικό πρόσβασης για προστασία. 
Μόνο ο κύριος ερευνητής θα γνωρίζει τον κωδικό πρόσβασης, ο οποίος κωδικός θα 
αλλάζεται κάθε 3 μήνες. 
 
Τα συμπληρωμένα ερωτηματολόγια θα κλειδώνονται σε μια ασφαλής θυρίδα φύλαξης 
στο γραφείο του συντονιστή της μελέτης, στο Ινστιτούτο Νευρολογίας και Γενετικής 
Κύπρου, αμέσως μετά τη συλλογή των δεδομένων. Μόλις ολοκληρωθεί η μεταφορά από 
τα ερωτηματολόγια χαρτιού στην ηλεκτρονική βάση δεδομένων, όλα τα ερωτηματολόγια 
θα αποθηκευτούν με ασφάλεια σε κλειδωμένο μεταλλικό συρτάρι. Κανένα άλλο 
πρόσωπο εκτός από τον κύριο ερευνητή της μελέτης δεν θα έχει πρόσβαση σε αυτά τα 
ερωτηματολόγια. Όλοι οι ηλεκτρονικοί υπολογιστές που περιέχουν δεδομένα της 
μελέτης, θα κλειδώνονται με ασφάλεια στις εγκαταστάσεις του Ινστιτούτου Νευρολογίας 
και Γενετικής Κύπρου όταν δεν βρίσκονται σε λειτουργία. 
 
 
Όλες οι πληροφορίες που θα συλλέγονται για εσάς κατά τη διάρκεια της έρευνας θα 
διατηρούνται αυστηρά εμπιστευτικές και κάθε πληροφορία σχετικά με εσάς που εξέρχεται 
από το νοσοκομείο / χειρουργείο / πανεπιστήμιο θα έχει το όνομα και τη διεύθυνσή σας 
καταργημένα, έτσι ώστε να μην μπορεί κανείς να σας αναγνωρίσει. 
 
Τι θα συμβεί στα αποτελέσματα της ερευνητικής μελέτης; 
 
Οποιοδήποτε δημοσιευμένο υλικό θα είναι ανώνυμο, ούτως ώστε να μην μπορεί κανείς να 
σας αναγνωρίσει.  
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Ποιος διοργανώνει ή χορηγεί την έρευνα; 
Η έρευνα αυτή διοργανώνεται από τον Δρ. Paul Johnson, κύριο ερευνητή. Δεν υπάρχει 
χρηματοδότηση ή χορηγία. 
 
Η μελέτη αυτή έχει εγκριθεί από την Επιτροπή Δεοντολογίας Έρευνας της Σχολής 
Ιατρικών Επιστημών, μέρος της Επιτροπής Δεοντολογίας  Έρευνας του Newcastle 
University. Η επιτροπή αυτή περιλαμβάνει μέλη τα οποία είναι εσωτερικά της Σχολής, 
καθώς και ένα εξωτερικό μέλος. Η μελέτη αυτή εξετάστηκε από τα μέλη της επιτροπής, 
τα οποία πρέπει να παρέχουν αμερόληπτες συμβουλές και να αποφεύγουν σημαντικές 
συγκρούσεις συμφερόντων. 
 














9.1.1.3 Appendix G 1 Study Debrief Information Sheet-English 
 
STUDY DEBRIEF INFORMATION  
 
This study is a Case-Control study of Multiple sclerosis (MS) among Greek Cypriots in Cyprus.  





This is a questionnaire-based study. Multiple sclerosis is a debilitating 
disease resulting in Central Nervous System demyelination.  
 
The research questions or hypotheses "Are there risk and protective factors 
associated with the development of multiple sclerosis in the Cypriot 
population of Cyprus?"  
 
Through statistical analysis of the data recorded, it is hoped that the 
environmental risk and protective factors for acquiring MS will be 
determined. 
 
Thank you for your time.        Date……… 
 
For further information or any queries, please contact Dr Paul Johnson via 
e-mail to: 
Johnson.p@unic.ac.cy 
Appendix G 2 Study Debrief Information Sheet-Greek 
 
ΕΝΗΜΕΡΩΤΙΚΗ ΠΛΗΡΟΦΟΡΗΣΗ ΣΧΕΤΙΚΑ ΜΕ ΤΗ ΜΕΛΕΤΗ 
 
Η μελέτη αυτή είναι μια μελέτη ασθενών μαρτύρων για τη Σκλήρυνση 
Κατά Πλάκας μεταξύ Ελληνοκυπρίων στην Κύπρο. 
Η μελέτη αποσκοπεί να προσδιορίσει τους περιβαλλοντικούς παράγοντες 
που συνδέονται με τον κίνδυνο απόκτησης σκλήρυνσης κατά πλάκας 
μεταξύ των Κυπρίων. 
Η μελέτη αυτή βασίζεται σε ένα ερωτηματολόγιο.  
Η Σκλήρυνσης Κατά Πλάκας είναι μια εξουθενωτική ασθένεια που 
προκαλεί απομυελίνωση στο Κεντρικό Νευρικό Σύστημα. 
 
Το ερώτημα της ερευνητικής μελέτης είναι: "Υπάρχουν κίνδυνοι και 
προστατευτικοί παράγοντες που σχετίζονται με την ανάπτυξη σκλήρυνσης 
κατά πλάκας στον Ελληνοκυπριακό πληθυσμό της Κύπρου;  
 
Μέσω στατιστικής ανάλυσης των καταγεγραμμένων δεδομένων, ελπίζεται 
ότι θα προσδιοριστούν οι κίνδυνοι και προστατευτικοί παράγοντες που 
συμβάλλουν στην εμφάνιση Σκλήρυνσης Κατά Πλάκας.  
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Η μελέτη αυτή έχει εγκριθεί από την Επιτροπή Δεοντολογίας Έρευνας της 
Σχολής Ιατρικών Επιστημών, μέρος της Επιτροπής Δεοντολογίας  Έρευνας 
του Newcastle University. Η επιτροπή αυτή περιλαμβάνει μέλη τα οποία 
είναι εσωτερικά της Σχολής, καθώς και ένα εξωτερικό μέλος. Η μελέτη 
αυτή εξετάστηκε από τα μέλη της επιτροπής, τα οποία πρέπει να παρέχουν 
αμερόληπτες συμβουλές και να αποφεύγουν σημαντικές συγκρούσεις 
συμφερόντων.  
 
Ευχαριστώ πολύ για το χρόνο σας. 
 
Ημερομηνία ……… 
Για περισσότερες πληροφορίες ή οποιεσδήποτε απορίες, παρακαλώ όπως 
επικοινωνήσετε με τον Δρ. Paul Johnson μέσω ηλεκτρονικού 
ταχυδρομείου στη διεύθυνση: Johnson.p@unic.ac.cy 
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9.1.1.4 Appendix H The Questionnaire This section has the questionnaire in English. The 
actual questionnaire was in English and Greek. 
 
SECTION 1: DEMOGRAPHICS 
Male/Female 
Q1.1  What is your date of birth?  
Q1.2  What is your ethnicity ? Greek Cypriot Other  
Q1.3  What is the ethnicity of your mother? Greek Cypriot Other  
Q1.4  What is the ethnicity of your father? Greek Cypriot Other  
Q1.5  Which town /city were you born in?  
 
Q1.6  Which town /city do you live in now?  
 
Q1.7  What is your highest level of education?  
Left after high school, Went to Gymnasium, Went to University but not yet finished, Went to 
University and graduated  
Q1.8  What is your highest qualification ? Please circle only one answer  
 
NONE, GCSE, Apolyterium, BA/BSC  
MA/MSC /MBA PHD or similar  
 
Q1.9  What is your current marital status?  
 
A civil partner in a legally-recognised Civil Partnership, Cohabiting, Remarried (second or later 
marriage), Widowed, Divorced /legally separated,  Single/never married, Married (first and only 
marriage)  
 
Q1.10  What is the ownership status of your current accommodation?   
Owned outright by you and/or your partner, Rented from a private landlord, Rented from the 
council/ local authority, Living rent free with a relative Other  
END OF SECTION 1 
 
SECTION 2 SMOKING   
Q2.1  Do you currently smoke cigarettes, cigars, shisha water pipe?  
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Yes /No  
If NO. have you you ever smoked cigarettes, cigars, shisha water pipe?   
(i)  Have you ever smoked as much as one cigarette a day, or one cigar a week, or one ounce (25 grams) of tobacco a month?  
Yes No  
Instruction  If NO to BOTH parts of Question 2.1, please go to question 2.12  
Q2.2  Do (did) you inhale the smoke?  
Yes/ No  
If YES...   
(i)  Would you say you inhaled the smoke slightly, moderately, or deeply? (Tick one box)  
Slightly Moderately Deeply  
Q2.3  How old were you when you started smoking ? (Write age in years)  
Years  
Q2.4  Do (did) you smoke manufactured cigarettes?  
If YES...   
(i)  How many do (did) you usually smoke per day on weekdays?  
Per day  
(ii)  How many do (did) you usually smoke per day on weekends?  
Per day  
(iii)  Do (did) you usually smoke plain or filter tip cigarettes?  
Plain /Filter  
 
Q2.5  Do (did) you smoke hand-rolled cigarettes?  
Yes /No  
If YES...   
(i)  How much tobacco do (did) you usually smoke per week in this way?  
Per week  
(ii)  Do (did) you put filters in these cigarettes?  
Yes No  
Q2.6  Do (did) you smoke a shisha/water pipe?  
Yes /No  
If YES...   
(i)  How much shisha pipe tobacco do (did) you usually smoke per day?  
 
Per day  
Q2.7  Do (did) you smoke small cigars?  
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Yes /No  
If YES...   
(i)  How many of these do (did) you usually smoke per day?  
 
Per day  
Q2.8  Do (did) you smoke other cigars?  
Yes/ No  
If YES...   
(i)  How many of these do (did) you usually smoke per week?  
 
Per week  
Have you been cutting down your smoking over the past year?  
Yes /NoOR EX SMOKERS (people who smoked in the past but have given up). 2.10  
When did you give up smoking altogether? (Write age in years) 1  
Years  
1. (a)  I felt it was bad for my health  
2. (b)  I felt it was bad for the health of my family/friends  
3. (c)  It was costing too much money  
4. (d)  Pressure from my family/friends who I live with  
5. (e)  Advice from a doctor or nurse  
6. (f)  I felt it was anti-social  
7. (g)  I was not allowed to smoke at work  
How important were the following reasons for you when you gave up smoking? (Tick one box 
for each statement)  
Very Important, Important, Fairly Important, Not Important  
The following questions relate to your exposure to other people’s tobacco smoke  
Q2.12  Are you regularly exposed to tobacco smoke from other people smoking around you?  
 
Yes /No  
 
Where are you regularly exposed to tobacco smoke? (Tick all that apply)  
At work/ At home T HOME  
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How many members of your household smoke (or smoked) at home, excluding yourself?  
END OF SECTION 
SECTION 3: ALCOHOL   
Your current alcohol consumption.  
I have never drunk (or I tried drinking but didn’t pursue it) If you tick this box please go to 
section 4  
Instruction  
If you have NEVER drunk alcohol (or you tried drinking and didn’t pursue it), 
please tick the following box. Otherwise read the guidance below and answer 
the questions from Q3.1  
 
In answering this section, please use the following information for guidance:  
Never Once or twice a month More than once or twice a week, but not every day  
1. (a)  Spirits (Whisky, Gin, Rum, Brandy, Vodka, Cognac, Ouzo, Zivania )  
2. (b)  sherry, port or vermouth or Commandaria  
3. (c)  Wine (red,white, rose)  
 
One Standard Drink (One Unit) 
Half a pint or small bottle (330ml) of Beer/Cider/Lager Half a can or half 660ml bottle of 
Beer/Cider/Lager small glass (1 x 125ml) of wine, Martini or Cinzano  
Half a large glass (1⁄2 x 250ml) of wine, Martini or Cinzano Half a small glass (1⁄2 x 125ml) of 
Sherry or Port  
1 pub measure (1 x 25ml) of Spirits (gin, whisky, vodka etc.) 1 pub measure (1 x 25ml) of liqueur  
 
 
Q3.1  How often do you typically have a drink containing alcohol?)  
Once or twice a week Every day  
Glasses per week  
 
Q3.2  In a typical 7-day week, including the weekend, how many glasses of the following do you usually have? (Write in number using the information above for guidance)  
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Q3.3  Maximum number of glasses you would drink per day  
 
1. (a)  Spirits (Whisky, Gin, Rum, Brandy, Vodka, Cognac, Ouzo, Zivania )  
2. (b)  Wine, sherry, port or vermouth or Commandaria  
3. (c)  Beer, lager, or cider 
4. (d) Beer, cider   
Glasses 
Q3.4  How much alcohol would you say that you now drink, compared to earlier in your adult life? (Tick one box)  
More than I used to Less than I used to  
How much wine do you drink per week?  
1. (a)  Red wine  
2. (b)  White wine  
3. (c) Rose  
How long have you been drinking wine?  
About the same 
I no longer drink alcohol 5  
36                                                END OF SECTION 3EF SECTION  
SECTION 4: DIET   
Your diet during the LAST YEAR.  
Q4.1  Did you eat any meat or fish in the last 12 months?  
Yes/ No . If no go to Question 4.5  
Q4.2  What did you do with the visible fat on your meat? (Tick one box)  
Ate most of the fat, Ate some of the fat, Ate as little as possible  
Q4.3  How often did you typically eat grilled or roast meat? (Write in average frequency, either per week or per month, in one of the spaces provided)  
 
Times per week OR Times per month  
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Well done / dark brown Lightly cooked / rare  
 
Q4.4  How well cooked did you usually have grilled or roast meat? (Tick one box)  
Medium 
Did not eat meat Q4.5  
Consumption of meat and fish during the last year.  
Meat and Fish  
(Medium Serving)  
1. (a)  Beef: roast, steak, mince, stew or casserole  
2. (b)  Beef burgers  
3. (c)  Pork: roast, chops, stew or slices  
4. (d)  Lamb: roast, chops or stew  
5. (e)  Chicken or other poultry e.g. turkey  
6. (f)  Bacon  
7. (g)  Ham  
8. (h)  Corned beef, Spam, luncheon meats  
9. (i)  Sausages  
10. (j)  Savoury pies, e.g. meat pie, pork pie, pasties, steak & kidney pie, sausage rolls  
11. (k)  Liver, liver pate, liver sausage  
12. (l)  Fried fish in batter, as in fish and chips  
13. (m)  Fish fingers, fish cakes  
14. (n)  Other white fish, fresh or frozen, e.g. cod, haddock, plaice, sole, halibut  
15. (o)  Oily fish, fresh or canned, e.g. mackerel, kippers, tuna, salmon, sardines, herring  
16. (p)  Shellfish, e.g. crab, prawns, mussels  
17. (q)  Fish roe, taramasalata  
Q Average use last year 4.6  
Never or < 1 a month, 1 - 3 x a month, 1 per week, 2 - 4 x per week, 5 - 6 x a week, daily, 2 - 3 x a day, 4 - 
5 x a day, 6 + a day  
Consumption of bread and savoury biscuits during the last year. 
Average use last year  
Bread and Savoury Biscuits  
(One slice or one biscuit)  
1. (a)  White bread and rolls  
2. (b)  Whole meal bread and rolls  
3. (c) Cream crackers, cheese biscuits ( 
4. d) Crispbread, e.g. Ryvita  
0 or < 1 - 3 a month, 1 a month, 1 a week, 2 -4 a week, 5 - 6 x a week, daily, 2 -3 x a day, 4 - 5 x a day, 6 + 
a day  
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Q4.7  Consumption of breakfast cereals during the last year.  
Breakfast Cereals  
(One bowl)  
1. (a)  Oat-based cereals such as porridge, mueseli and Readybrek  
2. (b)  Refined breakfast cereal such as Cornflakes, Rice Crispies, Frosties  
3. (c)  Whole-grained breakfast cereal such as Shredded Wheat, Cherios,Weetabix,Wheat Flakes  
Average use last year  
0 < 1 a month, 1 - 3 x a month, 1 a week, 2 - 4 x a week, 5 - 6 x a week, daily, 2 - 3 x a day, 4 - 5 x a day, 6 
+ a day  
Write below the top three breakfast cereals you normally consume.  
 
 
Q4.8  Please estimate your average consumption of potatoes, rice and pasta during the last year, taking care to complete every line. (Complete every line - tick one box per line)  
Potatoes, Rice and Pasta  
(Medium Serving)  
1. (a)  Boiled, mashed, instant, or jacket potatoes  
2. (b)  Chips  
3. (c)  Roast potatoes  
4. (d)  Potato salad  
5. (e)  White rice  
6. (f)  Brown rice  
7. (g)  White or green pasta, e.g. spaghetti, macaroni, noodles  
8. (h)  Wholemeal pasta  
9. (i)  Lasagne, moussaka  
10. (j)  Pizza  
Average use last year  
0 < 1 a month, 1 - 3 x a month, 1 a week, 2 - 4 x a week, 5 - 6 x a week, daily, 2 - 3 x a day, 4 - 5 x a day, 6 
+ a day  
Average consumption of dairy products and fats during the last year. 
Average use last year  
Diary Products and Fats  
(Serving Size in Brackets)  
1. (a)  Single or sour cream (tablespoon)  
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2. (b)  Double or clotted cream (tablespoon)  
3. (c)  Low fat yoghurt, fromage frais (125g carton)  
4. (d)  Full fat or Greek yoghurt (125g carton)  
5. (e)  Daily Desserts, e.g. chocolate mousse (125g carton)  
6. (f)  Cheese, e.g. Halloumi, Cheddar, Brie, Edam (medium serving)  
7. (g)  Eggs as boiled, fried, scrambled, etc. (one)  
8. (h)  Quiche (medium serving)  
9. (i)  Low calorie, low fat salad cream (tablespoon)  
10. (j)  French dressing (tablespoon)  
11. (k)  Other salad dressing (tablespoon)  
The following on bread or vegetables  
(Teaspoons)  
1. (a)  Butter  
2. (b)  Block margarine, e.g. Stork  
3. (c)  Polyunsaturated or olive oil margarine (tub), e.g. Flora, Vitalite, Bertolli  
4. (d)  Other soft margarine / dairy spread (tub), e.g. Clover, Utterly Butterly  
5. (e)  Low fat spread (tub), e.g. Flora light, Flora Proactive, Bertolli light  
6. (f)  Very low fat spread (tub), e.g. Flora proactiv extra light  
0 or < 1 a month, 1-3 x a month, 2 - 4 x a week, 5 - 6 x a week, 1 a week, daily, 2 - 3 x a day, 4 -5 x a day, 6 
+a day  
Q4.10  Average consumption of the following fats (spread onto bread or vegetables) during the last year.  
Average use last year  
0 or < 1 a month, 1-3 x a month, 2 - 4 x a week, 5 - 6 x a week, 1 a week, daily, 2 - 3 x a day, 4 -5 x a day, 6 
+a day   
Q4.11  Consumption of fruit during the last year.  
Fruits  
(1 Fruit or Medium Serving)  
For seasonal fruits such as strawberries, please estimate your average consumption when the fruit is in 
season  
1. (a)  Apples  
2. (b)  Pears  
3. (c)  Oranges, satsumas, mandarins  
4. (d)  Grapefruit, pomelo  
5. (e)  Bananas  
6. (f)  Grapes  
7. (g)  Melon, water melon  
8. (h)  Peaches, plums, apricots  
9. (i)  Strawberries, raspberries, kiwi fruit  
10. (j)  Tinned fruit  
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11. (k)  Dried fruit, e.g. raisins, prunes, dates, figs  
Average use last year  
0 or < 1 a month, 1-3 x a month, 2 - 4 x a week, 5 - 6 x a week, 1 a week, daily, 2 - 3 x a day, 4 -5 x a day, 6 
+a day  
 
Q4.12  Consumption of vegetables (fresh, frozen, or tinned) during the last year.  
Vegetables—Fresh, frozen or tinned  
(Medium Serving)  
1. (a)  Carrots  
2. (b)  Spinach  
3. (c)  Broccoli, spring greens, kale  
4. (d)  Brussels sprouts  
5. (e)  Cabbage  
6. (f)  Peas  
7. (g)  Capers  
8. (h)  Marrow, courgettes, cucumber  
9. (i)  Cauliflower  
Average use last year  
0 or < 1 a month, 1-3 x a month, 2 - 4 x a week, 5 - 6 x a week, 1 a week, daily, 2 - 3 x a day, 4 -5 x a day, 6 
+a day  
Vegetables—Fresh, frozen or tinned  
(Medium Serving)  
10. (j)  Parsnips, turnips, Swedes  
11. (k)  Leeks  
12. (l)  Onions  
13. (m)  Garlic  
14. (n)  Mushrooms  
15. (o)  Sweet peppers  
16. (p)  Beansprouts  
17. (q)  Green salad, lettuce, cucumber, celery  
18. (r)  Watercress  
19. (s)  Tomatoes  
20. (t)  Sweetcorn  
21. (u)  Beetroot  
22. (v)  Coleslaw  
23. (w)  Avocado  
24. (x)  Baked Beans  
25. (y)  Dried/tinned lentils, beans, green beans, broad beans, runner beans, black-eyed peas, Fava 
beans  
26. (z)  Tofu, soya meat, TVP, Veggie-burger  
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Average use last year 
0 or < 1 a month, 1-3 x a month, 2 - 4 x a week, 5 - 6 x a week, 1 a week, daily, 2 - 3 x a day, 4 -5 x a day, 6 
+a day   
Q4.13  What kind of fat did you most often use for frying, roasting, grilling etc? (Tick one box)  
Butter  
Margarine / dairy spread  
Solid vegetable fat  
Vegetable /sunflower oil  
Olive oil  
None  
If Olive OIL...  
 
(i)  
(i) What type of Olive oil did you use? E.g. extra virgin, home pressed, etc  
 
Q4.14  What kind of fat did you most often use for baking cakes? (Tick one box)  
Butter 
Margarine / dairy spread  
Solid vegetable fat Vegetable oil  
Lard/dripping None  
Q4.15  How often did you typically eat food that was fried at home? (Tick one box)  
Daily, < 1 a week, Rarely, 4-6 x a week, Never, 1-3 x a week  
Q4.16  How often did you typically eat food that was fried away from home? For example, at someone else’s home, a takeaway, or at a restaurant?   
 
Q4.17  How often did you (or whoever usually cooked for you at home) typically add salt to food while cooking?   
 
Q4.18  How often did you typically add salt to any food at the table?  
 
Q4.19  Did you regularly use a salt substitute (e.g. LoSalt)?  
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Brand of salt substitute used?  
Q4.20  
Have you taken any vitamins, minerals, fish oils, fibre or other food supplements during 
the past year?  
  
Yes /No /Don’t Know 
Please list any supplements taken, during the last year eg Vitamin D, Vitamin C, Cod-liver Oil, 
Omega 3,  
 (a) (b) (c) (d) (e)  
Name of Supplement  
Dose  
(State number of pills, capsules, or teaspoons consumed)  
Frequency of consumption (Tick one)  
0 or < 1 a month, 1-3 x a month, 2 - 4 x a week, 5 - 6 x a week, 1 a week, daily, 2 - 3 x a day, 4 -5 x a day, 6 
+a day  
 
Q4.22  Please list below any foods you avoid and state why.  
Q4.23  Please list below any foods you eat more of to help a medical condition and state why?  
Q4.24  Have you ever had any specific dietary advice? If yes state from whom?  
Yes /No  
Q4.25  Please list below any herbs or herbal remedies taken during the last year eg St. John's wort (Hypericum perforatum) Ginkgo (Ginkgo biloba). Saw palmetto (Serenoa repens) Ginseng etc  
 (a) (b) (c) (d) (e)  
SOUVLAKI AND SOUVLA  
Q4.26  -SOUVLAKI AND SOUVLA during the last year.  
Souvlaki  
Frequency of consumption (Tick one) 
or < 1 a month, 1-3 x a month, 2 - 4 x a week, 5 - 6 x a week, 1 a week, daily, 2 - 3 x a day, 4 -5 x a day, 6 
+a day  
Amount (weight in grams)  
Souvla  
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Other Charcoal grilled meat  
Charcoal grilled vegetables  
Charcoal grilled fish  
 
 How often do you consume organic foods? Never/ Rarely /Often /All the time  
                         End of Section 4  
SECTION 5: GENERAL HEALTH WEIGHT HEIGHT  
Q5.1  What is your current height without shoes .  
Metres  
Q5.2  What is your current weight without shoes or clothes.  
Kilograms 
Q5.3  In the last year have you tried to lose weight but were unable to do so? Yes/No  
 
End of Section 5 
 
 
